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 Subarachnoid hemorrhage (SAH) following cerebral aneurysm rupture is 
associated with substantial morbidity and mortality.  The ability of SAH to induce 
vasospasm in large diameter pial arteries has been extensively studied, although the 
contribution of this phenomenon to patient outcome is unclear.  Conversely, little is 
known regarding the impact of SAH on intracerebral (parenchymal) arterioles, which are 
critical for regulation of cerebral blood flow.  To assess the function of parenchymal 





membrane potential were performed in intact arterioles from unoperated (control), sham-
operated and SAH model rats.  At physiological intravascular pressure, parenchymal 
arterioles from SAH animals exhibited significantly elevated [Ca
2+
]i and enhanced 
constriction compared with arterioles from control and sham-operated animals.  Elevated 
[Ca
2+
]i and enhanced tone following SAH were observed in the absence of vascular 
endothelium and were abolished by the L-type voltage-dependent Ca
2+
 channel (VDCC) 
inhibitor nimodipine.  Molecular assessment of the L-type VDCC CaV1.2 indicated 
unchanged mRNA and protein expression in arterioles from SAH animals.  Increased 
CaV1.2 activity following SAH may also reflect enhanced pressure-induced membrane 
potential depolarization of arteriolar smooth muscle.  Membrane potential measurements 
in arteriolar myocytes using intracellular microelectrodes revealed approximately 7 mV 
depolarization at 40 mmHg in myocytes from SAH animals.  Further, when membrane 
potential was adjusted to similar values, arteriolar [Ca
2+
]i and tone were similar between 
groups.  These results demonstrate that greater pressure-dependent membrane potential 
depolarization results in increased activity of CaV1.2 channels, elevated [Ca
2+
]i and 
enhanced constriction of parenchymal arterioles from SAH animals.  Thus, impaired 
regulation of parenchymal arteriolar [Ca
2+
]i and diameter may restrict cerebral blood flow 
in SAH patients. 
 
 Although nimodipine is used clinically to prevent delayed neurological deficits 
in SAH patients, the use of this drug has been limited by hypotension and treatment 
options remain inadequate.  Therefore, our next objective was to explore strategies to 
selectively suppress CaV1.2 channels in the cerebral vasculature.  To do so, we examined 
the physiological role of smooth muscle CaV1.2 splice variants containing the 
alternatively-spliced exon 9* in cerebral artery constriction.  Using antisense 
oligonucleotides, we demonstrate that suppression of exon 9*-containing CaV1.2 splice 
variants results in substantially reduced cerebral artery constriction to elevated 
extracellular [K
+
].  In addition, no further reduction in constriction was observed 
following suppression of all Cav1.2 splice variants, suggesting that exon 9* splice 
variants are functionally dominant in cerebral artery constriction.  In summary, results 
shown in this dissertation demonstrate that increased CaV1.2 activity following SAH 
results in enhanced constriction of parenchymal arterioles.  Furthermore, evidence is 
provided supporting the concept that CaV1.2 splice variants with exon 9* are critical for 
cerebral artery constriction and may provide a novel target for the prevention of delayed 
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Maintenance of adequate blood flow to the brain is essential for human life.  Insufficient 
delivery of oxygen and glucose to metabolically active regions of the brain quickly 
results in neuronal necrosis, neurological impairment and death. Therefore, the function 
of small diameter cerebral arteries and arterioles, which control blood flow, is highly 
regulated.  Following intracranial aneurysm rupture and subarachnoid hemorrhage 
(SAH), mechanisms mediating cerebral artery diameter may become compromised, 
leading to enhanced vasoconstriction and reduced blood flow.  Consequently, ischemia 
leads to further morbidity and mortality in a large number of patients surviving the initial 
intracranial bleed (Kassell et al., 1985).  The complex mechanisms involved in arterial 
narrowing and reduced blood flow associated with SAH are not well understood, but may 
involve enhanced contraction of vascular smooth muscle. 





]i), representing averaged Ca
2+
 throughout the cell.  In the 
vasculature, smooth muscle [Ca
2+
]i is largely determined by membrane potential and the 
degree of Ca
2+
 influx via plasmalemmal L-type voltage-dependent Ca
2+
 channels 
(VDCCs).  The L-type VDCC α1 pore-forming subunit in vascular smooth muscle is a 
splice variant of the gene CaV1.2, which also encodes cardiac muscle and neuronal 
VDCCs.  Although the molecular identity of L-type VDCCs involved in cerebral artery 
constriction is not known, evidence suggests that these channels may be more active 
following SAH, leading to elevation of smooth muscle [Ca
2+
]i and enhanced 
vasoconstriction (Faraci and Heistad, 1998; Wellman, 2006).  Given their relevance in 
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cerebrovascular physiology, understanding the function of L-type VDCCs in cerebral 
artery myocytes is critical for improvement of therapeutic strategies preventing reduced 
cerebral blood flow following SAH.  
This literature review will provide an overview of the regulation of 
cerebrovascular tone in both normal conditions and in pathological conditions following 
SAH.  Part one will discuss mechanisms involved in vascular smooth muscle contraction, 
with a focus on the role of intracellular Ca
2+
 and L-type VDCCs.  Part two will discuss 
prominent pathways involved in enhanced arterial constriction following SAH.  In 
addition, this section will also review emerging evidence in support of SAH-induced 
dysfunction of the cerebral microcirculation.   
 
Part 1: Cerebrovascular physiology 
 
General anatomy of the cerebral arterial blood supply 
Blood is supplied to the human brain by two vertebral arteries and two internal carotid 
arteries.  The vertebral arteries enter the skull through the foramen magnum and converge 
to form the basilar artery on the ventral brain stem.  The internal carotid arteries enter 
through the base of the skull and join the basilar artery to form an arterial circle on the 
base of the brain called the Circle of Willis (Figure 1).  The unique anatomic structure of 
the Circle of Willis functions to provide collateral blood supply to the entire brain in the 
event of occlusion of any of the arteries contributing to the circle. 
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 Three major pairs of arteries supply blood to the cerebral hemispheres.  The 
anterior cerebral arteries (ACA) arise from the internal carotid arteries at the Circle of 
Willis and supply the most medial portions of the frontal and parietal lobes.  The major 
branches supplying the majority of the lateral hemispheres are the middle cerebral 
arteries (MCA).  The posterior cerebral arteries extend from the intersection of the 
posterior communicating and basilar arteries and supply the inferior and medial regions 
of the temporal and occipital lobes.  Each major cerebral artery divides to form a highly 
interconnected grid of surface or “pial” arteries and arterioles.  It has been shown that 
occlusion of a pial cerebral artery leads to only modest decreases in downstream blood 
flow due to the reversal of flow in downstream communicating arterioles (Schaffer et al., 
2006).  Therefore, redundant connections among pial arteries and arterioles may also 
provide a source of collateral blood flow following arterial occlusion. 
Penetrating arterioles arise from pial arteries and arterioles and enter the brain 
parenchyma.  The penetrating arterioles are surrounded by an invagination of the pia 
mater, called the Virchow-Robin space, which is continuous with the subarachnoid space 
(Figure 2).  Downstream of penetrating arterioles and the Virchow-Robin space are 
intracerebral or parenchymal arterioles.  Whereas an interconnected arterial network 
exists in pial arteries on the surface of the brain, limited collateral flow exists between 
penetrating and parenchymal arterioles (Nishimura et al., 2007).  Hence, thrombosis in 
penetrating arterioles results in greatly diminished downstream flow (Nishimura et al., 
2007) suggesting that ischemia may be most severe following enhanced constriction or 
occlusion of these vessels.   
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Also distinguishing the parenchymal arterioles from pial vessels is a lack extrinsic 
perivascular innervation (Cipolla et al., 2004; Handa et al., 1990).  Consistent with this, 
parenchymal arterioles do not respond to the neurotransmitters norepinephrine or 
serotonin, which are potent vasoconstrictors in pial vessels (Cipolla et al., 2004).  In 
addition, parenchymal arterioles are almost completely encased by astrocytic endfeet and 
are essential for coupling neuronal activity to local blood flow (“functional hyperemia”) 
(Filosa et al., 2006; Iadecola and Nedergaard, 2007).  Thus, parenchymal arterioles 
operate in a unique environment and are functionally distinct from pial vessels on the 
brain surface.    
 
Control of cerebral blood flow: cerebrovascular resistance 
Blood moves through the circulatory system from regions of high pressure (i.e. aorta) to 
regions of low pressure (i.e. capillaries) (Silverthorn, 2004).  As this pressure gradient 
(ΔP) increases, blood flow also increases.  On the other hand, blood flow is opposed by 
vascular resistance.  Hence, blood flow is directly proportional to ΔP, and inversely 
proportional to vascular resistance (R): 
Flow  ΔP/R 
Resistance is a function of length (L) and radius (r) of the vessel as well as the viscosity 
(η) of the fluid moving through the vessel.  Accordingly, resistance can be expressed by 




Because the length of the circulatory system and blood viscosity are essentially constant, 
this equation may also be expressed as:  
R 1/r4 
This equation states that vascular resistance is inversely proportional to radius to the 
fourth power.  In an example, a 20 percent decrease in arterial diameter will cause greater 
than 50 percent reduction in blood flow.  Thus, arterial diameter is a major determinant of 
vascular resistance and small changes in diameter can have profound effects on blood 
flow and organ perfusion. 
 
Cerebral autoregulation and Ca
2+
-dependence of vascular tone 
To maintain a constant level of blood flow to the brain during fluctuations in blood 
pressure, the cerebral resistance vasculature constricts when intravascular pressure 
increases and dilates when pressure is reduced.  The phenomenon of arterial constriction 
in response to increases in intravascular pressure, or “myogenic tone” was first described 
by Bayliss in 1902 (Bayliss, 1902).  Constrictions to increases in intravascular pressure 
were found to be independent of neurogenic, humoral or endothelial influences (Falcone 
et al., 1991; Knot and Nelson, 1995; McCarron et al., 1989).  Thus, myogenic tone is an 
intrinsic characteristic of vascular smooth muscle within the arterial wall.  It is now 
established that increasing intravascular pressure in the physiological range leads to 
membrane potential depolarization of vascular smooth muscle, activation of voltage-
dependent Ca
2+
 channels (VDCCs), a rise in [Ca
2+
]i and contraction of vascular smooth 
muscle (Brayden and Wellman, 1989; Harder, 1984; Knot and Nelson, 1998).  In the 
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cerebral circulation, the degree of pressure-dependent constriction varies with diameter 
and is more prominent in small diameter arteries and arterioles (Thorin-Trescases et al., 
1997).   In addition, this physiological response to pressure is thought to maintain vessels 
in a partially constricted state in vivo (Meininger and Davis, 1992), allowing various 
vasoactive factors to increase or decrease arterial diameter and blood flow depending on 
the metabolic demands of the brain.   
 
Initiation of Smooth muscle contraction: Vascular smooth muscle contraction is a Ca
2+
-
dependent process.  The first step in excitation-contraction coupling in arterial myocytes 
is a rise in [Ca
2+
]i and activation of the ubiquitous Ca
2+
-binding protein calmodulin 
(CaM) (Figure 3).  Upon binding Ca
2+
 at two EF hand motifs on the N- and C-termini 
(Gifford et al., 2007), CaM undergoes a conformational change that allows it to interact 
with numerous proteins, including myosin light chain kinase (Walsh, 1981).  CaM-
dependent activation of myosin light chain kinase leads to a subsequent increase in 
phosphorylation at serine-19 on the 20 kDa regulatory myosin light chain protein 
(Kamisoyama et al., 1994).  This phosphorylation event induces a conformational change 
in the myosin molecule which enhances myosin ATPase activity, actin binding and cross-
bridge cycling (Chacko et al., 1977).  Shortening of the contractile filaments results in 
force generation or increased muscle tension (Hai and Murphy, 1989).  An increase in 
crossbridge cycling and contraction may also result from an increase in the sensitivity of 
the contractile machinery to intracellular Ca
2+
.  For example, the regulatory proteins 
caldesmon and calponin tonically inhibit myosin ATPase activity in smooth muscle 
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(Horowitz et al., 1996).  This inhibition is relieved by phosphorylation and leads to 
increased smooth muscle contraction and vascular tone independent of increases in 
[Ca
2+
]i (Horowitz et al., 1996; Mino et al., 1995).   
Relaxation of smooth muscle is triggered by a decrease in [Ca
2+
]i and 
dephosphorylation of myosin light chain at serine-19 by myosin light chain phosphatase 
(Murphy, 1982).  Ca
2+
 ions are extruded from the cytoplasm by the plasmalemmal Ca
2+
 




 exchanger, and sequestered into the SR by the sarco-
/endoplasmic reticulum Ca
2+
-ATPase (SERCA) (Floyd and Wray, 2007).  PMCA and 
SERCA both use energy from the hydrolysis of ATP to transport Ca
2+
 ions against a 




 exchanger uses the electrochemical 
gradient for Na
+




 ATPase, to transport a single Ca
2+
 
ion out of the cell in exchange for three Na
+
 ions into the cell (Blaustein and Lederer, 
1999).  Therefore, arterial myocytes expend energy in the form of ATP hydrolysis in 
order to maintain cytosolic Ca
2+
 at low concentrations relative to extracellular levels.  
Previous work using the ratiometric Ca
2+
-sensitive fluorescent dye fura-2 estimates that 
smooth muscle [Ca
2+
]i of fully dilated middle cerebral arteries is ~50-100 nM (Knot and 
Nelson, 1998).  Further, the Ca
2+
 sensitivity of arterial diameter was found to be 1 µm/ 
nM [Ca
2+
]i with the entire range of arterial diameters associated with a change in arterial 
wall Ca
2+
 of approximately 250 nM (Knot and Nelson, 1998).  Thus, [Ca
2+
]i in vascular 
smooth muscle is tightly regulated and small changes in the cytosolic concentration of 




Regulation of vascular smooth muscle [Ca
2+




Calcium ions enter the cytosol of vascular smooth muscle predominantly via voltage-
dependent calcium channels (VDCCs) in the plasma membrane and Ca
2+
 release channels 
in the sarcoplasmic reticulum.  Thus, [Ca
2+
]i in cerebral artery myocytes is determined by 
the steady-state balance between Ca
2+
 influx from the extracellular fluid or intracellular 
stores and Ca
2+
 extrusion from the cytoplasm or SR sequestration.  In cerebrovascular 
smooth muscle, Ca
2+
 influx via VDCCs is the major pathway by which [Ca
2+
]i increases 
for initiation of contraction (Brayden and Wellman, 1989; Knot and Nelson, 1998; 
Nelson et al., 1990; Nelson et al., 1988).  Blocking VDCCs with the selective L-type 
VDCC antagonist nisoldipine reduces [Ca
2+
]i to resting levels and abolishes pressure-
induced constrictions (Figure 3), essentially uncoupling the relationship between 
membrane potential and arterial diameter (Knot and Nelson, 1998).  Thus, in cerebral 
artery myocytes, [Ca
2+
]i is largely determined by the activity of dihydropyridine-sensitive 
L-type VDCCs.  Further, many vasoactive factors exert their effects on arterial diameter 
and cerebral blood flow by directly altering VDCC gating or by changing membrane 
potential (Nelson et al., 1988; Worley et al., 1991).  This section will review the basic 
structural, electrophysiological and pharmacological properties of VDCCs with a focus 
on L-type VDCCs encoded by Cav1.2.   
 
Structure: In 1984, Curtis and Catterall first purified voltage-dependent Ca
2+
 channels 
from skeletal muscle transverse tubule membranes (Curtis and Catterall, 1984).  It was 
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found that these channels were heterooligomeric complexes comprised of a pore-forming 
α1 subunit in association with accessory β, α2-δ, and γ subunits (Catterall, 2000; Curtis 
and Catterall, 1984).  It is now known that the α1 subunit confers most functional 
properties of the channel including voltage sensitivity, Ca
2+
 permeability, sensitivity to 
pharmacological activators and inhibitors, and Ca
2+
-dependent inactivation (Catterall, 
2000).  Ten distinct α1 subunits have been described: CaV1.1-1.4 (“L-type”), CaV2.1-2.2 
(“P- or Q-type”), CaV2.3 (“R-type”), and CaV3.1-3.3 (“T-type”).  The α1 proteins (~2000 
amino acids; ~190-240 kDa) consist of four repeat domains (I-IV), each containing six 
transmembrane segments (S1-S6) (Tanabe et al., 1987).  The S4 transmembrane 
segments each contain positively charged arginine and lysine residues and confer voltage 
sensitivity to the channel.  These segments rotate and move outward in response to 
membrane depolarization, inducing a conformational change which opens the pore 
(Tanabe et al., 1987; Yamaguchi et al., 1999).  In addition to cytoplasmic N- and C- 
termini, domains I-IV are connected in tandem by intracellular linker regions.  The C-
terminus, which contains sites of interaction for cAMP-dependent protein kinase (PKA) 
and A-kinase anchoring protein (AKAP15), is proteolytically cleaved in vivo (De Jongh 
et al., 1996; Hulme et al., 2003).  Although the functional importance of this post-
translational modification is currently unclear, one report suggests that the cleaved C-
terminal portion may remain associated with the remainder of the α1 subunit to regulate 
channel function by formation of an autoinhibitory complex (Hulme et al., 2006). 
Although α1 subunit expression is sufficient to produce functional VDCCs, 
abnormal expression, kinetics and voltage-dependence of Ca
2+
 currents are observed in 
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the absence of auxiliary subunits.  Non-covalent association between the α1 and cytosolic 
β subunit appears to be most important in the modulation of VDCC expression and 
function.  The four known β subunits (β1-4) belong to the membrane-associated guanylate 
kinase (MAGUK) family of scaffolding proteins and consist of two conserved central 
alpha helix domains flanked by subtype-specific N- and C- termini (Cohen et al., 2005).  
The guanylate kinase (GK) region of the β interactive domain (BID) is required for high 
affinity interaction with the alpha interactive domain (Maeda et al.) within the I-II 
intracellular linker of the α1 subunit (Pragnell et al., 1994).  Coexpression of α1 and β 
subunits leads to significantly increased transmembrane currents and causes channel 
activation and inactivation at more negative membrane potentials (Kamp et al., 1996).  It 
is thought that this modulation of channel function may reflect both increased insertion of 
the α1 subunit in the plasma membrane as well as a conformational change in the α1 
subunit upon binding the β subunit (Chien et al., 1995; Kamp et al., 1996).  Protein for 
both β2 and β3 has been reported in the vasculature (Hullin et al., 1992; Murakami et al., 
2003).  Aortic myocytes from mice lacking the β3 subunit exhibited significantly reduced 
Ca
2+
 currents (Murakami et al., 2003).  It was proposed that residual Ca
2+
 currents after 
β3 gene ablation may represent a redundant role for the β2 subunit in channel trafficking 
and gating.  Altered channel function by β subunits may represent an important means of 
integration of intracellular signals to alter Ca
2+ influx.  For example, β subunits contain 
conserved sites for PKA-mediated phosphorylation (Puri et al., 1997).  In cardiac muscle, 





currents may be partially due to phorphorylation of the β2a subunit at serine 478 and 
serine 479 (Bunemann et al., 1999).    
While the expression profile and functional role of VDCC γ subunits in vascular 
smooth muscle remain unclear (Sonkusare et al., 2006), the importance of the α2δ subunit 
has recently been evaluated.  Four genes encoding α2δ subunits have been cloned (α2δ1-
4) (Davies et al., 2007).  Each α2δ protein (~170 kDa) is the product of a single gene 
which undergoes proteolytic cleavage and reassociates via a disulfide bond as an 
extracellular α2 and transmembrane δ (Takahashi et al., 1987).  One recent study found 
that suppression of membrane bound α2δ-1 subunits in myocytes from resistance-sized 
cerebral arteries inhibits membrane insertion of α1 subunits, decreases CaV1.2 currents 
and causes prolonged vasodilation (Bannister et al., 2009).  Interestingly, it was 
discovered that a class of drugs used to treat neuropathic pain, the gabapentenoids (i.e. 
pregabalin), exert their effects through binding VDCC α2δ-1 and α2δ-2 subunits (Bian et 
al., 2006).  Hence, α2δ subunits may also play an important role in the functionality of 
neuronal L-type VDCCs in addition to smooth muscle channels. 
 
Physiological and Pharmacological Properties: VDCCs switch between open conducting 
states to closed nonconducting states.  As membrane potential becomes more positive, the 
amount of time spent in the open state, or open-state probability (Popen), increases.  In 
vivo membrane potential of resistance artery myocytes (-55 to -40 mV) (Neild and Keef, 
1985) is within the range in which the opening of L-type VDCCs is steeply voltage-
dependent (Nelson et al., 1988).  For example, at membrane potentials negative to -40 
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mV, VDCC activation is an exponential function of membrane potential with an 
approximately e-fold increase in Popen per 8.5 mV depolarization (Figure 5) (Nelson et al., 
1990).  At membrane potentials positive to -40 mV, increases in Popen are opposed by 
long-term channel inactivation, which is both voltage- and Ca
2+
-dependent.  Thus, Popen 
can be expressed by (Nelson et al., 1990): 
Popen=(Pact)(1-Pinact)(Pfunct) 
where Pact is Popen in the absence of inactivation, 1-Pinact is the probability of the channel 
not being in the inactivated state and Pfunct is the probability that the channel is functional.  
It has been estimated that each cerebral artery myocyte has approximately 5000 
functional channels (Rubart et al., 1996).  Each channel has a measured conductance of 3 
to 5 pS and can produce currents of 0.1 to 0.3 pA at 2 mM Ca
2+
 and physiological 
membrane potentials (Gollasch et al., 1992; Rubart et al., 1996).  It has been shown that a 
depolarization from -40 mV to -20 mV causes approximately four-fold increase in 
steady-state Ca
2+
 current, which is capable of raising [Ca
2+
]i 1.3 µM/second in the 
absence of Ca
2+
 buffering and sequestration (Rubart et al., 1996).  Thus, altering 
membrane potential can lead to substantial changes in the rate of Ca
2+
 influx in arterial 
smooth muscle.   
Since Ca
2+
 currents were first recorded in cardiac myocytes (Reuter, 1979), multiple 
types of Ca
2+
 channels have been categorized by physiological as well as 
pharmacological characteristics (Catterall, 2000).  In addition to their high voltage-
dependent activation and slow voltage-dependent inactivation, L-type VDCCs can be 
defined pharmacologically by sensitivity to selective Ca
2+
 channel antagonists including 
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dihydropyridines, phenylalkylamines, and benzothiazepines (Catterall, 2000; Reuter, 
1983).  Inhibition by dihydropyridine compounds is state-dependent and VDCCs become 
more sensitive to these compounds as membrane potential is more depolarized 
(Sanguinetti and Kass, 1984).  The binding sites for L-type VDCC antagonists are located 
on the α1 subunit and binding locks the channel in the inactive or closed state (Williams 
and Tremble, 1982).  Given the critical role of L-type VDCCs in cardiovascular function, 
L-type VDCC antagonists are an important therapeutic option in the treatment of a 
variety of disorders including several types of arrhythmia, hypertension, and angina 
pectoris. 
 Several other VDCC subtypes have been reported in the vasculature including a 
low-voltage activated (T-type; CaV3) (Nikitina et al., 2007), ω-agatoxin IVA-sensitive 
(P/Q; CaV2.1) (Hansen et al., 2000), and a nifedipine-resistant high-voltage activated 
Ca
2+
 channel (Itonaga et al., 2002; Morita et al., 1999).  However, as dihydropyridine 
compounds completely abolish pressure-induced as well as agonist-induced cerebral 
artery constriction (Gokina et al., 1999; Knot and Nelson, 1998), L-type VDCCs are 
widely accepted as the major route of Ca
2+
 influx in arterial smooth muscle. 
 
Alternative splicing of mRNA encoding CaV1.2: In addition to vascular smooth muscle 
contraction, CaV1.2 channels play a critical role in numerous physiological processes 
such as cardiac muscle contraction, neurotransmitter release, gene expression and 
hormone secretion.  Transcript scanning of the human CaV1.2 gene indicated that 19 of 
the 55 exons comprising the channel are subject to alternative splicing, suggesting that 
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structural diversity among tissue-selective splice variants may account for functional 
distinctions between cell types (Tang et al., 2004).  The 40 identified splice variations at 
12 splice loci of CaV1.2 are shown in Figure 6 (Liao et al., 2005).   
The essential role of L-type VDCCs in cardiovascular function has been 
demonstrated by embryonic fatality in homozygous knockout mice lacking CaV1.2 
(Seisenberger et al., 2000) and severe hypotension and death in mice following 
conditional smooth muscle-specific ablation of CaV1.2 (Moosmang et al., 2003).  The 
cardiac muscle form of CaV1.2 was proposed to consist of exons 1a/8a/31 while the 
predominant smooth muscle form consists of exons 1c/8/32 with the addition of a 75 
nucleotide cassette exon between exons 9 and 10 (termed exon 9*).  These tissue-specific 
combinatorial splicing patterns may underlie electrophysiological and pharmacological 
distinctions between cardiac and smooth muscle channels.  For example, dihydropyridine 
calcium channel antagonists are potent vasodilators and are routinely used to treat 
hypertension and angina pectoris.  Although these agents bind with high affinity to 
constitutively expressed residues at IIIS5, IIIS6, and IVS6, selective expression of exon 8 
within IS6 of smooth muscle channels determines dihydropyridine sensitivity (Welling et 
al., 1997).  In addition, smooth muscle channels may be functionally specialized in order 
to allow activation at physiological membrane potentials.  An early study aiming to 
determine the role of exon 9* in smooth muscle CaV1.2 found that 9* inclusion resulted 
in a hyperpolarized shift in voltage-dependent activation when expressed in HEK293 
cells (Liao et al., 2004).  The authors of this study proposed that functional specialization 





 influx and smooth muscle tension to modest membrane potential 
depolarization.  Further studies have also shown that expression of the N-terminal exon 
1c can produce a similar shift in voltage-dependent activation, but this effect is not 
additive to the effect of exon 9* expression (Cheng et al., 2009).  Although exon 1c and 
exon 9* are within close proximity to the site of interaction between α1 and β subunits 
(see Figure 6), whether these effects are dependent on β subtype is currently unknown.  
Regardless, these studies together suggest that alternative splicing may be responsible for 
generating significant functional diversity among cardiac and smooth muscle L-type 
VDCCs.  Further, alternative splicing patterns may become altered in pathophysiological 
conditions as a shift in alternative exon expression has been observed in atheroschlerosis, 
Timothy syndrome and hypertension (Tang et al., 2008a; Tiwari et al., 2006; Yarotskyy 
et al., 2009).  For example, cardiomyocytes of hypertrophic hearts from spontaneously 
hypertensive rats were found to express channels with significantly altered combinations 
of mutually exclusive exons 21/22 and 31/32 compared with cardiomyocytes isolated 
from normotensive rats (Tang et al., 2008b).  Although splice variants expressed in hearts 
of hypertensive rats display distinct electrophysiological characteristics when expressed 
in HEK293 cells, the functional importance of Cav1.2 molecular remodeling in 




Regulation of smooth muscle membrane potential 
Smooth muscle Potassium channels 
As described above, VDCC Popen and smooth muscle [Ca
2+
]i is determined by membrane 
potential.  Due to the relatively high permeability of the plasma membrane to K
+
 ions and 
the chemical gradient for K
+
, the resting membrane potential is largely determined by the 
intracellular and extracellular K
+










≈ 3 mM), the direction of the chemical driving force for K+ ions is toward the 
extracellular fluid.  However, efflux of K
+
 ions loss of positive charge increases the 
electrical driving force, which is toward the intracellular fluid.  The membrane potential 
at which the inward and outward driving forces are zero and there is no net movement of 
K
+
 ions is termed the K
+
 equilibrium potential (EK).  In arterial smooth muscle, 
membrane potential is always positive to EK (Hulme et al.).  Thus, increasing the 
permeability of the plasma membrane to K
+
 will result in efflux of K
+
 such that 
membrane potential will hyperpolarize towards EK.  Vascular smooth muscle is equipped 
with various K
+
-selective channels to regulate membrane potential.  This section briefly 
reviews properties of K
+
 channels expressed by cerebral artery myocytes: voltage-
dependent (KV), large conductance Ca
2+






 channels: Voltage-dependent K
+
 (Kv) channel subtypes expressed 
in cerebral artery myocytes include KV1.2, KV1.3, KV1.5, KV2.1 (Xu et al., 1999).  
Studies have also suggested expression of KV2.2 in canine cerebral artery myocytes 
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(Jahromi et al., 2008a).  However, heteromeric channels composed of KV1.2 and KV1.5 
subunits have been shown to play a predominant role in the regulation of arterial diameter 
(Albarwani et al., 2003; Plane et al., 2005).  KV channels open in response to membrane 
depolarization, resulting in K
+
 efflux and hyperpolarization.  In addition to increasing the 
open probability of KV channels, depolarization also increases the electrical driving force 
for K
+
 efflux.  Steady-state KV activity represents a balance between voltage-dependent 
activation and inactivation, and currents are observed in cerebral artery myocytes at 
physiological membrane potentials (Nelson and Quayle, 1995).  Studies have suggested 
that tonic KV channel activity in cerebral artery myocytes may represent an important 
feedback mechanism in response to pressure-induced depolarization.  Consistent with 
this, application of the non-selective KV blocker 4-aminopyridine causes robust 
constriction of pressurized cerebral arteries (Robertson and Nelson, 1994).  In addition, a 
number of vasodilators may function via activation of KV channels.  Endogenous factors 
resulting in activation of the cyclic adenosine monophosphate→PKA, or cyclic 
guanosine monophosphate→PKG pathways (see below) may relax vascular smooth 
muscle at least partially via increased activity of KV channels (Aiello et al., 1995; Keef et 











 (BKCa) channels occurs in response to micromolar increases in Ca
2+
 as 
well as membrane potential depolarization (Ledoux et al., 2006).  Similar to blocking KV 
channels, inhibition of BKCa channels with paxilline or iberiotoxin causes profound 
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constriction of pressurized cerebral arteries (Knot et al., 1998), suggesting an important 
feedback role for these channels in the regulation of cerebral artery tone.  In smooth 
muscle, the majority of BKCa activity occurs in response to transient localized increases 
in Ca
2+
 release events from clusters of ryanodine receptors (RyR) in the sarcoplasmic 
reticulum, or “Ca2+ sparks” (Wellman et al., 2002).  Each spark can elevate local Ca2+ to 
10-100 µM and activates ~20-100 plasmalemmal BKCa channels (Perez et al., 2001).  
Thus, the frequency of transient outward currents via activation of BKCa channels is 
directly proportional to Ca
2+
 spark frequency (Benham and Bolton, 1986; Nelson et al., 
1995).  Studies in toad stomach smooth muscle have shown that Ca
2+
 spark frequency 
can be modulated by the concentration of SR Ca
2+ 
(ZhuGe et al., 1999), which reflects 
changes in cytosolic Ca
2+
.  Thus, Ca
2+
 sparks, activation of BKCa channels and 
subsequent hyperpolarization may also represent a feedback mechanism for a rise in 
cytosolic Ca
2+
 following depolarization and activation of VDCCs.  Furthermore, 
mechanisms which result in increased uptake of Ca
2+
 by the SR (i.e. PKA stimulated 
phosphorylation of the SERCA regulatory protein phospholamban ) (Wellman et al., 
2001) may cause relaxation of smooth muscle through increased Ca
2+
 spark frequency 




 channels: Inwardly rectifying K
+
 channels pass K
+
 ions inward 
more readily than outward.  When membrane potential is negative to EK, inward 
conductance of K
+
 ions via KIR channels occurs.  However, membrane potential of 
cerebral artery myocytes in vivo (-50 mV to -35 mV) is positive to EK (approximately -85 
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mV), yet currents through KIR channels at positive potentials is less than expected.  This 
inward rectification is caused by voltage-dependent intracellular block of the channel by 
polyamines and Mg
2+
 ions (Nichols and Lopatin, 1997).  KIR channels display voltage-
dependent block by relatively low external concentrations (Ki ≈ 5 μM) of Ba
2+
 ions.  
Cerebral artery myocytes express mRNA transcripts for KIR2.1, and KIR currents are 
absent in cerebral artery myocytes from genetically altered mice lacking this gene 
(Zaritsky et al., 2000).  Patch-clamp electrophysiology experiments have demonstrated 
KIR currents in cerebral artery myocytes suggesting that these channels function to 
regulate arterial tone in the cerebral circulation.     
 Inhibition of KIR channels by positively charged ions and proteins is relieved by 
modest elevation in extracellular K+ ions (5-20 mM) (Nichols and Lopatin, 1997).  Given 
that membrane potential of cerebral artery myocytes is positive to EK at physiological 
intravascular pressures, activation of KIR channels by external K
+
 results in K
+
 efflux and 
hyperpolarization toward EK.  These K
+
-induced dilations are inhibited by Ba
2+
 (Knot et 
al., 1996) and are absent in knockout mice lacking KIR2.1 (Sobey and Faraci, 2000; 
Zaritsky et al., 2000).  This mechanism is thought to be important for coupling cerebral 
blood flow to metabolic demands of the brain (Filosa et al., 2006; Paulson and Newman, 
1987).  For example, increases in neuronal activity can dilate local parenchymal arterioles 
via activation of astrocytic BKCa channels, release of K
+
 ions and activation of vascular 
smooth muscle KIR channels to induce hyperpolarization and relaxation (Filosa et al., 
2006).  In addition, activation of KIR channels may result following release of K
+
 from 
neurons and glial cells during hypoxia, ischemia and hypoglycemia (Sieber et al., 1993; 
21 
 
Somjen, 1979).  Thus, when oxygen and glucose delivery to metabolically active neurons 
is compromised, K
+
-induced dilations via activation of KIR channels may represent an 




 channels: Adenosine 5’-triphosphate-sensitive K+ channels 
(KATP) are also expressed in cerebral artery myocytes and are thought to couple metabolic 
signals to blood flow.  These channels open in response to reduced [ATP]i, Po2, or pH,  
and increased Pco2 and prostacyclin, causing hyperpolarization and vasodilation (Faraci 
and Heistad, 1998; Ko et al., 2008).  KATP channels are heteromultimers comprised of 
pore-forming subunits (typically KIR subunits) and sulfonylurea receptor subunits 
(Babenko et al., 1998).  KATP channels are selectively inhibited by sulfonylureas such as 
glibenclamide (de Weille et al., 1988) and activated by synthetic compounds such as 
cromakalim and pinacidil (Grover, 1997; Standen et al., 1989).  Intraparenchymal 
injection of cromakalim produces an increase in local cerebral blood flow that is blocked 
by glibenclamide (Reid et al., 1995), suggesting that KATP channels are present and 
functional in cerebral vessels.  However, application of glibenclamide does not alter 
myogenic tone in basilar artery (Faraci and Heistad, 1993) or cerebral arterioles 
(Armstead, 1996) suggesting that tonic KATP channel activity does not oppose pressure-
dependent constriction.  However, KATP channels are reported to play an important role in 
vasodilation produced by a number of endogenous compounds including calcitonin gene-
related peptide (CGRP) (Kitazono et al., 1993b), prostacyclin (Fredricks et al., 1994), 
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adenosine (Armstead, 1997), norepinephrine (Kitazono et al., 1993a), and vasoactive 
intestinal peptide (Faraci and Heistad, 1998; Standen et al., 1989).   
 
Mechanosensitive ion channels: 
Chloride channels: Considering intracellular [Cl
-
] of 40-70 mM and extracellular [Cl
-
] of 
140 mM, the equilibrium potential for Cl
-
 ions is in the range of -30 to -20 mV.  
Therefore, it was postulated that activation of outward Cl
-
 currents may represent a 
mechanism for depolarization of smooth muscle in response to increased intravascular 




 channels and volume-
regulated Cl
-
 channels have been reported in vascular smooth muscle and increasing 
intravascular pressure results in Cl
-
 efflux (Doughty and Langton, 2001).  Further, 
shifting ECl from -25 mV to -2 mV augments the myogenic tone response at 
physiological intravascular pressures (Nelson et al., 1997).  Inhibition of Cl
-
 channels 
with indanyloxyacetic acid (IAA-94) and 4,4’-diisothiocyanatostilbene-2,2’-disulfonic 
acid (DIDS) hyperpolarizes and dilates pressurized (80 mmHg) cerebral arteries (Nelson 





niflumic acid had no effect on arterial tone suggesting that pressure-induced 
depolarization of cerebral artery myocytes may be mediated by volume-regulated Cl
-
 
channels.  However, later isolation of a current induced by cell swelling was found to 
shift with the equilibrium potential for Na
+
, rather than ECl (Welsh et al., 2000).  Further, 
these swelling-activated currents and pressure-induced depolarizations were blocked by 
Gd
3+





 conductance and instead indicated a direct role for non-selective cation channels 
in pressure-induced depolarization of cerebral artery myocytes.     
 
Non-selective cation channels: The mammalian TRP superfamily of cation channels are 
grouped into the following major subfamilies: TRPC (canonical), TRPM (melastatin), 
TRPV (vanilloid), TRPP (polycystin), TRPML (mucolipin) and TRPA (ankyrin) 
(Clapham, 2003).  With a few exceptions, TRP channels permeate both monovalent and 
divalent cations.  Vascular smooth muscle has been reported to express TRPC1, TRPC3, 
TRPC4, TRPC6, TRPM4, TRPV2 and TRPV4 (Facemire et al., 2004; Inoue et al., 2006).  
The finding that Gd
3+
 ions blocked swelling-induced currents in vascular smooth muscle 
led to the hypothesis that mechanosensitive TRP channels may play a major role in 
depolarization of cerebral artery myocytes to increasing intravascular pressure.  Welsh 
and colleagues were the first to demonstrate that downregulation of TRPC6 channels, 
which are mechanosensitive and highly expressed in vascular smooth muscle, greatly 
attenuates cation currents in response to swelling as well as pressure-induced 
depolarization and constriction in rat cerebral arteries (Welsh et al., 2002). 
Recent studies also indicate an important role for TRPM4 channels in pressure-
induced depolarization of cerebral artery myocytes.  TRPM4 channels permeate 
monovalent cations and are activated by intracellular Ca
2+
 and membrane stretch (Morita 
et al., 2007; Owsianik et al., 2006).  Cerebral artery myocyte depolarizations in response 
to increased intravascular pressure are attenuated when TRPM4 channels are suppressed 
in vitro (Earley et al., 2004).  Furthermore, infusion of antisense oligonucleotides into the 
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cerebral spinal fluid to suppress TRPM4 channels in vivo caused significantly increased 
cerebral blood flow over a range of mean arterial pressures (Reading and Brayden, 2007) 
suggesting disruption of autoregulatory function.  Considering that suppression of either 
TRPC6 or TRPM4 channels results in a similar reduction in pressure-induced 
depolarization suggests that these channels may function in series rather than in parallel.  
Hence, a current model of pressure-induced depolarization of cerebral artery myocytes 
proposes that mechanical forces in response to increased pressure leads to Ca
2+
 entry via 
TRPC6 channels (Brayden et al., 2008).  The resulting increase in local Ca
2+
 thereby 
activates TRPM4 channels leading to Na
+
 influx, depolarization, activation of VDCCs 
and smooth muscle contraction.   
  
Second messenger pathways involved in smooth muscle contraction 
Cerebrovascular tone can also be modulated by the activity of several second messengers.  
One particularly important signal transduction system in the control of vascular smooth 
muscle contraction involves the generation of inositol 1,4,5 trisphosphate (IP3) and 
diacylglycerol (DAG) following Gq-dependent activation of phopholipase C.  Activators 
of this pathway include intravascular pressure, vasoconstrictors circulating in the blood 
(i.e. angiotensin II) as well as neurotransmitters (i.e. serotonin) (Gokina et al., 1999; 
Mattiazzi, 1997; Parsons et al., 1996).  Pharmacological inhibitors of PLC and PKC 
reduce pressure-induced constrictions in cerebral artery segments (Osol et al., 1991).  
Following activation of PLC, an increase in IP3 signals a release of Ca
2+
 from 
intracellular stores via IP3 receptors on the SR (Johns et al., 1987).  On the other hand, 
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diacylglycerol is a potent endogenous activator of protein kinase C (PKC).  PKC-
mediated contraction of vascular smooth muscle can occur via direct phosphorylation of 
myosin light chain kinase (Nishikawa et al., 1985), phosphorylation of actin binding 
proteins (i.e. caldesmon, calponin) (Horowitz et al., 1996; Mino et al., 1995) and 
decreased myosin light chain phosphatase activity (Masuo et al., 1994).  All of these 
effects increase the sensitivity of the smooth muscle contractile apparatus to Ca
2+
, a 
process referred to as “Ca2+ sensitization”.  Thus, an increase in smooth muscle PKC 
activity results in a greater level of arterial constriction for a given level of cytosolic Ca
2+
.  
However, it has been shown that cerebral artery constriction in response to the synthetic 
PKC activator indolactam V is blocked by nisoldipine suggesting that constriction 
following PKC stimulation requires VDCC-mediated Ca
2+
 influx (Gokina et al., 1999).   
In addition, PKC activation can also have widespread effects on the activity of smooth 
muscle ion channels to promote membrane potential depolarization and increased VDCC 
activity.  A number of endogenous vasoconstrictors have been suggested to stimulate 
smooth muscle VDCC activity via a PKC-dependent mechanism (Gollasch and Nelson, 
1997; Keef et al., 2001).  For example, PKC activation can directly decrease the activity 
of both KATP and KV channels (Aiello et al., 1996; Quayle et al., 1997) and indirectly 
decrease BK channel activity via a reduction in Ca
2+
 spark frequency (Bonev et al., 
1997).  In addition, constriction of cerebral arteries in response to PKC-stimulation is 
attenuated following suppression of TRPM4 channels (Earley et al., 2007), suggesting 
that mechanosensitive cation channels may also be a target of PKC.  Furthermore, 
agonist-induced (i.e. phenylephrine, UTP) vasoconstriction may involve activation of 
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TRPC channels by diacylglycerol in a PKC-independent manner (Inoue et al., 2001; 
Reading et al., 2005).  These effects of PLC/DAG/PKC activation would presumably 
lead to enhanced depolarization and increased activity of VDCCs.  Thus, agonists of Gq-
coupled receptors lead to enhanced smooth muscle contraction via elevation of cytosolic 
Ca
2+ 
as well as increased Ca
2+
 sensitivity of the contractile machinery.  
 The small GTPase Rho can also regulate the function of vascular smooth muscle 
through its downstream effector Rho-kinase.  Rho-kinase activation leads to inhibition of 
myosin light chain phosphatase via phosphorylation at the myosin binding subunit 
(Kimura et al., 1996).  A subsequent increase in myosin light chain phosphorylation 
levels then enhances smooth muscle contraction and vasoconstriction.  Thus, activation 
of the Rho-kinase pathway reduces the calcium requirement for prolonged contraction.  
Agonists of G protein coupled receptors such as serotonin, endothelin-1 and angiotensin 
II may promote Ca
2+
-independent contraction via activation of Rho-kinase (Kawano et 
al., 2002).  Rho and Rho-kinase have now been implicated in several cardiovascular 
disorders and are attracting interest as potential targets for future therapeutics (Hu and 
Lee, 2003). 
 Cyclic nucleotides also play an important role in the regulation of cerebral blood 
flow.  A rise in the cytoplasmic concentration of cyclic guanosine 3’,5’ monophosphate 
(cGMP) activates cGMP-dependent protein kinase (PKG) and triggers smooth muscle 
relaxation and vasodilation by several mechanisms.  PKG-mediated phosphorylation at 
specific sites within the VDCC complex may inhibit the channel and reduce Ca
2+
 influx 
(Jiang et al., 2000).  Other potential mechanisms of PKG-induced relaxation of arterial 
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smooth muscle involve direct activation of BKCa channels by PKG (Robertson et al., 
1993) as well as enhanced uptake of Ca
2+
 into the SR, resulting in increased Ca
2+
 spark 
frequency and increased BKCa channel activity (Porter et al., 1998).  Evidence suggests 
that this vasodilatory pathway may also contribute to relaxation in response to Gs 
stimulation, increased production of cyclic adenosine 3’,5’ monophosphate (cAMP) and 
activation of cAMP-dependent protein kinase (PKA).  Consistent with this, inhibitors of 
Ca
2+
 sparks such as ryanodine, abolish both PKA and PKG-mediated increases in 
transient BKCa channel activity (Porter et al., 1998).  Studies have demonstrated that PKA 
phosphorylates the SERCA regulatory protein phospholamban, leading to increased SR 
Ca
2+
 uptake and Ca
2+
 spark frequency in myocytes of pressurized cerebral arteries 
(Wellman et al., 2001).  In addition to the effect on BK channel activity, the cAMP-PKA 
pathway can also increase the activity of KATP and KV channels (Aiello et al., 1995; 
Quayle et al., 1994), leading to membrane potential hyperpolarization and decreased 
VDCC Popen.    
 
Endothelial influences 
For over one hundred years after their discovery in brain capillaries in 1845, endothelial 
cells were regarded as the inactive lining of blood vessels and capillary walls.  However, 
the modulation of vascular tone by the release of vasoactive factors from endothelial cells 
has been under intense investigation.  Following is a brief overview of major mechanisms 
in endothelial modulation of vascular smooth muscle contraction, focusing on major 
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vasoacitve substances released by endothelial cells: Nitric oxide (NO), endothelium-
dependent hyperpolarizing factor (EDHF), eicosanoids, and endothelin-1 (ET-1). 
 
Nitric oxide: In 1978, Furchgott observed that acetylcholine, acting on muscarinic 
receptors, stimulates the release of diffusible substances from the endothelium that cause 
relaxation of vascular smooth muscle, or “endothelial-derived relaxing factor” (Furchgott 
and Zawadzki, 1980).  Later, Furchgott and Ignarro demonstrated that endothelium-
derived relaxing factor was in fact nitric oxide (Furchgott, 1999).  In independent studies 
at the same time, Murad and colleagues found that the potent vasodilator nitroglycerin 
exerts it effects by releasing nitric oxide, which relaxes vascular smooth muscle and 
increases blood flow.     
Nitric oxide is produced in the conversion of L-arginine to L-citrulline by  nitric 
oxide synthase (NOS) (Fleming and Busse, 1999).  Three NOS isoforms have been 
identified: neuronal (nNOS), endothelial (eNOS) and inducible (iNOS).  Under normal 
conditions, vascular endothelial cells express only eNOS.  Increased endothelial 
Ca
2+
 causes eNOS activation and NO production by Ca
2+
/calmodulin-dependent 
displacement of the eNOS protein from the inhibitory scaffolding protein caveolin-1 
(Michel et al., 1997).  eNOS can also be directly activated by the regulatory heat shock 
protein (HSP90) (Khurana et al., 2000).  Studies suggest this mechanism may be 




 Diffusion of NO to smooth muscle results in activation of soluble guanylate 
cyclase and increased production of cGMP (Murad, 2004).  PKG activation causes 
increased activity of K
+
 channels, smooth muscle hyperpolarization, and decreased 
VDCC activity (Faraci and Sobey, 1999).  For example, PKG can increase BKCa channel 
activity directly (Robertson et al., 1993), or indirectly by suppressing synthesis of the 
BKCa inhibitor 20-HETE and increasing Ca
2+
 spark frequency (Alonso-Galicia et al., 
1997).  A recent report also suggests that NO-mediated relaxation may occur via reducing 
the sensitivity of contractile apparatus to Ca
2+
 (Lehen'kyi et al., 2005).   
 Release of NO by the endothelium represents an important vasodilator pathway 
that contributes to modulation of vascular tone both in vitro and in vivo.  Inhibition of 
eNOS with L-NNA results in reduced cerebral blood flow in normal mice, but not in 
mice lacking the gene for eNOS (Ayata et al., 1996; Ma et al., 1996).  These findings 
suggest that tonic release of NO from the endothelium is a major contributor to 
cerebrovascular tone and cerebral blood flow.   
   
EDHF: Following the discovery of nitric oxide as an endothelium-derived relaxing 
factor, another endothelium-dependent vasodilatory mechanism was found which was 
independent of NOS or cyclooxygenase (COX) (Hoeffner et al., 1989; Vanhoutte, 2004).  
For example, substances such as UTP and ATP can maximally dilate cerebral arteries 
following inhibition of NOS and COX (You et al., 1997; You et al., 1999).  This 
vasodilatory process, which may or may not be a diffusible factor, is referred to as 
endothelium-derived hyperpolarizing factor (EDHF) and is characterized by 
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 channels (Golding et al., 2002).  EDHF-mediated dilation 
requires an increase in endothelial Ca
2+
 and endothelial hyperpolarization.  This 





 channels (Marrelli, 2001; Marrelli et al., 2003).  In 





 (SKCa) channels may also contribute to endothelial 
hyperpolarization involved in EDHF (Burnham et al., 2002; Eichler et al., 2003).  
Although it is not clear how hyperpolarization of endothelial cells leads to smooth muscle 
hyperpolarization, this may depend on myoendothelial gap junctions (Griffith et al., 
2004; Xu et al., 2002b) or SKCa/IKCa-mediated K
+
 release leading to activation of 
smooth muscle KIR channels (McNeish et al., 2005).  
 Whereas NO is important in large diameter vessels, EDHF may play a more 
prominent role as arterial diameter decreases (You et al., 1999).  Dilations in response to 
ATP in middle cerebral arteries are blocked by the NOS inhibitor nitro-L-arginine methyl 
ester.  However, these dilations in penetrating arterioles are resistant to NOS and COX 
inhibition, but are completely abolished by the endothelial IKCa inhibitor charybdotoxin 
(Xu et al., 2001).  Heterogeneity in EDHF-mediated control of vascular tone may be 
important for controlling blood flow to metabolically diverse brain regions.    
   
Prostacyclin and other eicosanoids: The term eicosanoid collectively refers to 
metabolites of arachidonic acid, which is liberated from the phopholipid membrane by 
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the enzyme phospholipase A2.  Arachidonic acid is metabolized by cyclooxygenase 
(COX), lipoxygenase, epoxygenase, or Ω hydroxylase (Bogatcheva et al., 2005).  The 
COX pathway was the first arachidonic acid metabolism pathway to be discovered.  In 
the cerebrovascular endothelium, COX produces vasodilator products including 
prostaglandin I2 (prostacyclin), prostaglandin E2 (Moore et al., 1988), and prostaglandin 
D2 (Smith et al., 1996), and vasoconstrictor products including prostaglandin F2 and 
thromboxane A2.  The effects of the endothelial vasodilatory compound prostacyclin are 
well established.  Upon prostacyclin binding to G-protein coupled receptors, GS 
stimulates activation of adenylyl cyclase and increased cAMP (Bogatcheva et al., 2005).  
A subsequent increase in PKA activity then enhances K
+
 channel activity, resulting in 
smooth muscle hyperpolarization (Parkington et al., 2004).  Vasoconstrictor eicosanoids 
are thought to be elevated in brain injury (Dewitt et al., 1988; Shohami et al., 1987; 
Yergey and Heyes, 1990) and may contribute to constriction following ischemia and 
reperfusion (Cole et al., 1993).   
Endothelial epoxygenase catalyzes the metabolism of arachidonic acid to 
epoxyeicosatrienoic acids (EETs).  EETs compounds relax vascular smooth muscle and 
have been proposed to be one form of EDHF (Fleming and Busse, 2006).  One recent 
study has demonstrated that endothelial-derived 11,12 EET increases the frequency of 
Ca
2+
 sparks and spontaneous BKCa currents in cerebral artery myocytes (Earley et al., 
2005).  This effect was prevented by suppression of TRPV4 channels using antisense 







 release events from the SR.  This increase in Ca
2+
 spark frequency 
enhances activity in nearby BKCa channels and relaxes vascular smooth muscle.    
 
Endothelin-1: The potent endothelium-derived vasoconstrictor endothelin-1 (ET-1) was 
first characterized in 1988 by Yanagisawa and colleagues (Yanagisawa et al., 1988).  
Under normal conditions, endothelin release does not significantly contribute to cerebral 
blood flow (Koedel et al., 1998).  However, ET-1 is increased and may contribute to 
vascular dysfunction in several pathophysiological states including ischemia and 
reperfusion (Matsuo et al., 2001; Petrov and Rafols, 2001), hyperoxia (Armstead, 1999), 
and diabetes (Dumont et al., 2003). 
 ETA and ETB receptors are expressed in vascular smooth muscle and endothelial 
cells, respectively (Arai et al., 1990; Sakurai et al., 1990).  Binding of ET-1 to smooth 
muscle ETA receptors causes vasoconstriction by several mechanisms (Faraci, 1989; Patel 
et al., 1996; Pierre and Davenport, 1999; Sagher et al., 1994; Zhou et al., 2004).  ETA 
activation initially elevates [Ca
2+
]i via a mechanisms involving IP3-mediated Ca
2+
 release 
from intracellular stores (Zubkov et al., 2004).  On the other hand, a sustained Ca
2+
 
increase that follows the initial phase is dependent on extracellular Ca
2+
 influx (Miyauchi 
and Masaki, 1999; Zubkov et al., 2004).  In addition, it has been shown that ET-1 can 
activate the Rho/Rho-kinase pathway in rabbit basilar arteries, which may lead to 
decreased activity of myosin light chain phosphatase (Zubkov et al., 2004).  
Depolarization and increased VDCC-mediated Ca
2+
 may also result from ET-1 release 
via activation of Cl
-
 channels (Dai and Zhang, 2004).  In contrast to activation of ETA 
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receptors on smooth muscle, exposure of cerebral arteries to low concentrations of ET-1 









Subarachnoid hemorrhage (SAH) is defined as the extravasation of blood in the 
subarachnoid space, or the area between the arachnoid membrane and pia mater (see 
figure 2).  Spontaneous SAH most commonly results from the rupture of an aneurysm, or 
congenital weakness in arterial tunica media, in a cerebral artery on the brain surface.  
Although the prevalence of unruptured intracranial aneurysms is controversial, reports 
estimate rates as high as 6 % of the general population are harboring these vascular 
abnormalities (McCormick and Nofzinger, 1965; Nakagawa and Hashi, 1994).  
Intracranial aneurysm rupture occurs in approximately 30,000 individuals in the United 
States each year (Kassell et al., 1985).  Major risk factors for SAH include smoking, 
hypertension, and alcohol consumption (Teunissen et al., 1996). 
 The consequences of aneurysm rupture and SAH are devastating, with 30 day 
mortality rates as high as 50% (Kassell et al., 1985; Teunissen et al., 1996; Weir, 1995).  
Immediately following rupture, the rapid discharge of blood into the subarachnoid space 
is followed by an acute rise in intracranial pressure.  Increased intracranial pressure above 
the level of intravascular pressure in the cerebral circulation may result in cessation of 
blood flow, global cerebral ischemia and death.  Of the patients surviving the initial 
hemorrhage, a significant portion develop delayed cognitive deficits that may lead to 
further morbidity and mortality (Kassell et al., 1985).  For decades, it has been widely 
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accepted that a blood-induced delayed and sustained constriction of conduit arteries on 
the brain surface (“cerebral vasospasm”) is the major contributor to death and disability 
in patients surviving the initial hemorrhage.  However, recent evidence suggests that 
phenomena other than large artery vasospasm contribute to the development of 
neurological deficits following SAH, including global transient ischemia, blood-brain 
barrier disruption, activation of inflammatory pathways and vascular remodeling, and 
dysfunction of the cerebral microcirculation (Ohkuma et al., 2000; Pluta et al., 2009).  In 
addition, pathological events independent of the cerebral vasculature may also contribute 
to neurological impairment in SAH patients including early brain injury and cortical 
spreading depression (Pluta et al., 2009).  This section will review major concepts 
regarding mechanisms of enhanced cerebral artery constriction following SAH, focusing 
on the role of elevated [Ca
2+
]i and enhanced smooth muscle contractility.  In addition, 
emerging evidence supporting a role for small diameter cerebral arteries and arterioles in 
cerebral ischemia following SAH will also be discussed. 
 
Experimental models of SAH 
Experimental models of SAH aim to reproduce the human pathological condition.  
However, this objective is compromised by the goal to achieve reproducibility and avoid 
high mortality rates in animals.  In addition, certain aspects of human SAH (i.e. 
spontaneous aneurysm rupture, etc.) are lacking in animal models, which use controlled 
surgical procedures.  Thus, although vasospasm has been reproducibly observed in a 
variety of animal models, the issue of the most appropriate model for studying the impact 
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of SAH on the cerebral vasculature has not been completely resolved.  Primate and 
canine SAH models are generally thought to most closely resemble pathology observed 
in human SAH (Megyesi et al., 2000).  However, rodent SAH models are far less 
expensive and also display many of the pathophysiological properties observed in 
humans (Lee et al., 2008). 
 In 1965, Echlin demonstrated that application of clotted autologous blood into 
the subarachnoid space produces marked spasm of primate basilar and vertebral arteries 
(Echlin, 1965).  Weir et al. reported chronic vasospasm and neurological deficits in these 
animals over a similar time course to that seen in humans (Weir et al., 1970).  In contrast, 
Simeone and colleagues used small needles to puncture the intracranial internal carotid 
artery in primates to mimic the rupture of an aneurysm and SAH (Simeone et al., 1968).  
This method also caused prolonged angiographic vasospasm lasting up to four days.  
Today, experimental animal models routinely employed to mimic the rupture of an 
intracranial aneurysm and SAH are: 1) fresh non-clotted autologous blood injected into 
the subarachnoid space (injection model) or 2) the internal carotid artery or basilar artery 
is punctured using an endovascular filament (perforation model) (Kozniewska et al., 
2006).  The perforation model has been limited by much higher mortality rates than the 
injection model and results vary depending on the size of the blood clot and location of 
the perforated vessel (Kozniewska et al., 2006; Lee et al., 2009).  On the other hand, 
procedures using a single intracisternal blood injection are associated with low mortality, 
yet this model fails to reproducibly exhibit significant changes in the vasculature (Clower 
et al., 1986; Megyesi et al., 2000).  To overcome this, the injection model was first 
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modified in dogs by Varsos et al. by performing a two successive injections of blood 48 
hours apart (“double hemorrhage” model) to increase the severity and reproducibility of 
vasospasm (Varsos et al., 1983).  In a variety of species, the double hemorrhage model 
has been found to exhibit many of the features of SAH found in humans including 
vasospasm, behavioral deficits and reduced cortical blood flow (Lee et al., 2009; Vatter et 
al., 2006).  Thus, the double injection SAH model has become widely used to study 
mechanisms of delayed cerebral vasospasm.   
   
Mechanisms of enhanced smooth muscle contraction following SAH 
Blood components: Whole blood consists of erythrocytes, leukocytes, platelets, soluble 
proteins, glucose, hormones and gases.  In the 1970’s, evidence was obtained supporting 
the hypothesis that the occurrence of vasospasm was correlated with erythrocyte lysis and 
levels of the blood component oxyhemoglobin in the cerebral spinal fluid (CSF).  
Purified oxyhemoglobin alone is capable of producing sustained cerebral artery 
constriction in vitro (Tanishima, 1980; Wellum et al., 1980).  Oxyhemoglobin 
concentrations measured in the CSF of SAH patients are sufficient to produce significant 
constriction of arteries in vitro and are correlated with development of vasospasm 
(Kajikawa et al., 1979).  Following erythrocyte lysis, oxyhemoglobin is oxidized to 
methemoglobin and superoxide radical.  Superoxide radical combines with water to form 
hydrogen peroxide, which can react with ferrous iron of methemoglobin to form hydroxyl 
radical.  Subsequent hydroxyl radical-induced lipid peroxidation can lead to functional 
and morphological changes and has been proposed as an important mechanism in the 
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pathogenesis of vasospasm (Sakaki et al., 1986).  In a primate SAH model, the inhibitor 
of iron-dependent lipid peroxidation U74006F was shown to greatly attenuate vasospasm 
(Steinke et al., 1989).  However, clinical trials using this agent as well as the antioxidants 
superoxide dismutase and catalase have failed to significantly benefit SAH patients 
(Wellum et al., 1982; Zhang et al., 2010).  As will be discussed, oxyhemoglobin may also 
lead to enhanced cerebral artery constriction by interfering with the NO-cGMP signaling 
pathway as well as inhibition of smooth muscle K
+
 channel activity. 
 In addition to erythrocyte lysis products, activated leukocytes and platelets have 
also been implicated in inflammatory processes contributing to vascular dysfunction 
following SAH.  Activation of leukocytes and platelets following SAH may occur due to 
the upregulated expression of specific adhesion molecules by endothelial cells or 
disruption of the endothelial monolayer, exposing leukocytes and platelets to collagen, 
elastin and basement membrane (Davies and Hagen, 1993; Vane et al., 1990).  Studies 
have shown the presence of platelet microthrombi surrounding vasospastic arteries as 
well as polymorphonuclear leukocytes in the intima of cerebral arteries following SAH 
(Minami et al., 1991; Suzuki et al., 1990).  Activated platelets and leukocytes are capable 
of releasing numerous vasoactive substances including thromboxane A2, endothelin-1, 5-
HT and ATP (Siminiak et al., 1995).  Thus, activation of these blood components 







Although vascular smooth muscle contractility is largely determined by the concentration 
of intracellular Ca
2+
, the role of elevated [Ca
2+
]i in cerebral artery myocytes leading to 
enhanced constriction following SAH is controversial.  In 1976, Peterson and Leblanc 
first proposed that vasospasm following subarachnoid hemorrhage was dependent on 
increased vascular smooth muscle [Ca
2+
]i caused by spasmogens in blood (Peterson and 
Leblanc, 1976).  The authors additionally proposed that increasing the intracellular 
concentration of cAMP may be effective for reversing vasospasm due to increased uptake 
of Ca
2+ 
into the SR.  Later, the development of Ca
2+
 sensitive fluorescent dyes made it 
possible to directly measure intracellular Ca
2+
 in vascular smooth muscle in spastic 
arteries isolated from experimental SAH animals.  Bulter et al. used the photoprotein 
aequorin from the luminescent jellyfish Aequorea victoria to measure intracellular Ca
2+
 
in vasospastic anterior spinal arteries isolated from a canine double-hemorrhage SAH 
model (Bulter et al., 1996).  It was found that [Ca
2+
]i in vasospastic cerebral arteries was 
significantly elevated (by ~140 nM) compared to normal arteries.  This elevation in 
[Ca
2+
]i was correlated with a marked increase in myosin light chain phosphorylation.  
Another study using the ratiometric Ca
2+
-sensitive fluorescent dye fura-2 also suggested 
that impaired regulation of smooth muscle [Ca
2+
]i may contribute to vasospasm following 
SAH (Kim et al., 1996b).  Conversely, reports have also suggested contribution of Ca
2+
-
independent contractile pathways (i.e. Rho-kinase mediated inhibition of myosin light 
chain phosphatase) to the development of vasospasm following SAH (Laher and Zhang, 
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2001; Nishizawa and Laher, 2005).  Thus, the role of increased [Ca
2+
]i in the 
pathogenesis of cerebral vasospasm remains unclear.   
 
Role of voltage-dependent Ca
2+
 channels 
Inhibitors of VDCCs are used clinically and provide a modest beneficial effect in SAH 
patients (Treggiari-Venzi et al., 2001).  Following SAH, elevated vascular smooth muscle 
[Ca
2+
]i may result from increased density of VDCCs, a direct alteration of VDCC gating, 
or indirect increase in channel activity via membrane potential depolarization.  Aihara et 
al. found no change in mRNA expression of CaV1.2 in basilar arteries from a canine SAH 
model (Aihara et al., 2004).  However, whether expression of CaV1.2 is altered in 
resistance sized cerebral arteries and arterioles following SAH is not known.  In addition, 
no studies to date have measured expression of auxiliary VDCC β subunits, which are 
critical for membrane insertion of α1 subunits (Chien et al., 1995), in cerebral arteries 
from SAH animals.  A study by Ishiguro et al. used patch clamp electrophysiology to 
measure whole cell VDCC currents in cerebral artery myocytes from SAH rabbits 
(Ishiguro et al., 2005).  These experiments found that VDCC currents in cerebral artery 
myocytes from SAH animals were increased by ~40% and were partially resistant to L-
type VDCC inhbitiors.  The selective R-type VDCC blocker SNX-482 abolished 
nifedipine-insensitive VDCC currents in myocytes from SAH animals.  Consistent with 
this, small diameter cerebral arteries from SAH animals were found to express mRNA 
and protein for both Cav1.2 (L-type) and CaV2.3 (R-type), whereas arteries from control 
animals expressed only CaV1.2.  Upregulated expression and function of R-type VDCCs 
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in cerebral arteries was also demonstrated following incubation for 5 days with the blood 
component oxyhemoglobin (Link et al., 2008).  Thus, although oxyhemoglobin does not 
appear to directly increase VDCC activity (Kim et al., 1996a), this spasmogen may lead 
to enhanced membrane Ca
2+
 currents via upregulation of R-type channels following 
SAH.  Further, vasoactive blood components released into the CSF following SAH, such 
as norephinephrine, serotonin, and 20-hydroxyeicostetraenoic acid (20-HETE), are 
reported to increase the VDCC activity in vascular smooth muscle and have been 
implicated in the development of cerebral vasospasm (Gebremedhin et al., 1998; Nelson 
et al., 1988; Svendgaard et al., 1977; Takeuchi et al., 2006; Worley et al., 1991).  Thus, 
substantial evidence supports the hypothesis that elevated smooth muscle [Ca
2+
]i 




 channels  
Smooth muscle membrane potential depolarization may lead to increased Ca
2+
 influx in 
cerebral artery myocytes via increased VDCC Popen.  Harder and colleagues were the first 
to propose that membrane potential depolarization of vascular smooth muscle following 
SAH may result from decreased K
+
 conductance (Harder et al., 1987).  In this study, it 
was shown that vasospasm could be reversed by hyperpolarization induced by application 
of the K
+
 channel opener nicorandil.  Since then, others have also reported that 
vasospastic cerebral artery myocytes from SAH model animals are more depolarized 
compared with controls (Harder et al., 1987; Waters and Harder, 1985; Zuccarello et al., 
1996a) and that dilations in response to synthetic K
+ 
channel activators are enhanced in 
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arteries from SAH animals (Sobey et al., 1997; Zuccarello et al., 1996b).  It is becoming 
increasingly clear that components of blood can constrict cerebral arteries via suppression 
of smooth muscle K
+
 channel activity.    
 
KV channels: Quan and Sobey first provided evidence that voltage-dependent K
+
 
channels were suppressed following SAH with the finding that constrictions to the non-
selective KV channel blocker 4-aminopyridine were reduced in basilar arteries from SAH 
rats compared with controls (Quan and Sobey, 2000).  Molecular assessment of Kv 
channel expression has revealed that mRNA for KV2.1 and KV2.2 are downregulated in 
canine basilar arteries following SAH (Aihara et al., 2004) and is correlated with ~50% 
decrease in KV2 currents (Jahromi et al., 2008a).  Additionally, studies in our laboratory 
have also demonstrated that KV1.5 channels are suppressed in cerebral artery myocytes 
following SAH by a mechanism involving oxyhemoglobin-induced activation of the 
tyrosine kinase EGF receptor and channel endocytosis (Ishiguro et al., 2006; Koide et al., 
2007).  Thus, suppression of KV channel activity is likely to contribute to membrane 
potential depolarization and enhanced arterial constriction following SAH.       
 
BKCa channels: BK channels act as an important feedback mechanism to limit membrane 
potential depolarization and elevated [Ca
2+
]i in cerebral artery myocytes.  Studies have 
shown that mRNA and protein for BK α and β1 subunits are unchanged following SAH 
(Aihara et al., 2004).  A later study found no significant differences between normal and 
vasospastic myocytes in BK current density, kinetics, Ca
2+
- or voltage-sensitivity, or 
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single channel conductance (Jahromi et al., 2008b).  However, BK channel activity may 
be suppressed in vivo following SAH due to increased levels of the endogenous BK 
channel inhbitor 20-HETE in the CSF (Poloyac et al., 2005; Roman et al., 2006).  
Further, studies in our laboratory have discovered decreased spontaneous transient BKCa 
currents and Ca
2+
 spark frequency in cerebral artery myocytes from SAH model rabbits 
(Koide, 2009).  This decrease in Ca
2+ 
spark frequency may be caused by reduced 
expression of ryanodine receptor type 2 (RyR2) and increased expression of the RyR2 
stabilizing protein FKBP12.6 in cerebral arteries from SAH animals (see Appendix C).  
In addition, incubation of cerebral arteries in purified oxyhemoglobin also reduces the 
frequency of Ca
2+
 sparks, leading to decreased outward BKCa currents, depolarization and 
enhanced constriction (Jewell et al., 2004).  Therefore, although BKCa channel density 
and functional properties may be unchanged following SAH, factors regulating the 
activation of these channels may be altered causing decreased activity of this vasodilator 
pathway.  
 
KIR channels:  Few studies have directly examined the expression and function of smooth 
muscle KIR channels in the cerebral vasculature following SAH.  However, Aihara et al. 
found a ~350% increase in KIR2.1 protein in vasospastic canine basilar arteries compared 
with normal arteries (Aihara et al., 2004).  Consistent with this, a subsequent study by 
Weyer et al. found that depolarization and constriction in response to Ba
2+
 in the presence 
of 4-aminopyridine (KV blocker) and paxilline (BKCa blocker) were greater in myocytes 
from vasospastic arteries from SAH animals compared with controls (Weyer et al., 2006).  
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Further, patch-clamp electrophysiology demonstrated significantly increased KIR currents 
in canine basilar artery myocytes following SAH (Weyer et al., 2006).  The authors of 
this report proposed that upregulation of KIR channels following SAH may represent a 
potential compensatory mechanism to counteract sustained arterial constriction.  
However, unpublished observations from our laboratory found no significant effect of 
SAH on the magnitude of KIR currents in myocytes from small diameter cerebral arteries 
arteries in rats and rabbits (Koide and Wellman, unpublished observations).  Thus, the 
impact of SAH on the function and expression of KIR channels in the cerebral vasculature 
may vary with vessel caliber or species.  
 
KATP channels:  Studies have shown that dilations induced by activators of KATP channels 
are enhanced following SAH (Sugai et al., 1999; Zuccarello et al., 1996b), suggesting 
that these channels remain functional in the cerebral vasculature.  However, other reports 
have demonstrated a decrease in the levels of the endogenous activator of KATP channels 
calcitonin gene-related peptide (CGRP) following SAH (Edvinsson et al., 1991; 
Edvinsson et al., 1994)  suggesting that decreased KATP activity may contribute to 
cerebral vasospasm in vivo.  Implantation of CGRP tablets in the subarachnoid space of 
SAH model animals was shown to reverse vasospasm (Inoue et al., 1996).  However, the 
use of CGRP in SAH patients did not improve patient outcome in a multi-center single-
blind trial (1992).  Hypotension was reported as a common limiting side effect in this 




Role of Protein Kinase C  





-independent mechanisms (see “second messenger pathways involved 
in smooth muscle contraction” above).  Activation of the PLC/PKC pathway may also 
contribute to the pathophysiologic regulation of vascular tone following SAH (Matsui et 
al., 1991; Nishizawa et al., 1996; Nishizawa et al., 1995; Shiota et al., 1996).  Levels of 
diacylglycerol, an endogenous activator of PKC, are elevated in basilar arteries following 
SAH on days 2, 4, and 7 but is reduced to normal levels on day 14 (Matsui et al., 1991).  
Several studies suggest significantly increased membrane bound activated PKCα and 
decreased cytosolic PKCα which is correlated with angiographic vasospasm on days 4 
and 7 following SAH (Matsui et al., 1991; Matsui et al., 1993; Nishizawa et al., 1992; 
Takuwa et al., 1993).     
The use of PKC inhibitors to relieve vasospasm has yielded inconsistent results.  
The PKC inhibitors staurosporine and H-7 reversed vasospasm on day 7 in a canine 
double hemorrhage SAH model (Matsui et al., 1991).  However, application of the PKC 
inhibitor staurosporine failed to reverse vasospasm in rabbit basilar arteries whereas the 
KATP channel opener cromakalim completely relaxed these vessels (Zuccarello et al., 
1996b).  Thus, it is possible that the contribution of PKC activation leading to enhanced 




Role of Rho/Rho kinase  
Activation of the small GTPase RhoA and subsequent activation of Rho kinase leads to a 
decrease in myosin light chain phosphatase activity and sensitization of smooth muscle 
contractile filaments.  Increased mRNA for RhoA and Rho kinase were demonstrated in 
arteries exhibiting vasospasm from a rat double hemorrhage SAH model (Miyagi et al., 
2000).  Increased Rho-kinase and myosin light chain phosphorylation were also 
demonstrated in canine basilar arteries following experimental SAH (Sato et al., 2000).  
Topical application of the Rho-kinase inhibitor Y-27632 caused a dose-dependent 
decrease in myosin light chain phosphorylation and dilation in spastic canine basilar 
arteries on day 7 following hemorrhage (Sato et al., 2000).  The partially selective 
inhibitor of Rho-kinase fasudil is approved for use in SAH patients in Japan and provides 
slight improvement in clinical outcome (Nakashima et al., 1998; Tachibana et al., 1999).   
 
Effect of SAH on the endothelium 
NO: Tonic NO release is an important regulator of cerebrovascular tone.  The 
bioavailability of this potent vasodilator may be reduced following SAH due to the high 
affinity binding of NO by hemoglobin following erythrocyte lysis (Edwards et al., 1992).   
Many reports suggest that SAH can also disrupt the NO→cGMP feedback process to 
cause enhanced cerebral artery constriction.  In support of this hypothesis, mRNA 
encoding eNOS was significantly decreased in vasospastic cerebral arteries from a 
primate SAH model (Hino et al., 1996).  However, the contribution of decreased NO 
release to enhanced cerebral artery constriction following SAH is controversial, as other 
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studies have demonstrated normal eNOS expression and activity in basilar arteries from 
SAH dogs (Kasuya et al., 1995; Kim et al., 1989; Naveri et al., 1994).  Some, but not all 
studies have also indicated diminished vasodilator response to exogenous NO after SAH 
(Afshar et al., 1995; Nakao et al., 1996; Pluta et al., 2000).  This may result from 
decreased expression or functionality of smooth muscle soluble guanylate cyclase or 
protein kinase G, or via increased phosphodiesterase activity in vascular smooth muscle, 
leading to reduced steady-state cGMP levels.  In addition, normal basal NO release prior 
to SAH may also function to inhibit PKC activation (Nishizawa et al., 1996).  Therefore, 
diminished release of NO or decreased cGMP levels may also lead to enhanced PKC-
dependent vascular smooth muscle contraction following SAH. 
 
Endothelin-1:  In addition to decreased NO release following SAH, other observations 
suggest that increased endothelial release of the potent vasoconstrictor ET-1 may be a 
major contributor to vasospasm.  Several studies have demonstrated increased ET-1 
levels in basilar arteries and CSF following SAH (Hirose et al., 1995; Kobayashi et al., 
1991; Kraus et al., 1991).  In a study by Itoh et al., mRNA encoding ETA receptors was 
not detected in basilar arteries from control animals but was markedly increased in 
vessels 3 days following SAH in dogs (Itoh et al., 1994).  Activity of endothelin 
converting enzyme (ECE), which converts preproendothelin-1 to active ET-1, is also 
increased 3-fold in basilar arteries from SAH model animals (Roux et al., 1995).  Further 
supporting a role for ET-1 in vasospasm, ETA receptor antagonists, ECE inhibitors, and 
antisense oligonucleotides against preproendothelin-1 mRNA substantially attenuate 
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vasospasm and constriction in response to hemolysate application (Itoh et al., 1994; 
Matsumura et al., 1991; Onoda et al., 1996).  In addition to increasing intracellular Ca
2+
, 
increased levels of ET-1 following SAH may also lead to enhanced vascular smooth 
muscle contraction via activation of PKC (Murray et al., 1992).  
 
Impact of SAH on the cerebral microcirculation 
Following angiographic demonstration of SAH-induced arterial narrowing in 1951, 
extensive clinical research has aimed at preventing enhanced constriction of large 
diameter conduit cerebral arteries in SAH patients.  Overall, clinical trials have been 
ineffective at reducing angiographic vasospasm.  However, one recent trial using a 
selective ETA receptor antagonist, clazosentan, demonstrated a significant dose-
dependent reduction in moderate to severe angiographic vasospasm at day 9 following 
aneurysm rupture (Macdonald et al., 2008).  Despite approximately 50% decrease in the 
occurrence of vasospasm, clazosentan did not significantly reduce the rate of poor 
clinical outcome based on the modified Rankin scale.  On the other hand, clinical use of 
the VDCC blocker nimodipine produces a modest improvement in clinical outcome in 
SAH patients (Petruk et al., 1988).  However, studies suggest that nimodipine does not 
significantly influence the incidence of moderate or severe angiographic vasospasm 
(Petruk et al., 1988).  Thus, large artery vasospasm does not always correlate with the 
occurrence of ischemia-related neurological deficits in SAH patients.      
Recently emerging evidence suggests that small diameter cerebral arteries and 
arterioles, which are critical for autoregulation of cerebral blood flow may be more 
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constricted following SAH.   Takeuchi and colleagues made the observation that cerebral 
blood flow was significantly reduced at mean arterial blood pressures from 40 to 100 
mmHg in SAH model primates (Takeuchi et al., 1991).  This finding suggests that SAH 
may impair cerebral autoregulation such that physiological increases in intravascular 
pressure lead to greater constriction of resistance arteries and arterioles in the cerebral 
circulation, thus reducing cortical blood flow.  Consistent with this hypothesis, Ishiguro 
et al. demonstrated enhanced pressure-dependent constriction of small diameter (100-200 
µm diameter) cerebral arteries from a rabbit SAH model at physiological intravascular 
pressures in vitro (Figure 7) (Ishiguro et al., 2002).  Decreased cerebral circulation time 
and regional cerebral blood flow measurements in humans 5 and 7 days after SAH 
(Ohkuma et al., 2000) also suggests decreased luminal caliber of intracerebral arterioles.  
Furthermore, Knuckey et al. observed decreased cerebral blood flow in SAH patients 
which was not secondary to increased intracranial pressure or angiographic vasospasm 
(Knuckey et al., 1985).  Although various histological studies of parenchymal arterioles 
from SAH model animals have suggested enhanced constriction of these vessels 
following SAH (Ohkuma et al., 1997; Ohkuma and Suzuki, 1999), the function of 
isolated parenchymal arterioles following SAH has not been investigated. 
 
Summary 
The cerebral circulation is exquisitely regulated by numerous mechanisms to ensure 
adequate delivery of oxygen and nutrients to the brain.  Under normal conditions, 
cerebral artery diameter is largely controlled by vascular smooth muscle membrane 
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potential and the activity of voltage-dependent Ca
2+
 channels, which represent a splice 
variant of the gene CaV1.2.  Following SAH, factors released into the cerebrospinal fluid 
exert a profound influence over vascular smooth muscle leading to enhanced contraction 
and decreased blood flow.  Although decades of research has focused on the impact of 
SAH on large diameter arteries on the brain surface, evidence suggests that small 
diameter arterioles within the brain parenchyma may be more constricted and reduce 
local cerebral blood flow.   
 
Part 3: Hypotheses 
 
1.  Increased L-type VDCC activity causes enhanced pressure-dependent 
constriction of parenchymal arterioles following experimental SAH. 
The overall objective in Chapter 2 of this dissertation was to examine the relationship 





potential and diameter of isolated parenchymal arterioles from unoperated, sham-
operated and SAH model rats.  A combination of techniques were used to test the 
hypothesis that increased activity of smooth muscle L-type VDCCs (CaV1.2) leads to 
elevated [Ca
2+
]i and enhanced pressure-induced constriction of parenchymal arterioles 
from SAH animals.  Therefore, it was also predicted that enhanced constriction of 





 sensitization of the smooth muscle contractile machinery (i.e. via increased 





constriction revealed that enhanced arteriolar tone was due to increased Ca
2+
 influx via L-
type channels and elevated [Ca
2+
]i.  We also hypothesized that increased L-type VDCC 
activity following SAH may result from either increased VDCC expression or membrane 
potential depolarization.  We provide evidence suggesting that L-type VDCC mRNA and 
protein expression is not altered in parenchymal arterioles from SAH animals.  However, 
parenchymal arteriolar myocytes were significantly depolarized at physiological 
intravascular pressures.  Our data support the hypothesis that membrane potential 
depolarization causes increased L-type VDCC-mediated Ca
2+
 influx and enhanced 
constriction following SAH.  We propose enhanced constriction of parenchymal 
arterioles may contribute to reduced cerebral blood flow and neurological deficits in SAH 
patients.  
 
2.  The smooth muscle selective L-type VDCC splice variant containing exon 9* is 
dominant in cerebral artery constriction.   
Oral administration of voltage-dependent Ca
2+
 channel antagonists is standard treatment 
in SAH patients and provides a modest beneficial effect (Treggiari-Venzi et al., 2001).  
However, these agents can also act on VDCCs in the systemic circulation leading to 
drastic reductions in vascular resistance and blood pressure.  Thus, the use of VDCC 
antagonists in SAH patients has been greatly limited by hypotension.  Therefore, the 
overall objective in Chapter 3 of this dissertation was to develop a strategy to suppress 
VDCC activity specifically in the cerebral vasculature.  We hypothesized that targeting a 
population of CaV1.2 splice variants specifically expressed by smooth muscle with 
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antisense oligonucleotides may provide a means of cerebral artery dilation while avoiding 
suppression of neuronal channels.  In addition, future administration of antisense into the 
cerebrospinal fluid of SAH model animals should limit effects to the cerebral vasculature.  
 Previous studies demonstrate that inclusion of the smooth muscle-selective 
alternatively-spliced exon 9* in CaV1.2 channels causes a shift in voltage-dependent 
activation towards more negative potentials (Liao et al., 2004).  Therefore, inclusion of 
exon 9* may be important for development of tone at physiological membrane potentials 
in vascular smooth muscle.  This finding led us to hypothesize that exon 9* CaV1.2 splice 
variants play a critical role in the regulation of cerebral artery diameter.  Data presented 
in Chapter three of this dissertation suggest that suppression of CaV1.2 channels 
containing exon 9* results in markedly reduced cerebral artery constriction in response to 
K
+
-induced membrane depolarization in vitro.  Our results suggest that exon 9* 
containing Cav1.2 channels are functionally dominant in cerebral artery constriction and 
may provide a novel target for prevention of elevated [Ca
2+



















Illustration of major arteries on the base of the brain.  The 
Circle of Willis receives blood from the basilar and internal 
carotid arteries.  These arteries are connected by the anterior 
communicating and posterior communicating arteries.  The 
major arteries supplying the cerebral hemispheres branch off 
of the Circle of Willis.  Modified from Gray, Anatomy of the 
Human Body: 20
th
 Edition. 2000 with permission.  
 
Figure 1: Cerebral blood supply. 
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Schematic representation showing pial cerebral arteries on the brain surface and 
penetrating and parenchymal arterioles within the cortex.  Superficially, the 
Virchow-Robin space is continuous with the subarachnoid space.  Distally, this space 
transitions into perivascular space separating astrocytic endofeet and vascular 
smooth muscle of parenchymal arterioles.  Modified from Edvinsson and Krause, 
Cerebral Blood Flow and Metabolism: Second Edition. 2002 with permission from 
Wolters Kluwer. 
Figure 2: Organization of pial and parenchymal vasculature. 
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Major pathways for Ca
2+
 influx and extrusion are shown.  SERCA: 
sarcoplasmic/endoplasmic reticulum Ca
2+







 exchanger; CaM: calmodulin; MLC: myosin light chain; 
MLCK: myosin light chain kinase.  






Elevation of Intravascular pressure results in increased cytosolic Ca
2+
 
and decreased diameter (constriction).  This response to increased 
pressure is abolished by the dihydropyridine L-type VDCC inhibitor 
nisoldipine or removal of Ca
2+
 from the bath solution.  Modified from 
Knot HJ and Nelson MT, Regulation of arterial diameter and wall 
[Ca
2+
]i in cerebral arteries of rat by membrane potential and 
intravascular pressure. J. Physiol., 1998 with permission. 
Figure 4: Role of VDCCs in pressure-induced constriction. 
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Top- On-cell patch recording from rabbit mesenteric artery myocytes.  Traces 
show single Ca
2+
 channel openings at -60 and -40 mV from holding potential 
of -95 mV, using Ba
2+
 as a charge carrier in the presence of  the 
dihydropyridine L-type VDCC agonist Bay R 5417.  Bottom- Steady state 
Popen  (from single channel openings during 1 second voltage pulses) over 
physiological range of membrane potentials.  Inset shows Popen over a wider 
range of voltages.  Modified from Nelson MT et al., Calcium channels, 
potassium channels and voltage dependence of arterial smooth muscle tone. 
Am J Physiol., 1990 with permission from American Physiological Society. 
Figure 5: Voltage-dependence of VDCC open-state probability. 
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The α1 subunit consists of four homologous domains (I-IV).  Each domain 
contains six transmembrane segments (S1-S6).  The S4 segments of each domain 
confers voltage-sensitivity to the channel.  Exons encoding the α1 subunit are 
numbered.  Boundaries between exons are denoted by perpendicular lines.  
Modified from Liao P. et al., Splicing for alternative structures of CaV1.2 
calcium channels in cardiac and smooth muscles., Cardiovasc Res., 2005 with 
permission from Oxford University Press.  




Enhanced pressure-induced constriction of small diameter cerebral 
arteries from SAH model rabbits.  Representative diameter traces from 
arteries isolated from control unoperated (Control, A) and SAH model 
animals (B).  Solid lines represent active constrictions in response to 
elevated pressure.  Dashed lines represent passive diameter obtained in 
Ca
2+
-free physiological saline solution containing the L-type VDCC 
inhibitor diltiazem.  Modified from Ishiguro M. et al., Enhanced 
myogenic tone in cerebral arteries from a rabbit model of subarachnoid 
hemorrhage, Am J Physiol., 2002 with permission from American 
Physiological Society. 
Figure 7: Impact of SAH on cerebral artery tone. 
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CHAPTER 2: JOURNAL ARTICLE
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Fundamental increase in pressure-dependent constriction of brain 
parenchymal arterioles from subarachnoid hemorrhage model rats due 
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Intracerebral (parenchymal) arterioles are morphologically and physiologically unique in 
comparison to pial arteries and arterioles.  The ability of subarachnoid hemorrhage 
(SAH) to induce vasospasm in large diameter pial arteries has been extensively studied, 
although the contribution of this phenomenon to patient outcome is controversial.  
Currently, little is known regarding the impact of SAH on parenchymal arterioles, which 





]i) and membrane potential measurements were used to 
assess the function of intact brain parenchymal arterioles isolated from unoperated 
(control), sham-operated and SAH model rats.  At low intravascular pressure (5 mmHg), 
membrane potential and [Ca
2+
]i were not different in arterioles from control, sham and 
SAH animals.  However, raising intravascular pressure caused significantly greater 
membrane potential depolarization, elevation in [Ca
2+
]i and constriction in SAH 
arterioles.  This SAH-induced increase in [Ca
2+
]i and tone occurred in the absence of the 
vascular endothelium and was abolished by the L-type voltage-dependent calcium 
channel (VDCC) inhibitor nimodipine.  Arteriolar [Ca
2+
]i and tone were not different 
between groups when smooth muscle membrane potential was adjusted to the same 
value.  mRNA and protein levels of the L-type VDCC, CaV1.2, were similar in 
parenchymal arterioles isolated from control and SAH animals, suggesting SAH did not 
cause VDCC upregulation.  We conclude that enhanced parenchymal arteriolar tone 
following SAH is driven by smooth muscle membrane potential depolarization, leading 
to increased L-type VDCC-mediated Ca
2+
 influx.  We propose that inhibition of VDCCs 
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by calcium channel antagonists or hyperpolarizing vasodilators may be therapeutic 
strategies to enhance cortical blood flow in SAH patients.  
 
 
Keywords: voltage-dependent calcium channels, vascular smooth muscle, cerebral blood 
flow, endothelium, ion channels 
64 
 
Introduction   
Cerebral blood flow is regulated by the diameter of resistance arteries and arterioles both 
on the surface of the brain and within the brain parenchyma. Parenchymal arterioles, 
unlike pial arteries and arterioles, lack extrinsic innervation and are encased by astrocytic 
processes (“endfeet”) (20, 28).  The close association of this microvasculature with 
astrocytic endfeet is essential for functional hyperemia, whereby focal increases in 
neuronal activity are coupled to vasodilation of nearby arterioles and increased blood 
flow (7, 18, 28, 42).  In addition to their role in neurovascular coupling, parenchymal 
arterioles also contribute significantly to autoregulation of global cerebral blood flow and 
account for approximately 40% of total cerebral vascular resistance (16).  Thus, 
parenchymal arterioles are a unique vascular bed, central in the regulation of both local 
and global cerebral blood flow.   
Pial arteries and arterioles constrict to physiological increases in intravascular 
pressure via a process involving vascular smooth muscle membrane potential 
depolarization, activation of voltage-dependent Ca
2+







(2, 17, 21, 33, 41).  Recent work has established that 
pressure-dependent constriction, or myogenic tone, is significantly greater in isolated 
parenchymal arterioles than pial arteries (4).  The cellular basis for enhanced pressure-
dependent myogenic tone in the parenchymal vasculature is unclear.  Further, the 
relationship between intravascular pressure, membrane potential, [Ca
2+
]i and diameter of 
isolated parenchymal arterioles is not known.   
65 
 
Dysfunction of the cerebral microcirculation, including parenchymal arterioles, 
has been implicated in a number of brain pathologies, including vascular dementia, 
Alzheimer’s disease and the development of delayed neurological deficits associated with 
cerebral aneurysm rupture and subarachnoid hemorrhage (SAH) (27, 58).  A number of 
studies have suggested that SAH causes enhanced constriction of the microcirculation to 
limit parenchymal blood flow (35, 44, 51, 52, 58).  However, the small size of 
parenchymal arterioles (maximum lumenal diameter: 30-60 µm) poses a significant 
technical challenge to directly examine their function (45, 53).  Consequently, the impact 
of SAH on the regulation of parenchymal arteriolar diameter is unknown.   
The objective of the present study was to elucidate the relationship between 
intravascular pressure, [Ca
2+
]i, membrane potential and diameter of isolated parenchymal 
arterioles from unoperated, sham-operated and SAH model rats.  In unoperated animals, 
membrane potential depolarization and elevations in [Ca
2+
]i are enhanced at lower 
intravascular pressures in parenchymal arterioles compared with pial arteries.  Our results 
are consistent with the concept that intravascular pressure constricts parenchymal 
arterioles through smooth muscle depolarization, activation of VDCCs, and elevation of 
intracellular calcium.  Furthermore, our data indicate that following SAH, intravascular 






Animals.  Sprague Dawley rats (males, 300-350 g, 10-15 weeks; Charles River 
Laboratories, Saint Constant, Quebec, Canada) were used in this study. All experiments 
were conducted in accordance with the
 
Guidelines for the Care and Use of Laboratory 
Animals (NIH Publication
 
85-23, Revised 1996) and followed protocols approved by the 
Institutional
 




Rat SAH model. Animals were initially anesthetized by isoflurane (5%) using an 
induction chamber, then maintained on
 
isoflurane (2-2.5%) anesthesia with the aid of a 
nose cone.  A small (0.5-1.5 cm), longitudinal, midline suboccipital incision
 
was centered 
over the foramen magnum, and the neck muscles were
 
dissected until dura was 
visualized.  Autologous unheparinized blood (0.5 ml) drawn from the tail artery was 
injected into the cisterna magna (day 0) using a 25-guage butterfly needle (38).
  
The 
animal was then positioned on an incline board at a 45° angle
 
with the head down in 
neutral position for 30 min. Twenty four hours later, a second injection of blood was 
delivered by repeating the above procedure.  Sham-operated
 
animals were treated in a 
similar manner except:
 
injection of 0.5 ml of saline was substituted for injection of 0.5 ml 
of unheparinized blood.
  
Buprenorphine (0.01 mg/kg) was given every 12 h (for 36 h, 
then
 
as needed) as an
 
analgesic.  On day 4, animals were euthanized under deep 
pentobarbital anesthesia by decapitation and parenchymal arterioles (30-60 μm in 
diameter) were dissected from the middle cerebral artery territory (8) in cold (4˚C) 
MOPS-buffered saline solution of the following composition (in mM):  145 NaCl, 5 KCl, 
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1 MgSO4, 2.5 CaCl2, 1 KH2PO4, 0.02 EDTA, 3 3-(N-morpholino)propanesulfonic acid, 2 
pyruvate, 5 glucose, 1% bovine serum albumin (pH 7.4).   
Measurement of intracellular Ca
2+
 concentration and diameter.  Freshly isolated 
parenchymal arterioles were cannulated on glass micropipettes mounted in a 5 ml 
myograph chamber (University of Vermont Instrumentation and Model Facility) as 
described previously (8, 30).  Vascular endothelium was removed from some arterioles 
by passing an air bubble through the lumen following cannulation of one end (55).  
Following cannulation, arterioles were loaded with the ratiometric Ca
2+
-sensitive dye 
fura-2 (acetoxymethyl (AM) ester membrane-permeable form) by incubating in MOPS 
buffered saline solution containing fura-2 AM (5 μM) (Invitrogen, Carlsbad, CA) with 
pluronic acid (0.1%) (Invitrogen, Carlsbad, CA) at room temperature (~22˚C) for 45 
minutes.  Next, the myograph chamber was mounted on a Nikon TE2000-S inverted 
fluorescence microscope.  To allow for equilibration and de-esterification of fura-2 AM, 
arterioles were pressurized to 5 mmHg and continuously superfused (37˚C, 30 min) with 
artificial cerebrospinal fluid (aCSF) of the following composition (in mM): 125 NaCl, 3 
KCl, 18 NaHCO3, 1.25 NaH2PO4, 1 MgCl2, 2 CaCl2, 5 glucose aerated with 5% CO2, 
20% O2, 75% N2.  Bath pH was closely monitored and maintained at 7.30-7.35 (11).   
Following the equilibration period, studies were performed in which intravascular 
pressure was increased to 10, 20, 40 and 60 mmHg or extracellular K
+
 was increased 
from 3 mM to 60 mM using aCSF made by isosmotic replacement of NaCl with KCl.  
Fluorescence ratio was obtained from background corrected ratio
 
of the 510 nm emission 
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from arterioles alternately excited
 
at 340 and 380 nm with hardware and software 




]i was estimated using the following equation 
(19): [Ca
2+





-saturated conditions, respectively, were measured from 
a separate set of ionomycin-treated arterioles, and β was determined.   Calibration values 
were not significantly different between arterioles obtained from either healthy or SAH 
animals (Table 1) and were pooled for calculations of [Ca
2+
]i, using an apparent 
dissociation constant
 
(Kd) of 282 nM of fura-2 for Ca
2+
 (33).  Total fluorescence counts 
(photomultiplier signal at F340 + F380) measured immediately following the equilibration 
period were not significantly different between endothelium intact (539 ± 66 counts) and 
denuded arterioles (532 ± 40 counts), suggesting  endothelial loading with fura-2 was 
negligible.   
Luminal diameter of arterioles was simultaneously recorded with [Ca
2+
]i using a CCD 
camera and the edge-detection function of IonOptix software.  Constriction is presented 
as a decrease in arterial diameter relative to the maximum diameter at a given pressure 
obtained at the end of each experiment using Ca
2+
-free aCSF containing nimodipine (300 
nM) (30, 59). 
Measurement of membrane potential: Arterioles were cannulated as described above 
and pressurized to either 5 or 40 mmHg.  Smooth muscle membrane potential was 
measured by insertion of a sharp glass microelectrode
 
( 100-MΩ resistance) filled with 
0.5 M KCl into the vessel wall.
  





negative potential deflection upon entry, 2) a stable membrane potential
 for ≥30 seconds, 
and 3) an abrupt positive potential deflection
 
upon removal (33, 46). Measurements were 
made using an electrometer (World
 
Precision Instruments), and recorded via computer
 
using Axotape and Dataq software. 
RT-PCR: Total RNA was extracted using RNA STAT-60 total RNA/mRNA isolation 
reagent (Tel-test, Friendswood, TX) and reverse transcribed to cDNA using SuperScript 
First-Strand synthesis system (Invitrogen, Carlsbad, CA) (43).  Polymerase chain reaction 
was performed using primers detecting CaV1.2 (Genbank accession No. X55763) 
[forward (5’-CAGCAGGTCCTATGTCAGCA-3’), reverse (5’- 
CCGACAGCAGTGAATGAAGA-3’)], and 18S (Genbank accession No. M11188) 
[forward (5’-AGTCGCCGTGCCTACCAT-3’), reverse (5’-GCCTGCTGCCTTCCTTG-
3’)].  Amplification was performed with a taq core PCR kit (Qiagen, Valencia, CA) using 
a thermocycler (Techne, Burlington, NJ).  Band intensity in the linear range of 
amplification (CaV1.2: 29 cycles; 18S rRNA: 30 cycles) was quantified using Quantity 
One 1-D Analysis software (Bio-Rad, Hercules, CA).  Expression levels were normalized 
to band intensity values for 18S rRNA.  
 
Western blot analysis: Parenchymal arterioles were pooled from two animals per sample 
(n).  Whole parenchymal arteriole lysates were prepared by sonication (20 min, 4˚C) in a 
triton lysis buffer solution containing (in mM): 50 HEPES, 150 NaCl, 1 EGTA, 1.5 
MgCl2, 1% triton-X, 10% glycerol with protease inhibitors (10 μg/mL of leupeptin, 
aprotinin, antipain and 10 mM phenylmethylsulfonyl fluoride).  Tissue debris and nuclear 
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fragments were removed by centrifugation at 7000 rpm (10 min, 4°C).  The whole cell 
lysate was obtained as the supernatant and protein concentration was determined by 
Bradford assay.  Molecular weight marker (Invitrogen, Carlsbad, CA) was loaded as a 
size standard and protein samples (~15 μg total protein) were separated under reducing 
conditions on a 7.5% polyacrylamide gel (Bio-Rad, Hercules, CA) by electrophoresis.  
Samples were run at 120 V for 1.5 hours on an 8x10-cm electrophoresis cell (BioRad, 
Hercules, CA) and electrophoretically transferred to a nitrocellulose membrane at 80 V 
for 2 hours (4˚C).  The membranes were washed in tris-buffered saline with 0.1% Tween-
20 (TBS-T), and blocked with 10% nonfat dried milk in TBS-T (1 hour, room 
temperature).  Membranes were then incubated with the specific polyclonal antibodies 
against CaV1.2 (1:200, overnight, 4˚C, Alomone, Jerusalem), or monoclonal antibody 
against GAPDH (1:100,000, 30 min, room temperature, Sigma, St. Louis, MO), prepared 
in 5% nonfat dried milk in TBS-T.  Membranes were then incubated (1 hour; room 
temperature) with horseradish peroxidase-labeled donkey anti-rabbit IgG (CaV1.2, 
1:5000; GAPDH, 1:10,000, GE Healthcare, Waukesha, WI) in TBS-T containing 5% 
nonfat dried milk.  Bands were identified by chemiluminescence and exposed to X-ray 
films.  Densitometry for immunoreactive bands was performed using NIH software 
(ImageJ) and density was expressed as a percent of GAPDH density for each lane.  
 
Statistical analysis.  Values are presented as means ± SEM.  One-way analysis of 
variance followed by Tukey multiple comparison test was used in the comparison of 
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multiple groups.  Student’s t-test was used in the comparison of two groups.  Statistical 
significance was considered at the level of p < 0.05 (*) or p < 0.01 (**).  
 




Parenchymal arterioles isolated from SAH model animals exhibit elevated cytosolic 
Ca
2+
 and enhanced tone at physiological intravascular pressures.   
To assess the role of cytosolic Ca
2+
 in pressure-induced parenchymal arteriolar 
constriction, simultaneous measurements of [Ca
2+
]i and diameter were obtained from 
freshly isolated parenchymal arterioles loaded with the ratiometric Ca
2+
 indicator fura-2.  
In response to step-wise increases in intravascular pressure, arterioles from unoperated 





]i) and active constriction.  At low intravascular pressure (5-10 mmHg), 
similar levels of [Ca
2+
]i and tone were observed in vessels isolated from all groups.  
However, as intravascular pressure was increased to physiological levels (i.e. 20 to 60 
mmHg) (16, 23), arterioles from SAH animals exhibited markedly enhanced levels of 
[Ca
2+
]i and constriction compared with arterioles from control and sham-operated animals 
(Fig. 1A-E).  For example, at 40 mmHg, [Ca
2+
]i was ~33% higher in arterioles from SAH 
animals (349 ± 11 nM, n = 5) compared with arterioles isolated from control animals 
(261 ± 8 nM, n = 6).  Corresponding to this SAH-induced increase in [Ca
2+
]i, at 40 
mmHg, vessels from SAH animals constricted 29 ± 2 μm (53 ± 4% decrease in diameter, 
n = 5), compared with a constriction of 14 ± 1 μm in arterioles from control animals (29 ± 
2% decrease in diameter, n = 6).  Although, [Ca
2+
]i and tone at a given pressure were 
greater in arterioles from SAH model animals, the relationship between [Ca
2+
]i and 
constriction were remarkably similar between arterioles isolated from control and SAH 
animals (Fig. 1F).  These data suggest that elevated [Ca
2+
]i is sufficient to account for 
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enhanced pressure-induced constriction of parenchymal arterioles from SAH model 
animals.   
 The role of L-type VDCCs in SAH-induced elevation of [Ca
2+
]i and arteriolar 
tone was examined by applying the dihydropyridine L-type VDCC inhibitor nimodipine 
(300 nM) prior to increasing intravascular pressure.  Pressure-induced increases in [Ca
2+
]i 
and constriction were abolished by nimodipine in control and SAH groups (Fig. 1D,E) 
indicating that Ca
2+
 influx in parenchymal myocytes from both control and SAH animals 
is mediated by L-type VDCCs.  These results indicate that elevation of intravascular 
pressure leads to greater L-type VDCC-mediated Ca
2+
 influx, increased [Ca
2+
]i and 
enhanced constriction of parenchymal arterioles from SAH animals. 
 
Increased L-type VDCC activity, rather than increased channel expression, mediates 
enhanced parenchymal arteriolar constriction following SAH. 
SAH-induced Ca
2+
 influx via L-type VDCCs could reflect either an increase in the 
density of functional channels or a more depolarized membrane potential leading to an 
increase in the open-state probability (Popen) of existing channels.  To explore whether 
upregulation of L-type VDCC expression occurs following SAH, RT-PCR was used to 
examine CaV1.2 mRNA, encoding the predominantly expressed L-type VDCC pore-
forming α1 subunit in vascular smooth muscle (3, 40).  Expression of CaV1.2 mRNA, 
normalized to 18S rRNA levels, was similar in parenchymal arterioles isolated from 
control and SAH animals (Fig. 2A, B).  In addition, protein levels of CaV1.2, determined 
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by Western blot, were not different between groups (Fig. 2C, D).  These data suggest that 




following SAH.   
 Based on the above data, we hypothesized that greater smooth muscle 
membrane potential depolarization, rather than increased VDCC expression, underlie 
enhanced pressure-induced constriction of parenchymal arterioles following SAH.  Thus, 
at a given membrane potential, similar [Ca
2+
]i and constriction would be predicted for 
arterioles from control and SAH animals.  To test this possibility, [Ca
2+
]i and constriction 




]o) was elevated from 3 mM to 
60 mM by isosmotic replacement of NaCl with KCl in the bath solution.  In pial arteries, 
membrane potential closely follows the K
+
 equilibrium potential (EK) at [K
+
]o greater 
than 16 mM (25, 33).  This also appears to be the case with parenchymal arterioles, as 
smooth muscle membrane potential in arterioles bathed in 60 mM [K
+
]o was very close to 
theoretical EK (Control: -22 ±  1 mV, n = 4; SAH –21 ± 1 mV, n = 4), predicted by the 
Nernst equation (-22 mV; assuming intracellular [K
+
] = 140 mM) (Fig. 3A).  When 
smooth muscle membrane potential was “clamped” using 60 mM [K+]o, [Ca
2+
]i was not 
different in parenchymal arterioles isolated from healthy (393 ± 18 nM, n = 7) and SAH 
animals (388 ± 14 nM, n = 5) (Fig. 3B).  Constriction was also similar for control and 
SAH arterioles in the presence of 60 mM [K
+
]o (Fig. 3C).  Elevations in [Ca
2+
]i and 
constrictions in response to 60 mM [K
+
]o were abolished by nimodipine (300 nM) in 
arterioles from both groups (Fig. 3B,C).  These findings suggest that enhanced pressure-
induced constrictions following experimental SAH likely reflect differences in smooth 




Elevation of intravascular pressure leads to greater smooth muscle membrane 
potential depolarization following experimental subarachnoid hemorrhage. 
To directly assess the impact of SAH on smooth muscle membrane potential, myocytes 
of intact parenchymal arterioles were impaled from the adventitial surface using 
intracellular microelectrodes.  At low intravascular pressure (5 mmHg), membrane 
potential was similar in arterioles isolated from control (-58 ± 2 mV, n = 4) and SAH 
animals (-59 ± 2 mV, n = 4) (Fig. 4A).  Raising intravascular pressure from 5 to 40 
mmHg resulted in membrane potential depolarization in arterioles from both groups.  
However, parenchymal arteriolar myocytes from SAH animals were significantly more 
depolarized at 40 mmHg (-28 ± 1 mV; n = 4) compared with arterioles from control 
animals (-35 ± 1 mV; n = 5) (Fig. 4B,C).  These data suggest that greater pressure-
dependent membrane potential depolarization underlies enhanced parenchymal arteriolar 
tone following SAH. 
 
Endothelial function promotes vasodilation in parenchymal arterioles following SAH.  
Membrane potential of arteriolar myocytes can be modulated by the vascular 
endothelium (17).  Previous work has indicated that endothelial SKCa and IKCa
 
channel 
activity promotes smooth muscle membrane potential hyperpolarization and plays an 
important role in the regulation of parenchymal arteriolar tone and cortical blood flow (5, 
14).  Thus, to assess endothelial function in parenchymal arterioles following SAH, we 







 channels (26, 50), on arteriolar [Ca
2+
]i and 
diameter.  At 40 mmHg intravascular pressure, NS309 (1 μM) caused hyperpolarization 
in endothelium-intact arterioles from both control (–67 ± 2 mV, n = 5) and SAH animals 
(–67 ± 2 mV, n = 4) (Fig. 5A).  Consistent with membrane potential hyperpolarization, 
NS309 also caused a significant decrease in [Ca
2+
]i in arterioles from control (242 ± 7 nM 
to 141 ± 15 nM; n = 4) and SAH animals (330 ± 11 nM to 151 ± 14 nM; n = 4) and 
induced >90% vasodilation in both groups (Fig. 5B).  These results demonstrate that 
activation of endothelial SKCa and IKCa channels causes a similar marked membrane 
potential hyperpolarization and vasodilation of arterioles from control and SAH animals.  
 To examine whether altered endothelial function contributes to elevated [Ca
2+
]i 
and enhanced constriction of parenchymal arterioles from SAH animals, [Ca
2+
]i and 
diameter were measured in endothelial-denuded vessels.  The endothelium was removed 
from parenchymal arterioles by passing an air bubble through the vessel lumen during the 
cannulation procedure.  Although endothelium-denuded arterioles displayed increased 
[Ca
2+
]i and constriction compared to corresponding endothelium-intact vessels in both 
groups, these parameters remained significantly higher in parenchymal arterioles from 
SAH animals (Fig. 5C).  Application of NS309 was used to confirm absence of 
endothelial function in denuded vessels.  Consistent with expression of SKCa and IKCa 
channels in endothelial cells but not smooth muscle, NS309 had no effect on [Ca
2+
]i or 
diameter in denuded arterioles from either control or SAH animals (Fig 5D).  These 
results suggest that SAH-induced elevated [Ca
2+
]i and enhanced arteriolar tone result 
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from a direct modulation of smooth muscle membrane potential, rather than decreased 




Here, we report that cytosolic Ca
2+
 is elevated and pressure-dependent constriction is 
enhanced in parenchymal arterioles from experimental SAH animals.  Our data 
demonstrate elevations in intravascular pressure cause greater membrane potential 
depolarization following SAH, leading to increased activity of L-type VDCCs and 
enhanced constriction.  The following observations are consistent with these novel 
findings: 1) Increasing intravascular pressure resulted in significantly greater elevation of 
[Ca
2+
]i and enhanced myogenic tone in parenchymal arterioles isolated from SAH model 
animals.  2)  Pressure-induced elevations in [Ca
2+
]i and myogenic tone were abolished by 
the L-type VDCC inhibitor nimodipine.  3)  Arteriolar [Ca
2+
]i and constriction were 
similar in arterioles from control and SAH animals when membrane potential was 
clamped at EK (≈ -22 mV) using 60 mM extracellular [K
+
].  4)  At 40 mmHg, smooth 
muscle membrane potential was approximately 7 mV more depolarized in arterioles 
isolated from SAH versus control animals.  5)  CaV1.2 mRNA and protein expression 
were not altered by SAH.  6)  Differences in [Ca
2+
]i and tone at 40 mmHg were 
independent of vascular endothelium. In addition, endothelium-dependent 




to basal levels and 
dilated parenchymal arterioles from control and SAH animals. 
 This work also provides novel information regarding the physiological function 
of arterioles within the brain parenchyma.  Previous studies have found that parenchymal 
arterioles develop significantly greater pressure-induced myogenic tone compared with 





]i to these differences, we compared our data presently obtained for isolated 
parenchymal arterioles from unoperated rats with data previously reported by Knot and 
Nelson (33) for rat middle cerebral arteries.  At a given level of intravascular pressure, 
parenchymal arterioles display greater [Ca
2+
]i compared with middle cerebral arteries 
(Fig. 6A) (i.e. 267 nM versus ~190 nM, respectively, at 60 mmHg intravascular 
pressure).  However, the relationships between [Ca
2+
]i and constriction are remarkably 
similar in these vascular beds (Fig. 6B), suggesting that in healthy animals, enhanced 
pressure-dependent constriction observed in parenchymal arterioles results from a greater 
elevation in [Ca
2+
]i.  A comparison of the relationship between intravascular pressure and 
membrane potential indicates that at a given intravascular pressure, smooth muscle 
membrane potential is more depolarized in parenchymal arterioles.  For example, 
membrane potential measured in parenchymal myocytes was approximately -35 mV at 40 
mmHg; however, this level of membrane potential depolarization was not reached in 
middle cerebral arteries until intravascular pressure was increased to 80-100 mmHg (33).  
Thus, the relationship between intravascular pressure and membrane potential appears to 
be shifted towards lower pressures in parenchymal arterioles, thereby accounting for the 
similar leftward shift in the pressure versus [Ca
2+
]i relationship (Fig. 6A).  This functional 
distinction may be critical for development of parenchymal arteriolar tone at the lower 
physiological pressures they experience in vivo.    
 We also demonstrate that the relationship between intravascular pressure and 
[Ca
2+
]i is further shifted to the left in parenchymal arterioles following SAH.  This effect 
is correlated with enhanced pressure-induced depolarization at physiological 
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intravascular pressure in arterioles from SAH animals.  Hence, increasing intravascular 
pressure within the physiological range leads to greater membrane potential 
depolarization, increased Ca
2+
 influx via L-type VDCCS, elevated [Ca
2+
]i and enhanced 
constriction of parenchymal arterioles following experimental SAH.  However, when 
membrane potential is equalized between SAH and control arterioles using 60 mM [K
+
]o 
or NS309, L-type VDCC-mediated Ca
2+
 influx and arteriolar [Ca
2+
]i is similar between 
groups.  Thus, our data imply that increased Ca
2+
 influx following SAH reflects 
membrane potential depolarization, rather than increased VDCC density at the plasma 
membrane.  The membrane potentials reported here for parenchymal arteriolar myocytes 
(± SAH) are within the range in which L-type VDCC current is steeply voltage-
dependent (41).  At voltages between -60 and -30 mV, VDCC open-state probability is an 
exponential function of membrane potential and it is estimated that depolarization of 7 
mV (-35 mV to -28 mV, Fig. 4C) could more than double VDCC Popen from 0.016 to 
0.035 (41).  Therefore, the depolarization observed following SAH in this study is 
consistent with a substantial increase in VDCC activity, leading to a marked increase in 
Ca
2+
 entry in parenchymal arteriolar myocytes. 
Vascular smooth muscle membrane potential can be modulated by vasoactive 
factors released by the endothelium.  A number of studies suggest that nitric oxide-
mediated vasodilation is impaired in large diameter cerebral arteries in experimental 
models of SAH (6, 17).  Similar findings have been reported in basilar arteries of SAH 
patients (24).  However, the contribution of endothelial dysfunction to cerebral artery 
constriction is controversial and others have reported that endothelium-dependent 
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relaxation is unchanged following SAH (10, 39).  The relative contribution of 
endothelium-dependent vasodilators to vascular tone may depend on vessel size and the 
effects of SAH on endothelial function may differ between large and small diameter 
vessels.  Whereas basal NO production seems to control tone in both cerebral arteries and 
arterioles, the contribution of endothelium-derived hyperpolarizing factor (EDHF) to 
blood flow regulation may be greater at the level of the microcirculation (57).  Previous 
studies suggest that EDHF-mediated relaxation requires the activity of endothelial SKCa 
and IKCa (13, 60) and these channels are involved in modulating basal tone in 
parenchymal arterioles, but not in middle cerebral arteries (5).  Here, we show that 
activation of endothelial SKCa and IKCa channels with NS309 caused a similar reduction 
of [Ca
2+
]i to basal levels and profound dilation of parenchymal arterioles from both 
control and SAH animals.  Further, endothelial removal did not ablate SAH-induced 
pressure-induced increases in [Ca
2+
]i and myogenic tone.  Therefore, reduced endothelial 
vasodilator influence cannot account for enhanced vasoconstriction of parenchymal 
arterioles following SAH.  These findings are in agreement with previous data for small 
diameter brainstem arteries (32) and penetrating arterioles (53) and suggest that a direct 
alteration of smooth muscle membrane potential regulation contributes to dysfunction of 
cerebral microvessels from SAH animals.   
 Our results indicate that elevated parenchymal arteriolar [Ca
2+
]i and tone 
following SAH depends on intravascular pressure.  At this time, it is unclear how SAH 
causes enhanced pressure-dependent depolarization in parenchymal arterioles.  
Activation of mechanosensitive non-selective cation channels belonging to the transient 
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receptor potential family (i.e. TRPC6,TRPM4) is reported to contribute to membrane 
potential depolarization of cerebral artery myocytes to increased pressure (15, 56).  Thus, 
increased expression or activity of these channels following SAH may lead to membrane 
depolarization and enhanced VDCC activity.  On the other hand, SAH-induced 
depolarization may also result from suppressed hyperpolarizing influence.  For example, 
significant voltage-dependent K
+
 channel (KV)-mediated current is observed at 
physiological membrane potentials (47) and activation of these channels represents an 
important feedback mechanism in response to pressure-induced depolarization.  
Consistent with this hypothesis, inhibition of KV channels with 4-aminopyridine causes 
membrane potential depolarization and vasoconstriction (34, 49).  Numerous studies have 
suggested that substances within blood may lead to membrane potential depolarization of 
cerebral artery myocytes via suppression of K
+
 channel activity (17, 22, 48).  For 
example, using pial arteries from a rabbit SAH model, our laboratory has shown that 
acute exposure of vascular smooth muscle to the blood component oxyhemoglobin can 
cause internalization of (KV1.5) via a mechanism involving protein tyrosine kinase 
activation (29, 36).  Others have additionally demonstrated that mRNA and protein levels 
of KV2.2 channels were decreased in basilar arteries from a canine SAH model (31).    
Hence, further studies are required to determine whether KV channel suppression 
contributes to enhanced pressure dependent depolarization of parenchymal arteriolar 
myocytes in SAH animals.     
 Enhanced constriction of cerebral arteries and arterioles associated with SAH 
requires Ca
2+
 influx via VDCCs in vascular smooth muscle (54).  Currently, oral 
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administration of the L-type VDCC inhibitor nimodipine is regarded as standard therapy 
for patients with SAH and is associated with a modest improvement in clinical outcome 
(37).  The mechanism of the beneficial effects of nimodipine in SAH patients is unclear, 
however this agent does not significantly reduce large artery, or “angiographic” 
vasospasm (1).  Our results are consistent with speculation that nimodipine treatment 
may be effective for reversal of enhanced constriction of microvessels within the brain 
parenchyma, which are beyond the resolution limits of angiography (12).  Although 
further studies are required to examine this possibility, such a mechanism would point to 
significant role for microcirculatory dysfunction in the development of delayed 
neurological deficits in SAH patients.   
 To summarize, we provide evidence that myocytes of parenchymal arterioles are 
more depolarized at physiological intravascular pressures leading to increased L-type 
VDCC activity, elevated [Ca
2+
]i and enhanced constriction.  Furthermore, we 
demonstrate that inhibitors of L-type VDCCs (i.e. nimodipine) as well as agents that 
cause hyperpolarization (i.e. NS309) are effective in reducing [Ca
2+
]i and dilating 
parenchymal vessels from SAH animals.  We propose that therapeutic strategies targeting 
this enhanced vasoconstriction of the cerebral microcirculation may be beneficial in 
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Figure 1: Elevated cytosolic Ca
2+
 and enhanced myogenic tone in parenchymal 
arterioles from SAH animals.  A-C: Representative simultaneous [Ca
2+
]i and diameter 
measurements obtained from intact arterioles isolated from unoperated (control; A), 
sham-operated (sham; B) and SAH (C) animals.  Recordings were obtained during step-
wise increases in intravascular pressure and subsequent nimodipine application (300 nM) 
at 60 mmHg.  D,E.  Summary of [Ca
2+
]i (D) and constriction (E) obtained from 
unoperated (control; n = 6), sham-operated (sham; n = 6) and SAH (n = 5) animals in the 
absence and presence of 300 nM nimodipine.  Myogenic tone is expressed as a percent 
decrease from the passive diameter (obtained in Ca
2+
-free aCSF with 300 nM 
nimodipine) of arterioles at a given intravascular pressure.  Passive diameters were not 
statistically different between groups at any intravascular pressure tested.  *P<0.05, 
**P<0.01 vs. control healthy and sham-operated.  F.  Relationship between [Ca
2+
]i and 
constriction for arterioles isolated from control and SAH animals derived from summary 
data depicted in panel D and E.  Numbers represent intravascular pressure (mmHg).  The 
concentration of Ca
2+
 causing half-maximal arteriolar constriction, obtained from 
Boltzmann fit of data (using 60 mM [K
+
]o as maximum; see figure 3), were similar 
between groups (Control: 226 ± 26 nM, n = 5-7; SAH: 240 ± 10 nM, n = 5).  
 
Figure 2:  CaV1.2 mRNA and protein expression is unchanged following SAH.  RT-
PCR and Western blotting were used to measure CaV1.2 mRNA and protein, 
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respectively.  A.  Representative PCR gel showing bands corresponding to CaV1.2 and 
18S ribosomal RNA (rRNA).  B.  Summary of RT-PCR data obtained from quantitative 
analysis of band intensities for arterioles isolated from control (n = 6) and SAH (n = 6) 
animals.  CaV1.2 mRNA is expressed as relative to 18S rRNA.  NS: P>0.05 vs. control.  
C.  Representative Western blot images for CaV1.2 and GAPDH using whole cell lysates 
of parenchymal arterioles (each lane represents pooled arterioles from two animals).  
CaV1.2 immunoreactivity (~200-240 kDa) was observed as a doublet representing the full 
length and truncated forms of CaV1.2 (9).  GAPDH (~36 kDa) was used as an internal 
standard.  D.  Summary of Western blot data obtained by densitometry using ImageJ 
software (NIH).  CaV1.2 protein levels were normalized to GAPDH and expressed as 
fold-change compared to corresponding control in each experiment (n = 4).  NS: P>0.05 
vs. control. 
 
Figure 3:  Elevated arteriolar Ca
2+
 and enhanced constriction following SAH 
depend on membrane potential depolarization.  A.  Summary membrane potential data 





]o).  Membrane potential closely matched the theoretical EK of -22 
mV in arterioles from both control (n = 4) and SAH animals (n = 4). B,C.  Summary data 
showing [Ca
2+
]i (B) and constriction (C; percent decrease in diameter) in control (n = 7) 
and SAH arterioles (n = 5) exposed to aCSF containing either 3 mM or 60 mM [K
+
]o.  
Nimodipine (300 nM) reduced [Ca
2+




Figure 4:  Myocytes of pressurized parenchymal arterioles are depolarized following 
SAH.  A-B.  Representative smooth muscle membrane potential measurements in 
arterioles isolated from control and SAH animals at 5 mmHg (A) and 40 mmHg (B) 
intravascular pressure.  Scale bars represent 10 seconds.  C. Summary of membrane 
potential measurements obtained at 5 and 40 mmHg.  At 40 mmHg, myocytes of 
arterioles isolated from SAH animals were significantly more depolarized (-28 ± 1 mV, n 
= 4) compared with myocytes of arterioles isolated from control animals (-35 ± 1 mV, n 
= 5) **P<0.01 vs. control. 
 
Figure 5: Elevated [Ca
2+
]i and enhanced myogenic tone following SAH is 
independent of endothelial function.  A.  Summary of membrane potential 
measurements obtained from pressurized (40 mmHg) endothelium-intact parenchymal 
arterioles in the presence of NS309 (1 µM).  B.  Summary of [Ca
2+
]i and dilation resulting 
from NS309 (1 µM) application for endothelium-intact parenchymal arterioles from 
control (n = 4) and SAH animals (n = 4).  C.  Summary of [Ca
2+
]i and myogenic tone 
(percent decrease in diameter) obtained from endothelium-denuded arterioles from 
control (n = 5) and SAH animals (n = 5).  Endothelium was removed by passing an air 
bubble through the vessel lumen for ~30 seconds.  **P<0.01 vs. control  D.  Summary of 
[Ca
2+
]i and dilation resulting from NS309 (1 µM) application for endothelium-denuded 





Figure 6:  The relationship between intravascular pressure, cytosolic Ca
2+
 and 
diameter of parenchymal arterioles vs. pial arteries from control animals.  A.  
Relationship between intravascular pressure and [Ca
2+
]i for parenchymal arterioles and 
middle cerebral arteries (MCA; obtained from results published in Knot et al., 1998) (33)  
B.  Relationship between [Ca
2+
]i and constriction for parenchymal arterioles and middle 
cerebral arteries (33).  Constriction is expressed as a percentage of maximal constriction 
obtained in 60 mM [K
+
]o (see figure 4). 
 
Table 1: Fura-2 Calibration values.  Rmin, Rmax and β was determined from a separate 
set of arterioles (see Methods).  No differences were found among control (n = 4) and 







Chapter 3 Figure 1: Elevated Ca
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Figure 3: Elevated arteriolar Ca
2+
 and enhanced constriction following SAH depend 









Figure 5: Elevated [Ca
2+
]i and enhanced myogenic tone following SAH is independent 




Figure 6: The relationship between intravascular pressure, cytosolic Ca
2+
 and diameter 





                 Values are means ± SEM. 
Chapter 2 Table 1: Fura-2 Calibration Values. 
 Rmin Rmax β 
Control (n = 4) 0.371± 0.008 9.969 ± 0.565 8.031 ± 0.895 
SAH (n = 4) 0.378 ± 0.005 10.064 ± 0.795 7.764 ± .370 
Pooled 0.374 ± 0.004 10.017 ± 0.483 7.898 ± 0.451 
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 channels (VDCCs) are essential for numerous processes 
in the cardiovascular and nervous systems.  Alternative splicing modulates proteomic 
composition of Cav1.2 to generate functional variation between channel isoforms.  Here, 
we describe expression and function of Cav1.2 channels containing alternatively spliced 
exon 9* in cerebral artery myocytes.  RT-PCR showed expression of Cav1.2 splice 
variants both containing (α1C9/9*/10) and lacking (α1C9/10) exon 9* in intact rabbit and 
human cerebral arteries.  Using laser capture microdissection and RT-PCR, expression of 
mRNA for both α1C9/9*/10 and α1C9/10 was demonstrated in isolated cerebral artery 
myocytes.  Quantitative real-time PCR revealed significantly greater α1C9/9*/10 expression 
relative to α1C9/10 in intact rabbit cerebral arteries compared with cardiac tissue and 
cerebral cortex.  To demonstrate a functional role for α1C9/9*/10, smooth muscle of intact 
cerebral arteries was treated with antisense oligonucleotides targeting α1C9/9*/10 
(α1C9/9*/10-AS) or exon 9 (α1C-AS), expressed in all Cav1.2 splice variants, by reversible 
permeabilization and organ cultured for 1-4 days.  Treatment with α1C9/9*/10-AS reduced 




]o) by approximately 75% 
compared with α1C9/9*/10-sense treated arteries.  Maximal constriction in response to the 
Ca
2+
 ionophore ionomycin and [K
+
]o EC50 values were not altered by antisense treatment.  
Decreases in maximal [K
+
]o-induced constriction were similar between α1C9/9*/10-AS and 
α1C-AS groups (22.7 ± 9% and 25.6 ± 4% constriction, respectively).  We conclude that 
although cerebral artery myocytes express both α1C9/9*/10 and α1C9/10 VDCC splice 









L-type voltage dependent calcium channels (VDCCs) play a crucial role in the 
physiological processes of numerous cell types.  In the resistance circulation, arterial 
constriction is dependent on membrane potential depolarization and Ca
2+
 entry via Cav1.2 





/calmodulin-dependent activation of myosin light chain kinase, myosin light chain 
phosphorylation, increased actin-myosin interaction, smooth muscle contraction and 
decreased vessel diameter.  This mechanism is essential for proper regulation of organ 
perfusion and systemic blood pressure.   
VDCCs are multimeric protein complexes comprised of an α1 pore-forming 
subunit associated with β and α2δ auxiliary subunits (5, 8, 24).  L-type VDCC currents 
are distinguished by high activation potentials, slow inactivation of barium currents, and 
selective inhibition by dihydropyridines (DHPs), phenylalkylamines, and 
benzothiazepines (5).  The Cav1.2 gene, CACNA1C consists of 55 exons, 19 of which are 
subject to extensive alternative splicing with 40 splice variations found at 12 loci (34).  
cDNA library screening studies have allowed the identification of the cardiac and smooth 
muscle Cav1.2 isoforms, differing in composition at four alternative splice sites (2, 22, 
28, 31).  The purported smooth muscle splice combination consists of exons 1/8/+ 9*/32 
while the cardiac form consists of exons 1a/8a/- 9*/31.  Smooth muscle L-type channels 
are reported to activate at more hyperpolarized (~15 mV) membrane potentials (14, 30) 
and display greater DHP sensitivity than analogous channels in the heart (35).  A 
previous study suggests that the presence of exon 8 rather than 8a to form transmembrane 
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segment 6 of domain I (IS6) in smooth muscle channels contributes to differences in 
DHP inhibition (36).  Other work has shown that the inclusion of the 25 amino acid 
insertion exon 9* in the intracellular linker region between homologous domains I and II 
affects channel gating properties resulting in a hyperpolarizing shift in activation 
potential and current-voltage relationship (26).  The electrophysiological alteration 
imposed by the addition of exon 9* to the channel protein structure suggests that 
expression of exon 9* may be a critically important mechanism for the fine-tuning of 
channel function such that smooth muscle VDCCs activate at physiologically relevant 
membrane potentials.  Although such a role for Cav1.2 channels expressing exon 9* 
would be suitable for proper vascular function, the physiological significance of this 
splice variant in the regulation of blood vessel diameter has not been directly 
investigated.    
Here, the objective was to determine the role of the exon 9* Cav1.2 splice variant 
in constriction of resistance size cerebral arteries.  Consistent with previous findings by 
others (3, 13, 26), we provide evidence for exon 9* expression in cerebral arteries and 
further show a significantly higher ratio of exon 9* mRNA relative to total Cav1.2 mRNA 
in cerebral arteries compared with cerebral cortex and cardiac tissue.  RT-PCR performed 
on cDNA obtained from myocytes isolated by laser-capture microdissection found 
expression of both splice variants in cerebral artery smooth muscle.  Antisense 
oligodeoxynucleotides were used to selectively suppress α1C9/9*/10 in cerebral artery 
smooth muscle to examine the functional role for this splice variant in cerebral artery 
constriction.  Our findings indicate that despite heterogeneous mRNA expression of both 
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α1C9/9*/10 and α1C9/10 isoforms by cerebral artery myocytes, α1C9/9*/10 channels play a 





Animals.  New Zealand White rabbits (males, 3.0-3.5 kg) were used in this study.  All 
experiments were conducted in accordance with the Guidelines for the Care and Use of 
Laboratory Animals (NIH Publication 85-23, 1985) and followed protocols approved by 
the Institutional Animal Use and Care Committee of the University of Vermont.  Animals 
were euthanized under deep pentobarbital anesthesia (150 mg/kg iv) by exsanguination 
and decapitation.  Posterior cerebral and cerebellar arteries were dissected in ice cold 
physiological saline solution (PSS) of the following composition (in mM): 118.5 NaCl, 
4.7 KCl, 24 NaHCO3, 1.18 KH2PO4, 2.25 CaCl2, 1.2 MgCl2, 0.023 EDTA, and 11 
glucose, aerated with 5% CO2, 20% O2, 75% N2 (bath pH: 7.4).  Cerebral artery 
myocytes (40-60 cells/sample) were collected from enzymatically dissociated freshly 
isolated posterior cerebral arteries (23, 37) using a P.A.L.M. Laser Capture 
Microdissection system (Zeiss, Bernried, Germany).  Human cerebral arteries, removed 
as a necessary part of a required procedure, were obtained from two consenting surgical 
patients.  Patients were not receiving calcium channel blockers or other antihypertensive 
agents at the time of surgery.  The University of Vermont has an approved assurance of 
compliance on file with the Department of Health and Human Services covering this 
activity (Assurance identification number: FWA723; IRB identification number 0485). 
 
RT-PCR.  Total RNA was extracted using RNA STAT-60 total RNA/mRNA isolation 
reagent (Tel-test, Friendswood, TX) (4).  Total RNA was reverse transcribed to cDNA 
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using SuperScript First-Strand synthesis system (Invitrogen, Carlsbad, CA).  Semi-
quantitative PCR was performed using primers detecting the region spanning exons 7-11 
of Cav1.2 (Genbank accession No. X55763) (Fig. 1a) of the following sequences: 
forward (5’-TGCTTTCGCCATGTTGACG-3’), reverse (5’-
GAATTTCGACTTGGAGATCCGG-3’).  Amplification was performed with Taq PCR 
core kit (Qiagen) using the following protocol: 94˚ C 3 min, 35 cycles of 94˚ C 1 min, 55˚ 
C 1 min, 72˚ C 1 min, and final extension at 72˚ C for 10 min.  PCR products were 
separated by electrophoresis using 2% agarose gel.  Quantitative real-time PCR was 
performed using primers detecting exons 9*-10 [α1C9/9*/10 forward (5’-
CTTGCATGCCCAGAAGAAAG-3’), reverse (5’-TAGCGGCTGAATTTCGACTT-
3’)], exons 9-10 [α1C9/9*/10 forward (5’-CCCGAAACATGAGCATGC-3’), reverse (5’-
GCACTTTCTCCTGCAGAACC-3’)] by using a sense primer specific for the boundary 
of exons 9/10 of Cav1.2 (Fig. 2A), and 18S [18S forward (5’-
AGTCGCCGTGCCTACCAT-3’), reverse (5’-GCCTGCTGCCTTCCTTG-3’)].  
Amplification was performed with SYBR Green JumpStart Taq ReadyMix (Sigma, St. 
Louis, MO) using a real-time PCR system (Applied Biosystems, Carlsbad, CA).  
Quantification was performed using standard curves constructed by amplification of 
serially diluted plasmids containing target genes.   
Cerebral artery myocytes samples were screened for cell-specific markers using 
the following primer sets: smooth muscle myosin heavy chain [forward (5’-
CACCACACATCTACGCCATC-3’), reverse (5’-TGATGCTCGTGTCCTTCTTG-3’)], 
endothelin 1 [forward (5’-AAAGGCAAAGACTGCTCCAA-3’), reverse (5’- 
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GCACTCCTTGGTCTCTCCTG-3’)], fibroblast specific protein 1 [forward (5’- 
GGGGTGACAAGTTCAAGCTC-3’), reverse (5’-CTGGAAGTCCACCTCGTTGT-3’)], 
and growth associated protein-43 [forward (5’-AGCCAAGGAGGAGCCTAAAC-3’) 
reverse (5’-TCAGGCATGTTCTTGGTCAG-3’)].  Nested PCR was performed using 
primers for exons 7-11 (above) of Cav1.2 for first round amplification (35 cycles) and 
using the following nested PCR primers for 35 cycles of amplification of 1:100 dilution 
of first round products: forward (5’-CGTGCTGTACTGGGTCAATG-3’), reverse (5’-
CAGCCACGTTTTCAGTGTTG-3’).  
 
Immunostaining of isolated cerebral artery myocytes.  Dissociated cell suspensions 
were fixed with 4% formalin and plated on Superfrost Plus microscope slides (Fisher 
Scientific, Waltham, MA) with a cytocentrifuge.  Cells were dried for 10 min and 
blocked and permeabilized in 3% milk/0.1% Triton-X 100 phosphate-buffered saline 
(PBS) for 20 min.  Cells were rinsed with PBS for 30 min and incubated (4˚C/overnight) 
in PBS containing mouse monoclonal antibody raised against rabbit smooth muscle 
myosin heavy chain 2 (SM-MHC) (1:125 dilution; Abcam, Cambridge, MA) or 
monoclonal antibody against α-smooth muscle actin conjugated to Cy3 (1:200; Sigma, St. 
Louis, MO).  Cells were then rinsed in PBS, and slides treated with anti-SM-MHC were 
incubated in anti-mouse IgG conjugated to Cy3 (1:500; Jackson ImmunoResearch 




Use of antisense oligonucleotides.  For suppression of α1C9/9*/10, antisense 
oligonucleotides (Operon Biotechnologies, Huntsville, AL) were designed to target a 
sequence specific to the coding region of exon 9* of Cav1.2 mRNA transcripts: α1C9/9*/10-
AS: 5’-A*A*G*C*CCGCTGGAGTGC*C*T*C*T-3’.  To suppress the total population 
of Cav1.2 channels, antisense oligodeoxynucleotides were designed to target exon 9 
which is not alternatively spliced and is expressed in all Cav1.2 transcripts: α1C-AS 5’-
C*T*C*T*TCCAGCTGCTGCTTC*T*C*C*C-3’.  Control sense oligonucleotides of the 
following sequences were designed: α1C9/9*/10-sense: 5’-
A*G*A*G*GCGCTCCAGCGG*G*C*T*T-3’ and α1C-sense: 5’-
G*G*G*A*GAAGCAGCAGCTGGA*A*G*A*G-3’.  The first and last four bases of 
each oligonucleotide were phosphorothioated to prevent degradation by cellular 
nucleases (designated by “*”).  All oligonucleotides were reconstituted with nuclease-
free water at a concentration of 10 mM.    
 
Reversible permeabilization and organ culture of cerebral arteries.  The introduction of 
oligonucleotides into smooth muscle of intact cerebral arteries was achieved by a 
reversible permeabilization (RP) procedure (9, 25).  Arterial segments were first 
incubated at 4˚C for 30 min in the following solution (in mM): 120 KCl, 2 MgCl2, 10 
EGTA, 5 NaATP, 20 N-tris-(hydroxymethyl)methyl-2-aminoethanesulfonic acid (pH 
6.8).  Arteries were then incubated in a similar solution containing oligonucleotide (10 
μM) for 90 min at 4˚C and then in a solution containing elevated MgCl2 (10 mM).  
Permeabilization of arteries was reversed by incubating arteries for 30 min at room 
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temperature in physiological solution containing the following (in mM): 140 NaCl, 5 
KCl, 10 MgCl2, 5.6 glucose, 2 3-(N-morpholino)propanesulfonic acid (pH 7.1).  Next, 
[Ca
2+
] was gradually increased in this solution from nominally Ca
2+
-free to 0.01, 0.1, and 
1.8 mM over a period of 45 min.  Following reversible permeabilization, arterial 
segments were organ cultured by placing the arteries in serum-free DMEM-F12 culture 
media (Invitrogen, Carlsbad, CA) and incubating at 37˚C and 5% CO2 for 1 to 4 days (18, 
27).    
 
Diameter measurements in isolated arteries. Freshly isolated and cultured cerebral 
artery segments were cannulated on glass micropipettes mounted in a 5 ml myograph 
chamber (University of Vermont Instrumentation and Model Facility) as described 
previously (18, 19, 27).  Following cannulation, arteries were pressurized at 20 mmHg 
and continuously superfused with aerated PSS at 37˚ C and pH 7.4 for 30 min to allow 
equilibration.  Arterial diameter was measured with video edge detection equipment and 
recorded using data acquisition software (Dataq Instruments Inc., Akron, OH).  Arteries 
were exposed to PSS containing elevated [K
+
], made by isoosmotic replacement of NaCl 
with KCl.  Arterial constriction was expressed using the following equation: % 
Constriction = (1-(D – Dmin/Dmax – Dmin)) X 100 where Dmax is the maximum diameter 
obtained in Ca
2+
-free PSS containing diltiazem (100 μM) and forskolin (1 μM) and Dmin 
is the minimum diameter obtained with the Ca
2+
 ionophore ionomycin (10 μM) at the end 
of each experiment.  Ionomycin-induced constrictions (table 1) are presented as a 
percentage of maximum diameter (Dmax).  Arteries not achieving >70 % constriction in 
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response to ionomycin were not used for analysis.  Half-maximal effective concentration 
(EC50) was determined from each [K
+
]o concentration-response experiment. 
 
Statistical analysis.  Values are presented as means ± SEM.  One-way analysis of 
variance followed by Tukey multiple comparison test was used in the comparison of 
multiple groups.  Student’s t-test was used in the comparison of two groups.  Statistical 




Cerebral arteries demonstrate enhanced expression of α1C9/9*/10 compared with brain 
and heart.  
Previous work has shown selective expression of α1C9/9*/10 splice variants by smooth 
muscle-containing tissues.  However, mRNA expression of both α1c splice variants 
including (α1C9/9*/10) and excluding (α1C9/10) exon 9* has been reported in aorta (3, 13, 
26).  Therefore, our first objective was to investigate whether small diameter (100-250 
μm) cerebral arteries express mRNA for both α1C9/9*/10 and α1C9/10.  To detect expression 
of α1C9/9*/10, we designed PCR primers to generate products consisting of exons 7-11 of 
α1c (Fig. 1A) such that a shift in product size would result if the 75 nucleotide (nt) 
insertion for exon 9* was expressed.  RT-PCR analysis resulted in two distinct bands 
from rabbit cerebral arteries (Fig. 1B; n=7).  Sequence analysis confirmed the lower band 
of 460 nt represents α1C9/10 while the upper band of 535 nt represents α1C9/9*/10.  Human 
cerebral arteries were also analyzed and found to express both α1C9/9*/10 and α1C9/10 
similar to arteries from rabbit (Fig. 1C).  In contrast, cardiac tissue (left ventricle; n=8) 
and brain tissue (cerebral cortex; n=5) were found to express one dominant product 
corresponding to α1C9/10 (Fig. 1B).      
Quantitative real-time PCR was used to evaluate relative expression levels of 
α1C9/9*/10 in these tissues.  We hypothesized the fraction of mRNA for Cav1.2 expressing 
exon 9* is greater in cerebral arteries than cardiac and brain tissue.  α1C9/9*/10 and α1C9/10 
expression was measured separately by using either a PCR primer specific for exon 9* 
sequence (α1C9/9*/10-specific) or a primer specific for the boundary of exons 9 and 10 
114 
 
(α1C9/10-specific; Fig. 2A).  α1C9/9*/10 and α1C9/10 expression was normalized to 18S 
ribosomal RNA levels.  This approach allows quantification of the α1C9/9*/10:α1C9/10 
mRNA ratio, which is representative of α1C9/9*/10 relative to overall Cav1.2 expression 
considering that α1C9/9*/10 and α1C9/10 are mutually exclusive splice variants.  We found 
that cerebral arteries express significantly higher relative levels of α1C9/9*/10 compared 
with brain and heart tissues (Fig. 2B; ~fifty-two fold and ~six fold difference, 
respectively).  Together, these results demonstrate mRNA for both α1C9/9*/10 and α1C9/10 
splice variants in cerebral arteries and enhanced relative expression of α1C9/9*/10 in 
cerebral arteries compared with brain and heart.   
 
Isolated cerebral artery myocytes express both α1C9/9*/10 and α1C9/10 splice variants. 
We next chose to clarify whether cerebral artery myocytes express mRNA for both splice 
variants or if α1C9/10 detection was due to the presence of non-smooth muscle cell types 
within the vascular wall, such as fibroblasts or perivascular neurons, which are reported 
to express Cav1.2 (10, 13, 17, 32).  Live freshly isolated cerebral artery myocytes (~40-60 
cells) were collected by laser capture microdissection for RT-PCR analysis (Fig. 3B).  
These elongated spindle-shaped cells showed strong immunofluorescent staining for SM-
MHC or SM-α-actin, markers commonly used to identify smooth muscle (1, 11) (Fig. 
3A).  RT-PCR was used to examine expression of specific cell markers: smooth muscle 
myosin heavy chain (SM-MHC; smooth muscle), endothelin-1 (ET-1; endothelium) (38), 
fibroblast specific protein-1 (FSP-1; fibroblast) (33) and growth associated protein-43 
(GAP43; neuron) (39) in mRNA isolated from both intact arteries and isolated myocytes.  
115 
 
The above cell markers all amplified using intact cerebral artery mRNA (Fig. 3C), 
consistent with the presence of multiple cell types in intact vessels.  However, only the 
smooth muscle marker SM-MHC was expressed in freshly isolated myocytes, confirming 
purity of our samples.  Nested PCR for exons 7-11 of Cav1.2 demonstrated two bands 
corresponding to α1C9/9*/10 and α1C9/10 in isolated cerebral artery myocytes, similar to the 
intact tissue (Fig. 3D).  These data demonstrate heterogeneous mRNA for both α1C9/9*/10 
and α1C9/10 in isolated smooth muscle from cerebral arteries.       
 
α1C9/9*/10 plays critical role in depolarization-induced constriction of cerebral arteries. 
High expression levels of α1C9/9*/10 in cerebral artery myocytes suggest this splice variant 
may have an important role in vascular function.  We therefore tested the hypothesis that 
α1C9/9*/10 splice variants are an important regulator of cerebral artery diameter.  Two 
antisense oligonucleotide sequences were designed to examine the functional role of 
α1C9/9*/10.  First, α1C9/9*/10-AS targeting a sequence specific for exon 9* was used for 
selective suppression of the α1C9/9*/10 variant.  Second, α1C-AS targeting a sequence 
specific for exon 9, which is constitutively expressed in all L-type VDCC splice variants, 
was used for non-selective suppression of all Cav1.2 isoforms.    Four days following 
treatment, standard RT-PCR and qPCR demonstrated a significant reduction (43 ± 6.9%) 
in α1C9/9*/10 expression following treatment with α1C9/9*/10-AS compared with α1C9/9*/10-
sense treated arteries (Fig. 4A and B).  However, suppression of α1C9/10 was not observed 
following treatment with α1C9/9*/10-AS.  In contrast to the effect of α1C9/9*/10-AS, arteries 
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treated with α1C-AS exhibited a significant reduction in expression for both α1C9/9*/10 
and α1C9/10 splice variants (Fig. 4A and B).     
To examine the effect of suppressing α1C9/9*/10 on arterial constriction, luminal 




]o) in the bath 
solution over a range of concentrations from 6 to 120 mM following a period of 1 to 4 
days in organ culture.  The relationship between extracellular [K
+





> 16 mM closely follows that which is predicted by the Nernst equation 
(16, 21).     
Step-wise increases in [K
+
]o caused graded arterial constriction of control freshly-
isolated vessels (Fig. 5 and 6).  α1C9/9*/10-AS, α1C9/9*/10-sense and RP only groups all 
responded similarly to freshly isolated vessels following one day in culture (Fig. 6).  
However, K
+
-induced constrictions, expressed as a percentage of maximum constriction 
caused by ionomycin (see methods), was significantly reduced in α1C9/9*/10-AS arteries 
compared with control α1C9/9*/10-sense treated and RP arteries after two days.  For 
example, α1C9/9*/10-AS treated vessels exhibited 52 ± 5.9% constriction in response to 60 
mM K
+
 on day 2 compared with 80 ± 2.1% and 75 ± 2.9% constriction in α1C9/9*/10-sense 
treated and RP vessels, respectively.  Further reductions were observed in α1C9/9*/10-AS 
treated arteries on day 3 (e.g., 26 ± 4.1% in [K
+
]o = 60 mM) and day 4 (e.g., 23 ± 4.9% in 
[K
+
]o = 60 mM) of organ culture (Fig. 6).  α1C9/9*/10-sense treated and RP arteries 
constricted to a similar degree as freshly isolated vessels at all time points tested (Fig. 5 
and 6).  Mean diameters of arteries exposed to these treatments are shown in Table 1.  No 
significant differences in EC50 values for K
+
 were observed between groups (Table 1).  
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Diameter values and maximal constriction to ionomycin were similar between groups at 
all time points tested (Table 1).  Fully dilated arterial diameter, obtained in Ca
2+
-free PSS 
containing diltiazem and forskolin, was not significantly different between groups 
(α1C9/9*/10-AS: 201 ± 13 μm, n=17;  Sense: 214 ± 16 μm, n=17, RP: 199 ± 13 μm, n=16).  
Taken together, these data demonstrate an important role for α1C9/9*/10 in the regulation of 
cerebral artery constriction. 
α1C9/9*/10 is the functionally dominant splice variant in cerebral arterial constriction. 
Our data imply that although cerebral artery myocytes express both α1C9/9*/10 and 
α1C9/10, α1C9/9*/10 plays a major role in cerebral artery constriction.  To examine the role 
of α1C9/10 in cerebral artery constriction, we compared the effect of suppressing α1C9/9*/10 
to supressing all Cav1.2 splice variants (both α1C9/9*/10 and α1C9/10) using α1C-AS.  
Arteries treated with α1C-AS exhibited diminished constriction to 60 mM [K+]o that was 
similar to that observed in arteries treated with α1C9/9*/10-AS (Fig. 7; α1C9/9*/10-AS: 23.5 
± 3.6%, n=6; α1C-AS: 25.6 ± 4.3%, n=5) suggesting that suppression of all Cav1.2 splice 
variants had no greater effect on constriction to 60 mM [K
+
]o than selectively suppressing 
α1C9/9*/10.  These data suggest that the isoform containing exon 9* is the functionally 




Here we demonstrate that cerebral artery myocytes express Cav1.2 splice variants both 
containing (α1C9/9*/10) and lacking (α1C9/10) exon 9* and that α1C9/9*/10 plays a dominant 
role in cerebral artery constriction.  The following observations are consistent with this 
novel finding: 1) cerebral arteries have a significantly higher ratio of α1C9/9*/10 : α1C9/10 
mRNA compared with cerebral cortex or cardiac tissue.  2) RT-PCR performed on cDNA 
from isolated cerebral artery myocytes confirmed expression of both α1C9/9*/10 and 
α1C9/10 in smooth muscle.  3)  Selective suppression of the α1C9/9*/10 splice variant 
caused a marked reduction in K
+
-induced arterial constriction.  4)  Suppression of all 
Cav1.2 splice variants caused no further reduction in K
+
-induced arterial constriction.  In 
addition, we found a similar expression profile of α1C9/9*/10 and α1C9/10 splice variants in 
cerebral arteries from humans.    
This work expands our understanding of the molecular composition of smooth 
muscle VDCCs responsible for the control of arterial diameter and blood flow.  Unlike 
cardiac myocytes, vascular smooth muscle operates in a state of tonic contraction 
responding to modest changes in membrane potential caused, for example, by changes in 
intravascular pressure, neurotransmitter release, circulating catacholamines, and 
endothelial influences.  Thus, L-type VDCCs expressed by vascular smooth muscle 
respond to small voltage changes at relatively negative membrane potentials  compared to 
more depolarized membrane potentials reached during action potentials in cardiac 
myocytes or neurons.  Recent studies using cell expression systems have found 
expression of the 25 amino acid insertion exon 9* causes a 9 mV hyperpolarizing shift in 
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L-type VDCC V0.5, act (6, 26).  This hyperpolarizing shift in the activation of this splice 
variant would be well-suited to the range of vascular smooth membrane potential in vivo 
(-45 to -35 mV) (29).  We now report that exon 9*-containing L-type VDCCs are the 
dominant Cav1.2 splice variant contributing to cerebral artery constriction.  To our 
knowledge, this is the first study directly demonstrating a physiological role for a single 
Cav1.2 splice variant.  
We have observed that whole arterial tissue containing smooth muscle, 
endothelial, fibroblast and perivascular neural cells expresses both α1C9/9*/10 and α1C9/10 
splice variants.  While endothelial cells are known to lack expression of VDCCs (13), 
Cav1.2 expression by fibroblasts and neurons is well documented (10, 17, 32).  To further 
explore the composition of Cav1.2 splice variants in vascular smooth muscle, we 
performed PCR on mRNA obtained from freshly isolated vascular myocytes using laser 
capture microdissection.  This approach demonstrated mRNA for both α1C9/9*/10 and 
α1C9/10 isoforms in a pure population native vascular smooth muscle.  Compared to 
vascular tissue, we found a relatively low level of α1C9/9*/10 mRNA in heart and cerebral 
cortex tissue providing additional support that exon 9* is selectively expressed by smooth 
muscle.  It is possible that apparent differences in the stoichiometry of α1C9/9*/10 and 
α1C9/10 splice variants may reflect discrepancies in total levels of Cav1.2 expressed 
between tissues.  However, an earlier study by Graf et al. demonstrated that the ratio of 
+9*:-9* Cav1.2 is not well correlated with expression levels of total Cav1.2 (13).  For 
example, it was shown that human cardiac ventricle and aorta express similar levels of 
total Cav1.2, although the +9*:-9* ratio is greater in aorta.  Increased α1C9/9*/10: α1C9/10 
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mRNA ratio observed in vascular smooth muscle is therefore unlikely to be due to 
differential expression of total Cav1.2 levels compared with brain and heart.   
The use of antisense oligonucleotides to specifically suppress 9*-containing 
Cav1.2 channels revealed a substantial decrease in K
+
-induced constriction supporting a 
functional role for this splice variant in vascular physiology.  In fact, antisense 
oligonucleotides targeting a region common to all Cav1.2 splice variants (exon 9) caused 
no greater decrease in contractility than suppression of only α1C9/9*/10.  These data 
suggest exon 9*-containing Cav1.2 channels play a dominant role in regulating smooth 
muscle contraction. It should be noted that this conclusion is based on the assumptions 
that both antisense oligonucleotides used in this study suppress translation of their target 
with similar efficiency and that functional effects are not due to non-specific suppression 
of total Cav1.2 levels.  Consistent with these assumptions, we observed a maximal 
response using both antisense oligonucleotides at day 4 with no greater suppression 
occurring after five days of treatment (data not shown).  Further, the EC50 for [K
+
]o was 
not altered by α1C9/9*/10-AS, consistent with a functional population of Cav1.2 channels 
with a uniform V0.5, act.  Considering the loss of endothelial function following prolonged 
organ culture of arteries (20), it is possible that compensatory changes in Cav1.2 splice 
variant expression may occur.  However, we have found using RT-PCR that the ratio of 
α1C9/9*/10:α1C9/10 does not change following up to four days in culture (data not shown).   
Future studies are needed to address whether α1C9/9*/10 also plays a dominant role in 




The unique location of exon 9* within the structure of the α1 subunit may also 
play a role in post-translational regulation of VDCCs in vascular smooth muscle.   
Interestingly, the site of α1/β subunit interaction, known as the alpha interaction domain is 
found 18 amino acids upstream of exon 9* within the I-II intracellular linker region of the 
α1c protein.  It has previously been shown that functional interaction between the α1 and β 
subunit is required for correct targeting of the channel to the plasma membrane (12).  It 
remains possible that α1 subunits expressing exon 9* may differentially bind specific 
Cavβ isoforms compared to α1 subunits lacking the insertion, leading to favored 
trafficking of α1C9/9*/10 to the membrane and a dominant functional role for this splice 
variant.  Further research is needed to elucidate whether the presence of exon 9* alters 
the binding of β subunit subtypes or splice isoforms.  It should be noted that smooth 
muscle-selective alternatively spliced exons other than exon 9* could be preferentially 
expressed in 9*-containing channels and may also contribute to functional distinction of 
vascular smooth muscle VDCCs.  For example, it has recently been shown that inclusion 
of exon 1c in full length cloned Cav1.2 channels can lead to a hyperpolarizing shift in 
V0.5,act in HEK293 cells, similar to inclusion of exon 9*(7).   
In summary, this study suggests that the exon 9*-containing Cav1.2 splice variant 
controls cerebral artery myocyte Ca
2+
 influx, arterial diameter and cerebral blood flow.  
We propose that α1C9/9*/10 may represent a novel target for therapeutics against vascular 
pathologies associated with increased Ca
2+
 influx in vascular smooth muscle leading to 
enhanced arterial constriction.  Future genetic or pharmacological strategies targeting 
smooth muscle-selective Cav1.2 splice variants could provide a valuable means of 
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modulating vascular tone while avoiding widespread effects on VDCC isoforms in 
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Figure Legends   
 
Figure 1: Cerebral arteries express α1C9/9*/10. A: PCR primer design for the detection of 
α1C9/9*/10 and α1C9/10.  Amplification of transcripts containing exon 9* results in 535 nt 
product while amplification of transcripts excluding exon 9* results in 460 nt product.  B: 
Representative gel demonstrating two bands corresponding to both α1C9/9*/10 and α1C9/10 
present in whole cerebral arteries (n=7) while α1C9/10 band is most prominent in brain 
(n=5) and heart tissue (n=8). C:  Resulting RT-PCR gel using cDNA obtained from 
whole cerebral arteries from human (n=2) demonstrates presence of two bands 
corresponding to α1C9/9*/10 and α1C9/10. 
 
Figure 2:  Quantitative real-time PCR (qPCR) shows high expression of α1C9/9*/10 in 
cerebral arteries.  A: PCR primer sets for the specific detection of α1C9/9*/10 and α1C9/10.  
α1C9/9*/10 specific (left) forward primer recognizes sequence specific to exon 9*.  α1C9/10 
(right) forward primer recognizes sequence of boundary between exons 9 and 10.  
Sequence analysis of PCR products confirmed specificity of primers for target sequences.  
B:  Summary qPCR data for cerebral arteries, brain (cortex) and heart (left ventricle).  
The ratio of α1C9/9*/10:α1C9/10 mRNA was significantly greater in cerebral arteries 
relative to brain and heart (0.289 ± 0.024; n=7 compared to 0.006 ± 0.001; n=4 and 0.050 




Figure 3: Cerebral artery myocytes express both α1C9/9*/10 and α1C9/10 splice variants.  
A: Immunostaining of isolated cerebral artery myocytes.  Red: SM-MHC; Green: SM-α-
actin (color changed from red to green to distinguish from SM-MHC); Blue: DAPI 
nuclear stain.  Scale bars represent 10 μm. A lack of staining was observed for SM-MHC 
or SM-α-actin by cells incubated without primary antibody (right panel).  B: 
Microdissection of isolated cerebral artery myocytes.  Live myocytes plated on P.A.L.M. 
Duplex dish (Ziess) were identified by cell morphology and the surrounding dish 
membrane was cut (i.).  Myocytes were then catapulted (ii.) onto P.A.L.M. Adhesivecap 
collection tubes (Ziess) for mRNA extraction.  Scale bars represent 25 μm.  C: 
Representative gel showing the presence of cell markers: smooth muscle myosin heavy 
chain (SM-MHC; smooth muscle), endothelin-1 (ET-1; endothelium), fibroblast specific 
protein-1 (FSP-1; fibroblast) and growth associated protein-43 (GAP43; neuronal).  All 
markers are amplified using cDNA from whole cerebral arteries.  cDNA from cerebral 
artery myocytes samples collected by laser capture microdissection demonstrate 
amplification of SM-MHC while other markers were not detected.  D: Results of nested 
PCR performed on cDNA from isolated cerebral artery myocytes.  First round of 
amplification (35 cycles) was performed using primers for exons 7-11 of Cav1.2 (see Fig. 
1A).  Second round of amplification (35 cycles) was done using nested primers (see 
methods) and 1:100 dilution of first-round PCR products.  Final products represent 




Figure 4:  Selective suppression of Cav1.2 splice variants following antisense treatment 
and organ culture for four days.  A:  RT-PCR was performed on cDNA from arteries 
treated with α1C9/9*/10-AS, α1C-AS, and corresponding sense oligonucleotides.  Band 
intensity corresponding to α1C9/9*/10 was reduced in α1C9/9*/10-AS treated artery samples 
following four days in organ culture compared with sense treated arteries (left, n=4).  
Lower band, corresponding to α1C9/10, was similar between two groups.  RT-PCR gel 
demonstrating reduction in both α1C9/9*/10 and α1C9/10 band intensity following treatment 
with α1C-AS and organ culture for 4 days (right, n=4).  Total RNA used was similar as 
shown by endogenous control 18S ribosomal RNA.    B:  Quantification of changes in 
mRNA levels using qPCR in antisense-treated arteries compared with sense treated 
arteries from same animal.  *p<0.05 (α1C9/9*/10-AS/S: n=4; α1C-AS/S: n=4). 
 
Figure 5:  Representative arterial diameter traces demonstrating important functional role 
for α1C9/9*/10 in arterial constriction.  All arteries were cannulated, pressurized to 20 
mmHg and perfused with PSS for 30 minutes prior to stepwise increases in [K
+
]o.  
Control freshly isolated and sense treated (day 4) arteries responded to increases in [K
+
]o 
by graded constriction.  α1C9/9*/10-AS treated (day 4) arteries exhibited a marked 
reduction in [K
+
]o-induced constriction.  Ionomycin (10 μM) was applied at the end of 
each experiment.  
 
Figure 6:  Time course for α1C9/9*/10-AS effect.  Day 1:  α1C9/9*/10-AS, α1C9/9*/10-sense 
treated (α1C9/9*/10-S), and RP arteries exhibit constriction similar to freshly isolated 
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cerebral arteries (day 0).  Day 2-4: α1C9/9*/10-AS arteries exhibit significantly reduced 
arterial constriction in response to increased [K
+
]o with constrictions nearly abolished 
following four days in organ culture compared with α1C9/9*/10-sense and RP arteries 
organ cultured for the same period of time. *p<.05, **p<.01.  No significant differences 
were observed in arterial constriction between α1C9/9*/10-sense treated artery groups (days 
1-4, n=4-5) and freshly isolated arteries (day 0, n=5).  * p<0.05; **p<0.01.   
 
Figure 7: α1C9/9*/10 plays a dominant role in cerebral artery constriction.    A:  
Representative diameter traces showing response to 60 mM [K
+
]o followed by application 
of 10 μM ionomycin.  B:  Summary of 60 mM [K+]o for antisense-treated arteries.  All 
constrictions were normalized to minimum diameter obtained in ionomycinand maximum 
diameter obtained in Ca
2+
-free PSS with diltiazem (100 μM) and forskolin (1 μM).   After 
four days in organ culture following oligonucleotide treatment, arteries treated with α1C-
AS exhibited similar response to 60 mM [K
+
]o as arteries treated with α1C9/9*/10-AS.  
α1C9/9*/10-AS and α1C-AS groups were significantly decreased compared with 
corresponding sense-treated groups.  No significant difference was observed between 
α1C9/9*/10-AS and α1C-AS groups (*p<0.05; α1C9/9*/10-sense, n=4; α1C9/9*/10-AS, n=6; 
α1C-sense, n=5; α1C-AS, n=5). 
 
Table 1:  Diameter values are shown for α1C9/9*/10-AS, α1C9/9*/10-S, and RP arteries in 
PSS (6 mM [K
+
]o), 80 mM [K
+
]o, and 120 mM [K
+
]o containing 10 μM ionomycin 
(ionomycin group) for all time points tested.  Also shown is ionomycin constriction, 
131 
 
expressed as % decrease from maximum diameter and EC50 values calculated from [K
+
]o 
























































Figure 7: Exon 9* plays a dominant role in cerebral artery constriction. 
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 Table 1: Diameter values for K
+
 concentration-response experiments. 
 
      
   RP α1C9/9*/10-
Sense 
α1C9/9*/10-AS 
Day 1    
 Diameter (μm)    
  6 mM [K
+
]o 170 ± 27.8 186 ± 18.7 182 ± 21.8 
  80 mM [K
+
]o 62 ± 16.1 66 ± 9.2 63 ± 7.6 
  Ionomycin 37 ± 13.1 37 ± 7.5 29 ± 2.6 
 Ionomycin-induced 
Constriction (% of 
maximum diameter) 
81 ± 4. 80± 3.1 85 ± 2.7 
 [K
+
]o EC50 35 ± 3.5 4 ± 1.2 34 ± 2.3 
Day 2    
 Diameter    
  6 mM [K
+
]o 194 ± 28.2 217 ± 34.7 165 ± 25.5 
  80 mM [K
+
]o 85 ± 11.7 87 ± 23.0 87 ± 12.5 
  Ionomycin 53 ± 9.7 49 ± 16.4 31 ± 5.6 
 Ionomycin-induced 
Constriction (% of 
maximum diameter) 
72 ± 5.2 80 ± 3.7 83 ± 2.7 
 [K
+
]o EC50 32 ± 7.4 31 ± 1.3 33 ± 2.0 
Day 3    
  Diameter    
  6 mM [K
+
]o 201 ± 20.4 216 ± 50.7 194 ± 13.0 
  80 mM [K
+
]o 81 ± 10.3 89 ± 14.3 149 ± 13.0** 
  Ionomycin 42 ± 11.4 51 ± 15.5 45 ± 8.9 
 Ionomycin-induced 
Constriction (% of 
maximum diameter) 
80 ± 4.1 86 ± 3.4 81 ± 3.4 
 [K
+
]o EC50 31 ± 3.0 30 ± 2.1 32 ± 3.0 
Day 4     
 Diameter    
  6 mM [K
+
]o 230 ± 25.5  205 ± 42.0 188 ± 4.6 
  80 mM [K
+
]o 78 ± 12.1 89 ± 14.3 155 ± 20.3** 
  Ionomycin 37 ± 12.7  51 ± 15.5 50 ± 15.3 
 Ionomycin-induced 
Constriction (% of 
maximum diameter) 
85 ± 4.9 75 ± 6.9 
 
73 ± 3.0 
 [K
+
]o EC50 33 ± 2.3 31 ± 2.3 30 ± 2.8 
**
 








CHAPTER 4: CONCLUSIONS AND FUTURE DIRECTIONS
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In Chapter one of this dissertation, it is demonstrated that constriction of parenchymal 
arterioles are markedly enhanced following SAH at physiological intravascular pressures.  
Evidence is provided suggesting that enhanced constriction results from greater pressure-
dependent depolarization of parenchymal arteriolar myocytes, increased activity of L-
type VDCCs and elevated [Ca
2+
]i.  One major aim of future work will address the 
mechanisms by which SAH causes membrane potential depolarization of parenchymal 
arteriolar myocytes.  As discussed in Chapter 2, this may result from increased activity of 
ion channels involved in pressure-dependent depolarization (i.e. transient receptor 
potential channels) or decreased activity of negative feedback pathways controlling 
vascular tone (i.e. K
+
 efflux).  Importantly, whether altered parenchymal arteriolar 
function results from exposure to spasmogens within blood, or vasoactive substances 
released from the brain parenchyma following SAH should also be addressed.  For 
example, studies have demonstrated that intracisternally injected biotinylated 
oxyhemoglobin is capable of penetrating to deeper layers of the cortex of the rat (Turner 
et al., 1998) suggesting that parenchymal arterioles may be exposed to this spasmogen 
following erythrocyte lysis in SAH patients.  Oxyhemoglobin has been shown to cause 
membrane potential depolarization of cerebral artery myocytes via reduction of Ca
2+
 
spark frequency (Jewell et al., 2004; Koide, 2009) and suppression of KV channel 
currents (Ishiguro et al., 2006; Koide et al., 2007).  In addition, purified oxyhemoglobin 
was shown to induce expression of R-type VDCCs (CaV2.3) in rabbit pial cerebral artery 
myocytes (Link et al., 2008).  Although we did not test whether CaV2.3 is expressed in 





and tone in the presence of the L-type VDCC inhibitor nimodipine argue against a 
significant contribution of R-type channels in parenchymal vessels from SAH animals.  
These differing results may reflect variation between species or vascular beds with 
respect to environment and functional regulation.     
 Previous studies suggest that parenchymal arterioles contribute significantly to 
cerebrovascular resistance and autoregulation of cerebral blood flow (Faraci and Heistad, 
1990; Harper et al., 1984).  The relative contributions of large diameter vasospasm and 
enhanced constriction of parenchymal vessels to ischemia-related deficits in SAH 
patients remains unclear.  It is plausible that in the absence of microcirculatory 
dysfunction, constriction of large diameter surface vessels following SAH may cause 
little reduction in regional perfusion due to compensatory redistribution of blood flow in 
downstream vessels (Schaffer et al., 2006).  Conversely, a significant reduction in cortical 
blood flow and focal neuronal infarction may follow SAH-induced constriction of 
parenchymal arterioles, which display little communication with parallel arterioles and 
represent a bottleneck in blood supply to the cortex (Nishimura et al., 2007).  Hence, 
enhanced pressure-dependent constriction of parenchymal arterioles may severely limit 
downstream blood flow and lead to significant neuronal damage after SAH.      
In addition to their function in regulating global cerebral blood flow, parenchymal 
arterioles are also an essential component of the neurovascular unit which functions to 
couple blood flow with local neuronal activity and metabolic demands.  Under normal 
physiological conditions, an increase in local neuronal activity signals release of 
vasodilatory substances from the astrocytic endfeet to cause vasodilation and increased 
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local blood flow (Iadecola and Nedergaard, 2007).  This process is critical for sufficient 
delivery of oxygen and nutrients to active regions of the brain.  Given the impact of blood 
on the function of arterioles deep within the cortex of SAH model animals shown in this 
study, future work should address the impact of SAH on neurovascular coupling 
mechanisms.  Brain slice experiments have suggested that the magnitude and polarity of 
diameter change to increases in neuronal activity are dependent on the level of vascular 
tone (Blanco et al., 2008).  For example, arterioles displaying greater myogenic tone 
exhibit more pronounced dilations in response to electrical field stimulation (neuronal 
activation).  Thus, enhanced arteriolar tone following SAH may be localized to less 
active brain regions in vivo if functional hyperemic phenomena remain unaltered.  
However, studies in our laboratory have found a fundamental change in the 
neurovascular response in brain slices from SAH model rats.  Whereas electrical field 
stimulation activates neurons and evokes parenchymal arteriolar dilation in brain slices 
from control animals, similar stimulation causes constriction in brain slices from SAH 
animals (Koide and Wellman, unpublished observations).  These findings indicate that 
SAH causes a remarkable shift in the polarity of vascular response from dilation to 
constriction following increased neuronal activity.  Therefore, impairment of mechanisms 
coupling neuronal activity with localized increases in blood flow may act in concert with 
enhanced pressure-dependent constriction to severely limit local cerebral blood flow 
following SAH.  These findings suggest that neuronal infarction may be more severe in 
active brain regions in SAH patients.   
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Enhanced parenchymal arteriolar constriction following SAH requires 
extracellular Ca
2+
 entry via smooth muscle L-type VDCCs.  Antagonists of L-type 
VDCCs are standard therapy for prevention of cerebral vasospasm and neurological 
deficits in SAH patients.  Although nimodipine treatment has been indicated to reduce the 
severity of ischemic deficits (Tomassoni et al., 2008; Treggiari-Venzi et al., 2001), these 
positive effects do not depend on reversal or prevention of angiographic vasospasm 
(Petruk et al., 1988).  Alternatively, consistent with our data is the hypothesis that 
nimodipine may increase blood flow to ischemic brain regions by preferential dilation of 
small diameter resistance arteries and arterioles.  However, systemic nimodipine 
administration also inhibits smooth muscle VDCCs in the peripheral vasculature and use 
of this agent in SAH patients has been limited by hypotension (Treggiari-Venzi et al., 
2001).  Therefore, it is clear that future efforts should focus on improving strategies to 
suppress L-type VDCC activity in both pial and parenchymal myocytes, while avoiding 
effects on systemic targets.   
 L-type channels in the vasculature represent a mixed population of splice 
variations of the gene CaV1.2 (Cheng et al., 2009).  In Chapter three of this dissertation, 
data is shown supporting an essential role for CaV1.2 containing the alternatively-spliced, 
smooth muscle-selective exon 9* (α1C9/9*/10) in cerebral artery constriction.  In this study, 
antisense oligonucleotides and organ culture were used to specifically reduce the 
expression of exon 9* channels in myocytes of small diameter pial arteries.  Following 
suppression of this splice variant, we observed dramatically reduced cerebral artery 
constriction to K
+
-induced depolarization in vitro.  We conclude that α1C9/9*/10 is the 
145 
 
major route of Ca
2+
 entry required for cerebral artery constriction resulting from 
membrane depolarization.  Future experiments will aim to transfer this strategy of 
suppressing cerebrovascular VDCCs into the live animal.  Information gained from this 
work will not only test the feasibility of reducing VDCC expression in vivo, but may also 
lead to new information regarding the function of VDCC splice variants in the control of 
cerebral blood flow.  Preliminary RT-PCR experiments have revealed similar expression 
profile of α1C9/9*/10 and α1C9/10 splice variants in rat pial and parenchymal arterioles 
(Figure 1).  Therefore, we hypothesize that suppression of α1C9/9*/10 channels in the 
cerebral vasculature will lead to significantly increased cerebral blood flow.    
 In summary, it is clear that long-term exposure of tissues within the central 
nervous system to whole blood causes a myriad of changes in multiple cell types.  While 
some of these effects may be beneficial, most are detrimental to neuronal viability.  As 
whole blood is a complex mixture of vasoactive substances, delayed neurological deficits 
in patients surviving aneurysm rupture caused by enhanced cerebral artery constriction 
are likely to result from a complex combination of factors.  In this dissertation, data is 
presented in support of increased Ca
2+
 influx via L-type VDCCs as a major cause of 
enhanced constriction of parenchymal arterioles following SAH.   In addition, smooth 
muscle-selective L-type VDCC splice variants may represent a novel target for the 








RT-PCR gel demonstrating expression of CaV1.2 splice 
variants containing and lacking exon 9* ((+)9*CaV1.2 and 
(-)9*CaV1.2, respectively).  Similar expression of both 
splice variants was observed in both pial and parenchymal 
arterioles from rat.  Conversely, rat brain expressed only (-) 
9*CaV1.2 splice variants. 
Figure 1: Similar expression of CaV1.2 splice variants in 
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Vascular tone and consequently, cerebral blood flow, are regulated by the concentration 




]i) in vascular smooth muscle.  Global [Ca
2+
]i is, in 
part, regulated by discrete Ca
2+
 release events from the sarcoplasmic reticulum (Ca
2+
 





to cause membrane potential hyperpolarization, decreased global [Ca
2+
]i, and 
vasodilation.  We have previously observed decreased Ca
2+





in cerebral artery myocytes using a rabbit model of subarachnoid 
hemorrhage.  Here, we describe and discuss laboratory methods and procedures using the 
fluorescent Ca
2+
 indicator dyes fura-2 and fluo-4 to assess global and local Ca
2+
 signaling 
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1.  Introduction 
The cerebral circulation delivers constant blood flow to the brain over a broad range of 
physiological blood pressures.  To achieve this remarkable phenomenon, cerebral arteries 
must actively constrict to elevations in blood pressure and dilate when blood pressure 
drops.  In cerebral resistance arteries and arterioles, the constriction (myogenic tone) 
response to graded increases in intravascular pressure is dependent on membrane 
potential depolarization, enhanced Ca
2+
 influx via L-type voltage-dependent Ca
2+
 




]i) [1-2].  Global 
[Ca
2+
]i represents average Ca
2+
 levels throughout the cytoplasm and mediates contraction 
of smooth muscle via Ca
2+
/calmodulin-dependent activation of myosin light chain kinase, 
myosin light chain phosphorylation and actin-myosin interaction [3].  Thus, global [Ca
2+
]i 
directly regulates the contractile state of vascular smooth muscle and therefore dictates 
cerebral vascular tone and blood flow.   
 
The discovery of spatially localized, transient calcium release events (“Ca2+ sparks”) has 
altered the view that an elevation of global [Ca
2+
]i is the only effective mode of calcium 
signaling in smooth muscle [4-6].  Calcium sparks result from the opening of a cluster of 
ryanodine receptors in the sarcoplasmic reticulum (SR) membrane, causing a highly 
restricted (1% of the cell volume) and large (µM) increase in local Ca
2+
 with little direct 
effect on global [Ca
2+
]i [5, 7].  In vascular smooth muscle, Ca
2+
 sparks are functionally 




 (BK) channels located on the 
plasma membrane [6, 8].  Elevation of intracellular Ca
2+
 causes a shift in the voltage-
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dependence of BK channel activation to more negative membrane potentials effectively 
leading to increased channel open probability [9].  Increased Ca
2+
 spark activity therefore 
leads to enhanced BK channel activity, membrane potential hyperpolarization, decreased 
global [Ca
2+
]i, and smooth muscle relaxation.  Ca
2+
 spark activity is increased by 
vasodilators such as nitric oxide and forskolin and by elevations in cytosolic and SR 
calcium [10-11].  Thus, Ca
2+
 sparks act as an important negative feedback mechanism to 
oppose vasoconstriction by promoting a reduction in VDCC activity and a decrease in 
global [Ca
2+
]i.   
 
Considering the pivotal role that vascular smooth muscle Ca
2+
 plays in the regulation of 
cerebral blood flow, precise measurement of local and global Ca
2+
 signaling in these cells 
is essential for understanding pathologies characterized by abnormal vascular tone, such 
as aneurysmal subarachnoid hemorrhage (SAH).  With respect to SAH-induced 
“classical” or “angiographic” vasospasm, observed in large diameter conduit arteries on 
the brain surface, the role of elevated global [Ca
2+
]i is unclear and controversial [12].  
However, recent evidence suggests that enhanced constriction of much smaller 
“resistance” arteries and arterioles (< 200 μm in diameter) following SAH is associated 
with increased global [Ca
2+
]i and enhanced VDCC activity [13].  Further, Ca
2+
 spark 
activity is decreased in cerebral arteries by the blood component oxyhemoglobin [14] and 
Ca
2+
 spark frequency is reduced in cerebral artery myocytes isolated from SAH model 
animals [13, 15].  In this chapter, we discuss the properties of two fluorescent Ca
2+
 







sparks, respectively,  in cerebral artery myocytes.  Further, we provide details of specific 
protocols used in our laboratory to assess global and local signaling in the cerebral 




2.1  The use of fura-2 to measure global [Ca
2+
]i in cerebral artery smooth muscle. 
 
The most popular technique for quantifying intracellular free Ca
2+
 is by monitoring the 
fluorescence of Ca
2+
-sensitive indicator dyes [16].  The dual-wavelength ratiometric 
indicator fura-2 is currently the most widely used indicator for measurement of global 
[Ca
2+
]i in isolated cerebral artery myocytes and intact pressurized vessels.  Fura-2 shows 
1:1 Ca
2+
 binding stoichiometry and undergoes a significant shift in excitation spectra 
depending on whether or not Ca
2+
 is bound  (λbound = 340 nm; λfree = 380 nm) while 
emission spectra (510 nm) is independent of Ca
2+
 binding to the dye [17].  Changes in 
fluorescence ratios are therefore independent of intensity, eliminating potentially 
confounding factors such as differential dye loading, photobleaching or time-dependent 
explusion of the dye by the cell.  As a result, fura-2 is preferred over single-wavelength 
intensity-modulating indicators for quantification of absolute intracellular Ca
2+
 
concentrations.  In this section, we describe techniques used for measuring global [Ca
2+
]i 




2.2  Materials and Instruments 
 
  5 ml myograph chamber (Fig. 1A) (Living Systems Instrumentation) 
 Fine-tipped forceps (Fine Science Tools) 
 Cell-permeant fura-2 AM (Invitrogen) 
 Calcium and diameter recording system (e.g. IonOptix Inc.) 
 Hyperswitch light source 
 Xenon arc lamp  
 IonWizard-Core and Analysis Soft Edge software 
 Fluorescence system interface  
 Myocam-S digital CCD video camera 
 Photomultiplier tube (PMT) sub-system 
  Dichroic mirror 
 Photon-to-voltage converter 
 Inverted fluorescence microscope 
 20X/0.50 NA objective lens 
 Peristaltic pump (Ismatec Inc.) 
 PS-200 pressure servo controller with peristaltic pump (Living Systems 
Instrumentation) 
 Dark room/red light 
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2.3  Procedures 
Tissue preparation and dye loading:  
Cerebral arteries and arterioles (50-200 μm in diameter) are dissected from the brain and 
kept in ice cold artificial cerebral spinal fluid (aCSF) of the following composition (in 
mM): 125 NaCl, 3 KCl, 18 NaHCO3, 1.25 NaH2PO4, 1 MgCl2, 2 CaCl2, 5 glucose aerated 
with 5% CO2, 20% O2, 75% N2 (pH, 7.30-7.35).  Freshly isolated cerebral artery 
segments are cannulated on glass micropipettes mounted in a 5 ml myograph chamber 
(Fig. 1) [18].  Following cannulation, blood vessels are incubated with previously aerated 
aCSF containing fura-2 AM (acetoxymethyl ester membrane-permeable form; 5 μM; 
Invitrogen, Carlsbad, CA) and pluronic acid (0.1%; Invitrogen, Carlsbad, CA) at room 
temperature (~22˚C) for 45 minutes in the dark.  The myograph chamber is then mounted 
on an inverted fluorescence microscope and arteries are pressurized and continuously 
superfused with aCSF (37˚C, 30 min) to allow equilibration and deesterification of fura-
2. 
It has previously been demonstrated that Ca
2+
 can be selectively measured in vascular 
smooth muscle or endothelium by loading fura-2 from the extraluminal or luminal side of 
the vessel, respectively [19].  However, the specific loading time and dye concentration 
described above may need to be slightly adjusted based on the specific tissue studied to 
enable sufficient permeation of dye into smooth muscle while avoiding loading of the dye 
into the endothelium.  To examine whether dye loading is smooth muscle-specific, 
studies can be performed on arteries in which the endothelium is physically removed by 
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luminal passage of an air bubble [2].  Endothelial removal can be confirmed by lack of 
response to endothelium-specific pharmacological agents (e.g. acetylcholine, bradykinin, 
NS309) [20-21].     
Data acquisition and estimation of intracellular Ca
2+
:   
First, an aperture located adjacent to the dichroic mirror is adjusted so that the blood 
vessel completely fills the rectangular field of view in the data acquisition software.  This 
minimizes the contribution of extraneous light to the fluorescence signal.  The dichroic 
mirror reflects fluorescence emission to the photomultiplier tube (PMT) while the use of 
a red filter in the microscope condenser allows the vessel image to be transmitted to the 
CCD camera.  Thus, the image collected by the CCD camera for diameter measurement 
represents the same field from which fluorescence is detected by the PMT.    
Following equilibration, fluorescence ratio (F340:F380) is obtained from background-
corrected 510 nm emission from arteries alternately excited
 
at 340 and 380 nm (Fig. 2) 
using software developed by IonOptix (Milton,
 
MA).  Arterial wall [Ca
2+
] is estimated 
using the following equation [17] [Ca
2+
] = Kd × β× (R  Rmin)/(Rmax  R).   





saturated conditions, respectively.  To obtain these values, arteries are first loaded with 
fura-2 and equilibrated as described above.  Arteries are then perfused (10 min, 37˚C) 
with a baseline solution containing the following (in mM): 5 NaCl, 140 KCl, 5 HEPES, 1 
MgCl2 (pH 7.4). Next, to obtain Rmin, arteries are perfused (30 min) with baseline 
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solution that includes EGTA (5 mM), ionomycin (10 μM) and nigericin (5 μM).  
Recording at the end of this period allows determination of Rmin.  EGTA is then washed 
from the bath by perfusion of baseline solution for 15 min.  To obtain Rmax, arteries are 
then perfused (15 min) with baseline solution containing CaCl2 (10 mM), ionomycin (10 
μM) and nigericin (5 μM) for 10 min.  The ratio of calcium-free over calcium-bound 
fluorescence intensities at F380 (β) is determined from these values. In our studies, we 
have used an apparent dissociation constant
 
(Kd) of 282 nM of fura-2 for Ca
2+
 determined 
by Knot and Nelson using rat cerebral arteries [2].   
Measurement of arterial diameter 
Luminal diameter is simultaneously recorded throughout the entire experiment using a 
CCD camera and the length-calibrated video edge detection function of IonOptix 
software (Fig. 1D and 2).  Constriction is analyzed as the decrease in arterial diameter 







where DP is the passive (fully-dilated) diameter of the artery in Ca
2+
-free aCSF 
containing a VDCC blocker (e.g. 100 μM diltiazem or 300 nM nifedipine) and a second 
vasodilator such as forskolin (1 μM) and DA is the active diameter of the artery in 
response to the stimulus in aCSF.  Percent dilation can be obtained using the following 










where DV is the arterial diameter in the presence of vasodilator, DA is the active arterial 
diameter before application of vasodilator, and DP is the passive arterial diameter.  
 
Variations in measurement of global [Ca
2+
]i 
Most investigators obtain ratiometric measurements of fura-2 in isolated arterial segments 
or dissociated cerebral artery myocytes by collecting emitted photons using a 
photomultiplier tube (PMT).  Fluorescence detection may also be achieved using electron 
multiplying CCD or intensified CCD cameras along with quantitative ratio imaging 
software for analysis and estimation of intracellular Ca
2+ 
[2].  However, high sensitivity 
cameras required for these measurements are expensive and do not offer significant 
spatial information when used with wide-field microscopy.  In cases where an 
investigator wishes to measure fura-2 fluorescence in a specific layer of the vascular wall 





3.1  The use of fluo-4 to measure Ca
2+




 indicators such as fluo-4, or its analogue fluo-3, have become 
widely used for imaging of fast, small volume Ca
2+
 signaling events   such as Ca
2+
 sparks 
[23].  One advantage of fluo-4 over ratiometric indicators (e.g. fura-2) in the 
measurement sub-cellular Ca
2+
 signaling events is superior signal-to-noise ratio.  Fluo-4 
is excited at 488 nm and exhibits increased fluorescence intensity (>100 fold) upon 
binding Ca
2+
 without a shift in absorption or emission spectra [24].  Moreover, fluo-4 has 
a lower affinity for Ca
2+
 than fura-2 (Kd ≈ 400 nM compared with Kd ≈ 282 nM for fura-
2) and fast binding and unbinding kinetics, making it suitable for tracking rapid Ca
2+
 
signaling events [24].  Ca
2+
 sparks can be measured using a number of imaging 
approaches including single photon and multiphoton confocal microscopy, total internal 
reflection fluorescence (TIRF) microscopy, and wide-field microscopy using low-noise 
CCD cameras [23].   
 
Previously, the temporal resolution of laser-scanning confocal microscope systems 
sufficient to measure Ca
2+
 sparks could only be achieved using line-scan mode, as 
opposed to two-dimensional (2-D) x-y image scanning [5].  However, the interpretation 
of images obtained using line-scanning is complicated by uncertainties in the position of 
the scan line with regard to the center of the Ca
2+
 release event resulting in a loss of 
spatial information such as accurate determination of Ca
2+
 spark area.  Another 
disadvantage of this method is the inability to measure the total number of active spark 
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sites within a cell.  Currently, a number of laser-scanning confocal microscope systems 
with sufficient 2-D sampling frequency (>30 Hz) are available.  The following section 
provides a detailed description of protocols that we have used to measure Ca
2+
 sparks in 
cerebral artery myocytes using fluo-4 and two-dimensional (2-D) laser-scanning confocal 
microscopy. 
 
3.2 Materials and Instruments 
 
 Cell chamber with glass coverslip bottom 
 Cell-permeant fluo-4 AM (Invitrogen) 
 Laser scanning confocal system (e.g. Oz, Noran Instruments)  
 Inverted  fluorescence microscope (Nikon Diaphot)  
 60X/1.2 NA water-immersion objective lens  
 Krypton/argon laser (480 nm is used to excite fluo-4)  
 Dark room 
 
3.3  Procedures 
Isolation of cerebral artery myocytes:  
Cerebral arteries are enzymatically dissociated to obtain individual smooth muscle cells 
(Fig. 3) [25].  After dissection, cerebral arteries are incubated in a glutamate-containing 
isolation solution (GIS) of the following composition (in mM) :  55 NaCl, 5.6 KCl, 80  L-
glutamic acid (mono-sodium salt), 2.0 MgCl2, 2 CaCl2, 10 HEPES, 10 glucose (pH 7.3; 
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37 °C; 30 min) using a 1 ml vial placed in a water bath.  Arteries are then transferred to a 
Ca
2+
-free GIS containing papein (0.3 mg/mL) and 1,4-dithioerythriol  (0.7 mg/mL; 37°C; 
17 min) using a fire-polished Pasteur pipette.  Next, arteries are incubated in GIS 
containing collagenase type F (0.7 mg/mL), collagenase type H (0.3 mg/mL) and 100 µM 
CaCl2 (37 °C; 20 min).  Finally, arteries are incubated in GIS containing 2 mM CaCl2 on 
ice (3x; 10 min) and gently triturated into individual cerebral artery myocytes using a 
small bore fire-polished Pasteur pipette.  Cerebral artery myocytes can easily be 
identified by characteristic spindle-shaped morphology (Fig. 3).  The cells are kept on ice 
and used within six hours of isolation. 
 
Dye loading:  
Isolated myocytes are loaded with fluo-4 by mixing equal volumes (e.g. 250 μl) of cell 
suspension and HEPES buffered physiological saline solution (HEPES-PSS) of the 
following composition (in mM): 134 NaCl, 6 KCl, 1 MgCl2, 1.8 CaCl2, 10 glucose, 10 
HEPES (pH 7.4) containing fluo-4 AM (20 µM) and pluronic acid (0.072%).  The cell 
suspension containing a final concentration of 10 μM fluo-4 and 0.036% pluronic acid is 
placed in the recording chamber to allow cells to attach to the glass coverslip on the 
bottom of the chamber during the 30 minute loading/deesterification period at room 






spark measurement:     
Initially, cells are located using bright field illumination.  Once a myocyte has been 
centered in the scan field, images of emitted light (wavelengths >500 nm) are acquired at 
a frequency of 58 Hz (every ~ 17 msec, 256 pixels x 256 pixels), and magnified (2X) by 
acquisition software (68 µm for 256 pixels).  Images are usually acquired for a period of 
10-20 seconds and saved for future analysis (Fig. 4).  Laser exposure can lead to cell 
damage which typically causes the cells to become much brighter in appearance and 
abolish Ca
2+
 spark activity.  Excessive laser exposure can also lead to photo-bleaching of 
the indicator dye.  Thus, it is recommended to combine the lowest laser intensity that 





 sparks can also be performed in intact pressurized cerebral arteries 
(Fig. 5) [11, 14, 26].  After dissection, intact arteries are loaded with fluo-4 AM (10 µM 
at room temperature for 1 hr, with 0.036% pluronic acid) followed by brief washes with 
aCSF (see section 2.3).  Arteries are then cannulated, pressurized (see section 2.3) and 
Ca
2+
 sparks imaged using 2-D laser-scanning confocal microscopy as described above for 
isolated myocytes.   Measurement of Ca
2+
 sparks in the intact tissue provides the 
ability to simultaneously examine events in multiple cells under more physiological 
conditions (i.e. at physiological intravascular pressures).  However, due to the presence of 
connective tissue and multiple cell layers, the signal-to-noise ratio is decreased in images 
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from intact tissue compared to isolated cells.   Thus, imaging performed on isolated cells 
is preferred for detailed analysis of the spatio-temporal properties of Ca
2+




 sparks:  
A variety of custom-written software packages provide the ability to detect and analyze 
Ca
2+
 sparks.  Ca
2+
 sparks are typically assessed using 2.1 μm X 2.1 μm analysis areas 
(centered over the Ca
2+
 spark-induced peak in fluorescence intensity) and defined as 
fractional fluorescence changes (F/F0) greater than 1.3 [5, 25].  Background fluorescence 
intensity (F0) is determined within analysis areas by averaging the first 30 consecutive 
images without Ca
2+
 spark activity (for example, see Fig. 4B).  Frequency is the most 
commonly used parameter to describe Ca
2+
 spark activity.  In isolated myocytes, Ca
2+
 
spark frequency, expressed in Hz, represents the total number of events occurring in a 
cell divided by the sampling period (in seconds).  In cerebral artery myocytes, Ca
2+
 spark 
frequency is increased by vasodilators acting via increased cyclic AMP-dependent 
protein kinase, cyclic GMP-dependent protein kinase and/or increased levels of cytosolic 
or SR Ca
2+
 [6, 10-11].  Conversely, enhanced cerebral artery constriction following 
subarachnoid hemorrhage is associated with a reduction in Ca
2+
 spark frequency in 
cerebral artery myocytes [13, 15].  Ca
2+
 spark amplitude is frequently expressed as the 







 (BK) channel activity as a biological Ca
2+
 indicator, 
Perez et al. have estimated that local increases in Ca
2+
 during a Ca
2+
 spark are in the 





 indicator dyes such as fluo-4, using the equation: [Ca
2+
] = Kd * F /(Fmax-
F) [23], given the Kd of fluo-4 is ≈ 0.4 μM, this approach may underestimate local Ca2+ 
concentrations attained during Ca
2+
 sparks.  Other frequently reported spatio-temporal 
characteristics of Ca
2+
 sparks include spark size or area (defined as the area measured at 
50% peak amplitude), rise time (measured from 10-90% rise in signal), decay time 
constants and half-time to decay [27]. 
 
4.1 Conclusions 
In this chapter, we provide a description of procedures used to assess both global and 
local Ca
2+
 signaling in cerebral artery myocytes using the Ca
2+
-sensitive fluorescent dyes 
fura-2 and fluo-4.  The ratiometric Ca
2+
 sensitive dye fura-2 is considered the indicator of 
choice for measurement of global cytosolic Ca
2+
, or averaged Ca
2+
 levels throughout the 
cytoplasm.  On the other hand, transient Ca
2+
 release events from the SR (Ca
2+
 sparks) 
require the use of single-wavelength Ca
2+
 indicators such as fluo-4.  A thorough 
knowledge of these Ca
2+
 signaling processes is imperative for understanding mechanisms 
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Figure 1: Arteriograph chamber for intact pressurized cerebral arteries.  A.  
Overhead view of 5 mL arteriograph chamber used for cannulation of cerebral artery 
segments.   B.  Glass micropipettes are pulled from capillary tubes and mounted in an 
arteriograph chamber.  C.  Image of a rat posterior cerebral artery (~150 μm diameter) 
cannulated on glass micropipettes.  Suture thread is used to tie each end of the artery 
segment onto the micropipettes.  D. Image of rat parenchymal arteriole (~60 μm 
diameter).  Video edge detection (black horizontal lines) is used for measurement of 
arterial diameter.   
 
Figure 2: Simultaneous measurement of global [Ca
2+
]i and diameter of an intact 
pressurized cerebral artery.  Fluorescence intensity (photomultiplier tube counts) at 
340 nm and 380 nm excitation (F340 and F380, respectively), F340/F380 ratio, 
calculated free [Ca
2+
]i and arterial diameter from a pressurized rabbit cerebellar artery.  
Smooth muscle membrane potential depolarization induced by elevating extracellular K
+
 
from 3 mM to 60 mM caused an increased in F340/F380 ratio (i.e. increased free [Ca
2+
]i) 
and vasoconstriction.  The response to 60 mM K
+
 was reversed by application of the 
VDCC blocker nifedipine (1 μM).        
 
Figure 3: Freshly isolated native cerebral artery myocytes.  A.  Cerebral arteries were 
enzymatically dissociated to obtain isolated vascular smooth muscle cells.  Image shows 
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individual smooth muscle cells using differential interference contrast microscopy (40X).  
B.  Vascular smooth muscle can be identified by spindle-shaped cell morphology as well 
as immunostaining of smooth muscle alpha actin and smooth muscle myosin heavy 
chain.  Scale bars represent 10 μm.  From Nystoriak et al., Am. J. Physiol., 2009 [28] with 
permission.     
 
Figure 4:  Ca
2+
 sparks in isolated cerebral artery myocytes.  A.  Original images of a 
Ca
2+
 spark recorded every 17 msec from an isolated cerebral artery myocyte.  White scale 
bar represents 10 µm.  Red arrow indicates a Ca
2+
 spark.  B.  F0 image obtained by 
averaging 30 consecutive images without a Ca
2+
 spark.  Trace represents time course of 
fractional fluorescence changes (F/F0) during the Ca
2+
 spark shown in panel A using the 
analysis area (2.1 μm x 2.1 μm) depicted as a red square in the F0 image.  Gray bar 
represents time elapsed during the images shown in panel A.  C.  Pseudo-colored images 
of the same Ca
2+
 spark depicted in panels A and B.  Each pixel is converted to pseudo-




 sparks in intact pressurized cerebral arteries.   Ca
2+
 sparks were 
recorded in 56 µm x 53 µm areas of intact pressurized mouse cerebral arteries in the 
absence (A) and presence (B) of forskolin (10 μM), an activator of adenylyl cyclase.  
During a 10 second recording period, a total of 13 Ca
2+
 sparks were observed in the 
image depicted in panel A, and a total of 38 Ca
2+
 sparks were observed in the image 
depicted in panel B.  White boxes represent sites where Ca
2+
 sparks occurred.  Three 
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representative F/F0 records (a-c) corresponding to three Ca
2+
 sparks sites (a-c) from each 
artery are displayed below their corresponding artery image. Horizontal scale bars 
represent a time of 1 second, and vertical scale bars represent a fractional fluorescence 
(F/F0) change of 0.5.  From Wellman et al., Am. J. Physiol. Cell Physiol., 2001 [11] with 















Figure 2: : Simultaneous measurement of global [Ca
2+
]i and diameter of an intact 




























 sparks in intact pressurized cerebral arteries. 
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 signaling mechanisms are crucial for proper regulation of vascular 





]i) causes contraction while an increase in local 
Ca
2+
 release events from the sarcoplasmic reticulum (Ca
2+
 sparks) leads to increased 




 channels, hyperpolarization and 
relaxation.  Here, we examined the impact of SAH on Ca
2+
 spark activity and [Ca
2+
]i in 
cerebral artery myocytes following SAH. 
Methods:  A rabbit double injection SAH model was used in this study.  Five days after 
the initial intracisternal injection of whole blood, small diameter cerebral arteries were 
dissected from the brain for study.  For simultaneous measurement of arterial wall [Ca
2+
]i 
and  diameter, vessels were cannulated and loaded with the ratiometric Ca
2+
 indicator 
fura-2.  For measurement of Ca
2+
 sparks, individual myocytes were enzymatically 
isolated from cerebral arteries and loaded with the Ca
2+
 indicator fluo-4.  Sparks were 
visualized using laser scanning confocal microscopy. 
Results: Arterial wall [Ca
2+
]i was significantly elevated and greater levels of myogenic 
tone developed in arteries isolated from SAH animals compared with arteries isolated 
from healthy animals.  The L-type voltage-dependent Ca
2+
 channel (VDCC) blocker 
nifedipine attenuated increases in [Ca
2+
]i and tone in both groups suggesting increased 
VDCC activity following SAH.  Membrane potential measurement using intracellular 
microelectrodes revealed significant depolarization of vascular smooth muscle following 
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Conclusions:  Our findings suggest decreased Ca
2+
 spark frequency leads to reduced BK 
channel activity in cerebral artery myocytes following SAH.  This results in membrane 
potential depolarization, increased VDCC activity, elevated [Ca
2+
]i and decreased vessel 
diameter.  We propose this mechanism of enhanced cerebral artery myocyte contractility 
may contribute to decreased cerebral blood flow and development of neurological deficits 















 is a ubiquitous second messenger, playing critical roles in a wide array 
of physiological processes including muscle contraction (2).  In the cerebral vasculature, 
average intracellular Ca
2+ 




]i) dictates smooth 
muscle contraction (and arterial diameter) via regulation of  myosin light chain kinase 
activity (4).  Thus, an elevation in global cytosolic Ca
2+
 leads to enhanced 
vasoconstriction and potentially a decrease in cerebral blood flow (12).  Paradoxically, 
localized intracellular Ca
2+
 release events, termed Ca
2+
 sparks, promote a decrease in 
[Ca
2+
]i and relaxation of cerebral artery myocytes (15, 27).  Ca
2+
 sparks are generated by 
the coordinated opening of ryanodine receptors (RyRs) located on the sarcoplasmic 





 (BK) channels leading to membrane potential hyperpolarization, decreased 
activity of voltage-dependent Ca
2+
 channels (VDCCs), decreased [Ca
2+
]i, and 
vasodilation.  Currently, the impact of subarachnoid hemorrhage on local and/or global 
Ca
2+




A rabbit double-injection model of SAH was used in this study.  Briefly, anesthetized 
New Zealand white rabbits (males, 3.0-3.5 kg) received an intracisternal injection of 
autologous arterial blood (2.5 ml) using a previously described surgical procedure (8, 9).  
Forty-eight hours after the initial injection, the procedure was repeated with animals 
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receiving a second injection of 2.5 ml of arterial blood.  Five days after the initial 
surgery, rabbits were euthanized and posterior cerebral and cerebellar arteries (100-200 
µm diameter) were dissected for in vitro studies.  All protocols were conducted in 
accordance with the guidelines for the care and use of laboratory animals (NIH 
publication 85-23, 1985) and followed protocols approved by the Institutional Animal 
Use and Care Committee of the University of Vermont, USA. 
 
Simultaneous measurement of global cytosolic Ca
2+
 and arterial diameter: 
Intact cerebral arteries were cannulated on glass micropipettes mounted in a Living 
Systems Inc. (Burlington, VT) arteriograph chamber.   Arteries were loaded, in the dark, 
with the ratiometric Ca
2+
 indicator fura-2-AM (5 μM) in a MOPS solution containing 
pluronic acid (0.05%) for 45 minutes at room temperature.  The MOPS loading solution 
had the following composition (in mM):  145 NaCl, 5 KCl, 1 MgSO4, 2.5 CaCl2, 1 
KH2PO4, 0.02 EDTA, 3 3-(N-morpholino)propanesulfonic acid (MOPS), 2 pyruvate, 5 
glucose, 1% bovine serum albumin (pH 7.4).  Arteries were then continuously superfused 
with aerated artificial cerebral spinal fluid (aCSF) at 37° C for the remainder of the 
experiment.  The composition of the aCSF was (in mM):  125 NaCl, 3 KCl, 18 NaHCO3, 
1.25 NaH2PO4, 1 MgCl2, 2 CaCl2, 5 glucose aerated with 5% CO2, 20% O2, 75% N2 (pH 
7.35).  Ratio images of the arterial wall were obtained from background corrected images 
of the 510 nm emission from arteries alternately excited at 340 and 380 nm using 
software developed by IonOptix Inc. (Milton, MA).   Arterial wall [Ca
2+
] is calculated 
using the following equation (3): [Ca
2+
] = Kd x  x (R-Rmin)/(Rmax-R).  An apparent Kd of 
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282 nM of fura-2 for Ca
2+
 was used (12).  Arterial constriction was expressed as a 
percent decrease from the maximal (fully dilated) diameter obtained at the end of each 
experiment in Ca
2+
-free aCSF containing the vasodilators nifedipine (1 μM) and forskolin 
(1 μM).  In some studies intracellular microelectrodes were used to measure smooth 
muscle membrane potential in intact pressurized arteries, as described previously (25). 
Measurement of Ca
2+
 sparks in isolated cerebral artery myocytes: 
Individual smooth muscle cells were enzymatically isolated from posterior cerebral and 
cerebellar artery segments (26).    Isolated myocytes were then loaded with fluo-4-AM 
(10 µM) for 60 minutes (21˚ C) in a HEPES-buffered physiological saline solution (PSS) 
containing pluronic acid (0.05%).  The HEPES-PSS had the following composition (in 




, 10 HEPES, 10 glucose (pH 7.4 with 
NaOH).  Myocyte images were acquired with a Noran Oz laser scanning confocal 
microscope (19).  Fluo-4 was excited using the 488 nm line of a krypton/argon laser and 
the light emitted by this dye (520 nm) was separated from the excitation light and 
collected.  Images were acquired at a frequency of ≈ 60 Hz for a period of 20 seconds.  
Ca
2+
 sparks are detected and analyzed using custom software (written by Dr. Adrian 
Bonev, University of Vermont, using IDL 5.0.2; Research Systems Inc., Boulder, CO).   
Baseline fluorescence (Fo) was determined by averaging 10 images without Ca
2+
 spark 
activity.  Fractional fluorescence increases (F/Fo) are determined in areas (2.1 μm  2.1 
μm) where Ca2+ sparks were observed.  Ca2+ sparks are defined as local fractional 





Elevated global cytosolic Ca
2+
 and enhanced myogenic tone in small diameter 
cerebral arteries following SAH: 
The relationship between intravascular pressure, arterial Ca
2+
 and myogenic tone was 
examined in small diameter (150-200 μm) cerebral arteries isolated from healthy control 
and SAH model rabbits.  Arterial wall Ca
2+
 and constriction increased as intravascular 
pressure was elevated within the range (60-100 mmHg) typically experienced by these 
arteries in vivo.  Arteries from SAH animals exhibited significant elevations in both 
arterial wall Ca
2+
 and constriction compared to similar arteries from control animals 
(Figure 1A).  For example, at 100 mmHg, arterial wall Ca
2+ 
was ~26% higher in arteries 
isolated from SAH animals (231 ± 17 nM, n = 4) compared with arteries isolated from 
healthy (184 ± 12 nM, n = 4).  The level of constriction (myogenic tone) at 100 mmHg 
was ~1.5 fold higher in arteries isolated from SAH animals (39 ± 3 % decrease in 
diameter, n = 4) compared with arteries isolated from healthy animals (27 ± 2 % decrease 
in diameter, n = 4).  In the presence of the L-type VDCC blocker nifedipine (1 μM), 
arterial Ca
2+
 was greatly reduced in arteries from both SAH (141 ± 15 nM) and control 
(118 ± 7 nM) rabbits.  Nifedipine (1 μM) also reduced pressure-induced constrictions by 
92 ± 1 % and 93 ± 1 % in arteries from SAH and control animals, respectively.   These 
data suggest that increased VDCC activity underlies enhanced pressure-induced 
constriction observed in small diameter cerebral arteries from SAH.   
Increased VDCC activity could reflect either increased L-type VDCC expression or 
enhanced VDCC activation due to smooth muscle membrane potential depolarization 
219 
 
following SAH.  Quantitative real-time PCR was used to assess L-type VDCC expression 
encoded by the gene CaV1.2 (17).  Using this approach, no significant difference in 
CaV1.2 mRNA levels was detected in cerebral artery homogenates from control and SAH 
animals (Figure 1B).  Next, we used intracellular microelectrodes to directly measure 
vascular smooth muscle membrane potential from intact pressurized cerebral arteries.  At 
80 mmHg, smooth muscle membrane potential was significantly depolarized by 
approximately 8 mV in arteries isolated from SAH animals compared with arteries from 
control animals (Figure 1C).  These findings suggest that membrane potential 
depolarization of vascular smooth muscle leads to increased VDCC activity, elevated 
global cytosolic Ca
2+
 and enhanced constriction of small diameter cerebral arteries 




 spark frequency is decreased in cerebral artery myocytes from SAH animals: 
A decrease in Ca
2+
 spark frequency and associated BK activity promotes membrane 
potential depolarization, elevated global cytosolic Ca
2+
, and vasoconstriction (15, 27).  
To explore whether decreased Ca
2+
 spark frequency may contribute to enhanced cerebral 
artery constriction, Ca
2+
 sparks were measured in isolated cerebral artery myocytes using 
laser scanning confocal microscopy and the Ca
2+
 indicator dye fluo-4.  As illustrated in 
figure 2, Ca
2+
 sparks were observed in cerebral artery myocytes obtained from both 
control and SAH animals.  However, Ca
2+
 spark frequency was markedly decreased (by 
approximately 50%) in myocytes isolated from SAH animals.  Consistent with the 
observed decrease in Ca
2+
 spark frequency, the frequency of transient BK currents 
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detected using patch clamp electrophysiology was also reduced by approximately 50 % in 
freshly isolated cerebral artery myocytes from SAH animals (Koide and Wellman, 
unpublished observations).  These data suggest that a decrease in the frequency of Ca
2+
 
sparks and their associated BK channel currents may contribute to enhanced constriction 
of small diameter cerebral arteries following SAH. 
 
Discussion 
Aneurysmal SAH is associated with high rates of morbidity and mortality (1).  It has been 
a long-held belief that delayed and sustained large diameter (conduit) cerebral artery 
vasospasm (“angiographic vasospasm”) is a major contributor to SAH-induced death and 
disability.  However, there is a growing appreciation that a host of other factors are also 
likely involved in the pathological consequences associated with cerebral aneurysm 
rupture (5, 20).   Here, we provide evidence that SAH enhances the dynamic constriction 
of small diameter pial arteries in response to physiological increases in intravascular 
pressure, an effect that could have a pronounced influence to decrease cerebral blood 
flow.  Our findings indicate that this augmented constriction is associated with enhanced 
smooth muscle contraction due to membrane potential depolarization, enhanced voltage-
dependent Ca
2+
 channel activity and elevated global cytosolic calcium.   Further, our 
recent findings suggest a decrease in the frequency of Ca
2+
 sparks and associated BK 
channel activity may contribute to enhanced cerebral artery constriction and elevated 
global cytosolic Ca
2+
 (figure 3). 
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The cerebral circulation maintains a constant level of blood flow to the brain despite 
physiological fluctuations in cerebral perfusion pressure (14).  To achieve stable cerebral 
blood flow in the face of changes in blood pressure, cerebral arteries must constrict in 
response to increased intravascular pressure and dilate when intravascular pressure is 
reduced.  In pial arteries from healthy animals, physiological increases in intravascular 
pressure lead to smooth muscle membrane potential depolarization, an increase in the 
activity of L-type CaV1.2 channels (encoded by the gene CACNA1C), and increased 
global cytosolic Ca
2+ 
(12, 17).  The open-state probability of CaV1.2 is steeply voltage-
dependent (16); thus, small changes in membrane potential can have a profound impact 
on smooth muscle Ca
2+
.  Our present results suggest membrane potential depolarization 
and enhanced L-type VDCC activity in small diameter arteries is likely to contribute to 
SAH-induced impairment in the autoregulation of cerebral blood flow reported by others 
(18, 23).   Our evidence also suggests enhanced activity of L-type VDCCs play a large 
part in the SAH-induced elevation in global cytosolic Ca
2+
.  However, in the presence of 
the L-type VDCC blocker nifedipine, global Ca
2+
 remained elevated (by approximately 
20%) in arteries from SAH animals.   This nifedipine-resistant increase in global Ca
2+
 in 
cerebral arteries from SAH animals may reflect the emergence of R-type VDCC channels 
(9), or the possible upregulation of additional Ca
2+
 entry pathways.  
Our present findings suggest decreased Ca
2+
 spark and associated BK channel activity 
contribute to SAH-induced membrane potential depolarization and enhanced VDCC 
activity in cerebral artery myocytes.  Harder and colleagues (6) were the first to report 
that the membrane potential of cerebral artery myocytes is depolarized following SAH 
222 
 
and a number of subsequent studies have provided further evidence for decreased 
voltage-dependent K
+
 (KV) channel activity in pial arteries following SAH (7, 10, 11, 13, 
21, 22, 24).  Interestingly, BK channel activity and expression have been reported to be 
unchanged in basilar artery myocytes obtained from a canine SAH model (11).   Our 
current work demonstrates that decreased BK channel activity following SAH results 
from a decrease in local Ca
2+
 signaling from the SR to the plasma membrane (i.e. 
decreased Ca
2+




In this study, we examined global and local Ca
2+
 signaling in cerebral artery myocytes 
following SAH.  As for global Ca
2+
, we observed a significant increase in averaged 
cytosolic Ca
2+
 and constriction in cerebral arteries from SAH animals at physiological 
intravascular pressures.   Regarding local Ca
2+
 signaling, we report a decrease in the 
frequency of Ca
2+
 sparks and associated transient outward BK currents, which likely 
contribute to membrane potential depolarization, increased VDCC activity and enhanced 
cerebral constriction artery following SAH.  These data suggest that increased global 
Ca
2+
 and impaired local Ca
2+
 signaling may contribute to decreased cerebral blood flow 






This work was supported by the Totman Medical Research Trust Fund, the Peter Martin 
Brain Aneurysm Endowment, the NIH (NIHLBI, R01 HL078983 and NCRR, P20 
RR16435) and the American Heart Association (0725837T, 0815736D).  The authors 
wish to thank to Ms. Sheila Russell for her assistance with this study.  The authors would 
also like to acknowledge the University of Vermont Neuroscience COBRE molecular 




 1. Bederson JB, Connolly ES, Jr., Batjer HH, Dacey RG, Dion JE, Diringer MN, 
Duldner JE, Jr., Harbaugh RE, Patel AB, Rosenwasser RH (2009) Guidelines for the 
management of aneurysmal subarachnoid hemorrhage: a statement for healthcare 
professionals from a special writing group of the Stroke Council, American Heart 
Association. Stroke 40:994-1025 
2. Clapham DE (2007) Calcium signaling. Cell 131:1047-1058 
3. Grynkiewicz G, Poenie M, Tsien RY (1985) A new generation of Ca2+ 
indicators with greatly improved fluorescence properties. J Biol Chem 260:3440-3450 
4. Hai CM, Murphy RA (1989) Ca2+, crossbridge phosphorylation, and 
contraction. Annu Rev Physiol 51:285-298 
5. Hansen-Schwartz J, Vajkoczy P, Macdonald RL, Pluta RM, Zhang JH (2007) 
Cerebral vasospasm: looking beyond vasoconstriction. Trends Pharmacol Sci 28:252-256 
6. Harder DR, Dernbach P, Waters A (1987) Possible cellular mechanism for 
cerebral vasospasm after experimental subarachnoid hemorrhage in the dog. J Clin Invest 
80:875-880 
7. Ishiguro M, Morielli AD, Zvarova K, Tranmer BI, Penar PL, Wellman GC 
(2006) Oxyhemoglobin-induced suppression of voltage-dependent K+ channels in 
cerebral arteries by enhanced tyrosine kinase activity. Circ Res 99:1252-1260 
8. Ishiguro M, Puryear CB, Bisson E, Saundry CM, Nathan DJ, Russell SR, 
Tranmer BI, Wellman GC (2002) Enhanced myogenic tone in cerebral arteries from a 
225 
 
rabbit model of subarachnoid hemorrhage. Am J Physiol Heart Circ Physiol 283:H2217-
2225 
9. Ishiguro M, Wellman TL, Honda A, Russell SR, Tranmer BI, Wellman GC 
(2005) Emergence of a R-type Ca2+ channel (CaV 2.3) contributes to cerebral artery 
constriction after subarachnoid hemorrhage. Circ Res 96:419-426 
10. Jahromi BS, Aihara Y, Ai J, Zhang ZD, Nikitina E, Macdonald RL (2008) 
Voltage-gated K+ channel dysfunction in myocytes from a dog model of subarachnoid 
hemorrhage. J Cereb Blood Flow Metab 28:797-811 
11. Jahromi BS, Aihara Y, Ai J, Zhang ZD, Weyer G, Nikitina E, Yassari R, 
Houamed KM, Macdonald RL (2008) Preserved BK channel function in vasospastic 
myocytes from a dog model of subarachnoid hemorrhage. J Vasc Res 45:402-415 
12. Knot HJ, Nelson MT (1998) Regulation of arterial diameter and wall [Ca2+] in 
cerebral arteries of rat by membrane potential and intravascular pressure. J Physiol 508 ( 
Pt 1):199-209 
13. Koide M, Penar PL, Tranmer BI, Wellman GC (2007) Heparin-binding EGF-
like growth factor mediates oxyhemoglobin-induced suppression of voltage-dependent 
potassium channels in rabbit cerebral artery myocytes. Am J Physiol Heart Circ Physiol 
293:H1750-1759 
14. Lee KR, Hoff, J.T. (1996) Intracranial Pressure. Neurological Surgery W.B. 
Saunders Co., Philadelphia 
15. Nelson MT, Cheng H, Rubart M, Santana LF, Bonev AD, Knot HJ, Lederer WJ 
(1995) Relaxation of arterial smooth muscle by calcium sparks. Science 270:633-637 
226 
 
16. Nelson MT, Patlak JB, Worley JF, Standen NB (1990) Calcium channels, 
potassium channels, and voltage dependence of arterial smooth muscle tone. Am J 
Physiol 259:C3-18 
17. Nystoriak MA, Murakami K, Penar PL, Wellman GC (2009) Ca(v)1.2 splice 
variant with exon 9* is critical for regulation of cerebral artery diameter. Am J Physiol 
Heart Circ Physiol 297:H1820-1828 
18. Ohkuma H, Ogane K, Tanaka M, Suzuki S (2001) Assessment of cerebral 
microcirculatory changes during cerebral vasospasm by analyzing cerebral circulation 
time on DSA images. Acta Neurochir Suppl 77:127-130 
19. Perez GJ, Bonev AD, Patlak JB, Nelson MT (1999) Functional coupling of 
ryanodine receptors to KCa channels in smooth muscle cells from rat cerebral arteries. J 
Gen Physiol 113:229-238 
20. Pluta RM, Hansen-Schwartz J, Dreier J, Vajkoczy P, Macdonald RL, Nishizawa 
S, Kasuya H, Wellman G, Keller E, Zauner A, Dorsch N, Clark J, Ono S, Kiris T, Leroux 
P, Zhang JH (2009) Cerebral vasospasm following subarachnoid hemorrhage: time for a 
new world of thought. Neurol Res 31:151-158 
21. Quan L, Sobey CG (2000) Selective effects of subarachnoid hemorrhage on 
cerebral vascular responses to 4-aminopyridine in rats. Stroke 31:2460-2465 
22. Sobey CG, Faraci FM (1998) Subarachnoid haemorrhage: what happens to the 
cerebral arteries? Clin Exp Pharmacol Physiol 25:867-876 
227 
 
23. Takeuchi H, Handa Y, Kobayashi H, Kawano H, Hayashi M (1991) Impairment 
of cerebral autoregulation during the development of chronic cerebral vasospasm after 
subarachnoid hemorrhage in primates. Neurosurgery 28:41-48 
24. Wellman GC (2006) Ion channels and calcium signaling in cerebral arteries 
following subarachnoid hemorrhage. Neurol Res 28:690-702 
25. Wellman GC, Bonev AD, Nelson MT, Brayden JE (1996) Gender differences in 
coronary artery diameter involve estrogen, nitric oxide, and Ca(2+)-dependent K+ 
channels. Circ Res 79:1024-1030 
26. Wellman GC, Nathan DJ, Saundry CM, Perez G, Bonev AD, Penar PL, Tranmer 
BI, Nelson MT (2002) Ca2+ sparks and their function in human cerebral arteries. Stroke 
33:802-808 
27. Wellman GC, Nelson MT (2003) Signaling between SR and plasmalemma in 





Figure 1: Elevated global cytosolic Ca
2+
 following SAH: A. Summary data from 
simultaneous measurement of arterial wall Ca
2+
 (using fura-2) and diameter.  Arterial 
wall Ca
2+
 and tone were significantly increased at intravascular pressures between 60 and 
100 mmHg in arteries isolated from SAH animals compared with controls.  B.  Summary 
data using quantitative real-time PCR.  Total RNA was collected from posterior cerebral 
arteries.  CaV1.2 expression was not altered following SAH.  NS: not statistically 
significant.  C.  Summary data from membrane potential measurement using intracellular 
microelectrodes.  Vascular smooth muscle membrane potential in arteries from SAH 
animals was significantly depolarized following SAH.  * P<0.05.   
 
Figure 2:  Decreased Ca
2+
 spark frequency in cerebral myocytes from SAH animals:  
Imaging of Ca
2+
 sparks in cerebral artery myocytes loaded with the fluorescent Ca
2+
 
indicator fluo-4.  Fluorescent images were detected using laser scanning confocal 
microscopy with Ca
2+
 sparks defined as a fractional fluorescent increase of greater than 
30% within 2.1 μm by 2.1 μm analysis areas.  Large size images represent an average of 
30 images in gray scale without Ca
2+
 spark activity.  White crosses depict where 
individual Ca
2+
 sparks occurred during the 20 sec recordings.  Scale bars represent 10 
µm.  Smaller images illustrate the time course of Ca
2+
 sparks in control and SAH 




Figure 3:  Summary cartoon:  In control cerebral artery myocytes, local Ca
2+
 release 
events from the sarcoplasmic reticulum (Ca
2+





 channels, causing membrane potential hyperpolarization, decreased 
voltage-dependent Ca
2+
 channel (VDCC) activity and decreased global cytosolic Ca
2+
.  
Following SAH, the frequency of Ca
2+
 sparks and therefore BK channel activity is 
decreased, promoting membrane potential depolarization, increased VDCC activity and 








     Figure 1: Elevated global cytosolic Ca
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 release events (“Ca2+ sparks”) and transient activation of large-
conductance Ca
2+
-activated potassium (BK) channels represent an important vasodilator 
pathway in the cerebral vasculature.  Considering the frequent occurrence of cerebral 
artery constriction following subarachnoid hemorrhage (SAH), our objective was to 
determine if Ca
2+
 spark and BK channel activity were reduced in cerebral artery 
myocytes from SAH model rabbits.  Using laser scanning confocal microscopy, we 
observed ≈50 % reduction in Ca2+ spark activity, reflecting a decrease in the number of 
functional Ca
2+
 spark discharge sites.   Patch clamp electrophysiology demonstrated a 
similar reduction in Ca
2+
 spark-induced transient BK currents, but no change in BK 
channel density or single channel properties.  Consistent with a reduction in active Ca
2+
 
spark sites, quantitative real-time PCR and western blotting revealed decreased 
expression of ryanodine receptor type 2 (RyR-2) and increased expression of the RyR-2 
stabilizing protein, FKBP12.6, in cerebral arteries from SAH animals.   Further, 
inhibitors of Ca
2+
 sparks (ryanodine) or BK channels (paxilline) constricted arteries from 
control, but not SAH animals.   This work demonstrates that an SAH-induced decrease in 
sub-cellular Ca
2+
 signaling events disables BK channel activity leading to cerebral artery 
constriction.  This phenomenon may contribute to decreased cerebral blood flow and the 
high rate of poor outcome following aneurysmal SAH.    Key Words:  cerebral 
aneurysm, FKBP12.6, potassium channels, ryanodine receptors, vascular smooth 





Cerebral aneurysm rupture and the ensuing subarachnoid hemorrhage (SAH) has an 
enormous impact on individuals and society, with 30-day mortality rates approaching 50 
% and the majority of survivors left with moderate to severe disability (Hop et al 1997).  
For decades, “angiographically-defined” cerebral vasospasm of conduit arteries (> 1 mm 
in diameter) has been thought to be the major contributor to death and disability in SAH 
patients surviving the initial intracranial bleed.  However, recent evidence indicates that 
factors other than large artery vasospasm contribute to SAH-induced pathologies 
(Macdonald et al 2007).  Additional factors contributing to the deleterious consequences 
of aneurysmal SAH may include global transient ischemia, early brain injury, disruption 
of the blood-brain barrier, and activation of inflammatory pathways (Ostrowski et al 
2006; Prunell et al 2005).  It is now appreciated that SAH may also impact small 
diameter arteries and arterioles, i.e. those involved in the autoregulation of cerebral blood 
flow (Hattingen et al 2008; Ishiguro et al 2002; Ohkuma et al 2000).   
  In resistance arteries from healthy animals, vasoconstrictor stimuli such as 
physiological increases in intravascular pressure lead to smooth muscle membrane 
potential depolarization, increased voltage-dependent Ca
2+
 channel (VDCC) activity, and 





 levels throughout the cytoplasm and is a key regulator of 
smooth muscle contraction.  One important dynamic negative feedback mechanism to 
limit vasoconstriction is the activation of large-conductance Ca
2+
- and voltage-sensitive 
potassium (BK) channels by Ca
2+
 sparks.  Ca
2+
 sparks are localized Ca
2+
 release events 
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occurring through ryanodine receptors (RyRs) in the sarcoplasmic reticulum (SR) 
abutting the plasma membrane.  Ca
2+
 sparks oppose the contractile actions of global 
cytosolic Ca
2+
 by promoting smooth muscle relaxation via activation of plasmalemmal 
BK channels leading to membrane potential hyperpolarization and decreased Ca
2+
 influx 
through VDCCs (Nelson et al 1995; Wellman and Nelson 2003).  In the vasculature, 
functional BK channels are composed of pore-forming α1 subunits, encoded by the gene 
KCNMA1 and regulatory β1 subunits, encoded by the gene KCNMB1 (Tanaka et al 
1997).  Loss-of and gain-of function polymorphisms of KCNMA1 and KCNMB1 have 
been linked to asthma and blood pressure regulation in humans (Kelley-Hedgepeth et al 
2009; Tomas et al 2008).  Further, decreased KCNMB1 expression causes reduced BK 
channel Ca
2+
 and voltage sensitivity, and is linked to enhanced vasoconstriction, 
hypertension and diabetes (Amberg and Santana 2003; Brenner et al 2000; Dong et al 
2008).  These vascular pathologies have all been associated with a decrease in BK 
channel activity in response to Ca
2+
 sparks, rather than a reduction in Ca
2+
 spark activity. 
  Decreased BK channel activity following SAH could lead to vasoconstriction 
and compromise cerebral autoregulation.  However, BK channel properties and 
expression appear to be unaffected in basilar arteries obtained from a canine SAH model 
(Jahromi et al 2008b).  In the present study, we demonstrate that decreased BK channel 
activity does contribute to enhanced pressure-dependent constriction of resistance-sized 
cerebral arteries from SAH model rabbits.  However, rather than reduced BK channel 
activity resulting from decreased KCNMA1 or KCNMB1 expression, we provide 





signaling from the SR to BK channels, i.e. reduced Ca
2+
 spark frequency.   To our 
knowledge, these findings represent the first demonstration of a vascular pathology due 
to a decrease in Ca
2+
 spark activity.  This SAH-induced reduction in Ca
2+
 spark frequency 
reflects a decrease in the number of functional Ca
2+
 spark discharge sites caused by a 
decrease in the expression of SR RyR-2 Ca
2+
-release channels and an increase in the 
expression of the RyR-2 stabilizing protein, FKBP12.6.  This novel pathway of decreased 
vascular BK channel activity may contribute to impaired autoregulation, reduced cerebral 
blood flow and the development of neurological deficits frequently observed in patients 
following aneurysmal SAH. 
 
 
Materials and Methods 
Rabbit SAH model 
New Zealand White rabbits (males, 3.0-3.5 kg; Charles River Laboratories) were used for 
a double injection SAH model using surgical procedures described previously (Ishiguro 
et al 2002; Ishiguro et al 2005).  Briefly, under isoflurane anesthesia, a small midline 
suboccipital incision was centered over the foramen magnum and neck muscles dissected 
until dura was visualized.  Unheparinized autologous blood (2.5 ml) was then injected 
into the subarachnoid space via the cisterna magna.  The animal was then positioned on 
an incline board at a 45 degree angle with the head down in neutral position for 30 
minutes.   To minimize increases in intracranial pressure, a similar volume of cerebral 
spinal fluid was removed prior to the injection of blood.  Forty-eight hours later, the 
239 
 
above procedures were repeated.  Buprenophine (0.01 mg/kg) was given every 12 hours 
for 36 hours after each surgery as an analgesic.  Five days after the initial surgery, rabbits 
were euthanized by exsanguination under deep pentobarbital anesthesia (i.v.; 60 mg/kg), 
and posterior cerebral and cerebellar arteries (100-250 μm diameter) were dissected for in 
vitro studies in cold (4°C), oxygenated (20 % O2 / 5 % CO2 / 75 % N2) physiological 
saline solution (PSS) of the following composition (in mmol/L): 118.5 NaCl, 4.7 KCl, 24 
NaHCO3, 1.18 KH2PO4, 2.5 CaCl2, 1.2 MgCl2, 0.023 EDTA, 11 glucose.  Age-matched 
animals that did not undergo surgical procedures were used as controls.  All protocols 
were conducted in accordance with the guidelines for the care and use of laboratory 
animals [National Institutes of Health (NIH) publication No. 85-23] and followed 
protocols approved by the Institutional Animal Care and Use Committee of the 
University of Vermont.       
 
Electrophysiology  
Transient BK currents:  Arteries were enzymatically dissociated to obtain individual 
smooth muscle cells as described previously (Ishiguro et al 2005).  Transient BK currents 
were measured using the perforated whole-cell patch-clamp technique at room 
temperature (Wellman et al 2002).  The composition of the HEPES-PSS bath solution 
was (in mmol/L): 134 NaCl, 6 KCl, 1 MgCl2, 1.8 CaCl2, 10 glucose and 10 HEPES (pH 
7.4).  Patch pipettes (8-10 M) were filled with an internal solution that contained (in 
mmol/L) 110 K
+
 aspartate, 30 KCl, 10 NaCl, 1 MgCl2, 10 HEPES, 0.05 EGTA and 0.2 
amphotericin B (pH 7.2).  Transient outward currents were recorded over a range of 
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holding potentials from -40 mV to 0 mV (~5 min at each membrane potential).  
Recordings were analyzed with the Mini Analysis 6.0.3 program (Synaptosoft Inc.), to 
determine transient BK current amplitude, frequency, rise time (30-70 %) and decay time 
(90-10 %).  The threshold for current peak detection was set at two and half times the 
single channel amplitude of BK channel (e.g. 5.0 pA at -40 mV) (Perez et al 2001).   
Single channel BK current recordings:  BK single channel currents were recorded in 
excised inside-out membrane patches at room temperature (Perez et al 2001).  The bath 
and pipette solution contained (in mmol/L): 140 KCl, 1 MgCl2, 5 EGTA, 1.9 CaCl2 and 
10 HEPES (pH 7.2), with a calculated free Ca
2+
 concentration of 100 nmol/L (WinMax C 
software, http://www.stanford.edu/%7Ecpatton/maxc.html).  When CaCl2 was omitted 
from the bath solution (“zero” Ca2+), free Ca2+ concentration was calculated to be < 1 





- and voltage-sensitivity of BK channels were determined from Boltzman 
fit of data. 
Whole-cell voltage-dependent K
+
 current recordings:  Whole cell K
+
 currents were 
measured using the conventional whole cell configuration of the patch-clamp technique 
(Koide et al 2007).  The composition of bath solution was the same as the 6 mmol/L K
+
 
HEPES-PSS described above.  The internal solution contained (in mmol/L): 87 K
+
 
aspartate, 20 KCl, 1 CaCl2, 1 MgCl2, 10 HEPES, 10 EGTA and 25 KOH (pH 7.2).  From 
a holding potential of -70 mV, outward K
+
 currents were elicited by a series of 500 msec 
depolarizing voltage steps followed by a step to -40 mV for 300 msec.  Voltage steps 
were made at 10 mV increments to +50 mV at intervals of 10 sec from a holding 
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potential of -70 mV.  All electrophysiological studies were performed using Axopatch 




 spark measurements 
Freshly isolated cerebral artery myocytes were incubated with the fluorescent Ca
2+
 
indicator fluo-4 AM (10 µmol/L; Ex 488 nm, Em 520 nm; Invitrogen) and 0.036 % 
pluronic acid for 30 min at room temperature followed by a brief wash with HEPES-PSS.  
Ca
2+
 sparks were detected as previously described using a Noran Oz laser scanning 
confocal system coupled to an inverted Nikon TMD microscope equipped with a 60X 
water-immersion lens (N.A.1.2) (Perez et al 2001).  Images were acquired at a frequency 
of 58.3 Hz (approximately every 17.2 msec) for 20 sec at room temperature.  Fractional 
fluorescent changes (F/F0) were analyzed in 2.1 μm x 2.1 μm analysis areas using custom 
software (SparkAn, written by Dr. Adrian Bonev), and F/F0 changes > 1.3 defined as 
Ca
2+




RNA isolation and quantitative real-time RT- PCR 
Total RNA was extracted from posterior cerebral arteries (100-250 µm in diameter, ~1 
mg wet weight) using RNA STAT-60 (Tel-Test Inc.) and cDNA was synthesized by 
SuperScript
TM
 First-Strand Synthesis System (Invitrogen).  The primer sets were 
designed using Primer-BLAST (NIH) for a unique region of targeted mRNA sequence 
and are detailed in the online supplementary information (Table 1).  Expression of 
mRNA was quantified by real-time PCR using SYBR Green JumpStart Taq ReadyMix 
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and a real-time PCR system (Applied Biosystems).  Quantification was performed using 
standard curves constructed by amplification of serially diluted plasmids containing 
target genes, and the threshold cycle value for each sample used to calculate the initial 
quantity of cDNA template.  The results of quantitative real-time PCR were normalized 
to glyceraldehyde-3-phosphate dehydrogenase (GAPDH) expression. 
 
Western blotting 
Freshly isolated cerebral arteries were homogenized in buffer containing (in mmol/L): 
100 NaCl, 20 Tris-HCl (pH 7.4), 1 EDTA, 1 EGTA, 5 dithiothreitol, 1 
phenylmethylsulfonyl fluoride, 0.1 leupeptin and 1 % Triton-X using glass 
microgrinders.  After sonication for 10 min on iced water, tissue debris was removed by 
centrifugation (8000 x g, 5 min).  The protein concentration of lysate was measured by 
modified Bradford assay (Coomassie Plus; Pierce) using bovine serum albumin as a 
standard.  The lysate (20 µg of protein) was mixed with 5X loading buffer (625 mmol/L 
Tris-HCl; pH 6.8), 20 % SDS and 25 % glycerol), and incubated at 37 °C for 15 min.  
Proteins were separated using 4-20 % acrylamide gradient gels, and electrophoretically 
transferred to a nitrocellulose membrane.  After blocking the membrane with 5 % non-fat 
milk (1 hr at RT), the membrane was incubated with primary antibody at 4 °C over night.  
Following incubation with appropriate secondary antibody for 1 hr at RT, signals were 
detected by chemiluminescence for RYR-2 or by an Odyssey
®
 infrared imaging system 
(LI-COR
®
 Biosciences) for FKBP12.6 and α-smooth muscle actin.  Bands depicting each 
protein were analyzed using Image J software (NIH).  Antibodies were used as follows: 
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anti-RyR2 mouse monoclonal antibody (clone C3-33, 1:200; ABR), anti-FKBP12.6 goat 
polyclonal antibody (1:200, SantaCruz), anti-α smooth muscle actin mouse monoclonal 
antibody (1:100,000, Sigma), peroxydase conjugated sheep anti-mouse IgG (1:5,000, GE 
Healthcare), IRdye700
®
 conjugated donkey anti-goat IgG and IRdye800
®
 conjugated 
goat anti-mouse IgG (1:10,000, Rockland). 
 
Diameter measurements in isolated arteries  
Freshly isolated arteries from control and SAH rabbits were cannulated in a 5 ml 
myograph chamber (Living Systems Instrumentation, Inc.) and perfused with PSS (pH 
7.4) aerated with 20 % O2 / 5 % CO2 / 75 % N2 at 37˚C, as previously described (Ishiguro 
et al 2002).  Arterial diameter was measured with video edge detection equipment and 
recorded using data acquisition software (Dataq Instruments Inc.).  Arteries were 
discarded if an initial constriction representing less than a 50 % decrease in diameter was 
observed when arteries were exposed to elevated extracellular K
+
 (60 mmol/L).  Arterial 
constrictions to paxilline and ryanodine are expressed as a percent decrease in diameter 
from the basal level of pressure-induced myogenic tone at an intravascular pressure of 80 
mmHg.  Vasodilation to cumulative additions of acetylcholine (ACh) and sodium 
nitroprusside (SNP) are expressed as percent dilation of pressure-induced (myogenic) 
tone. Fully-dilated (passive) diameter was determined at the end of each experiment by 
exposing arteries to Ca
2+





Measurement of cytosolic Ca
2+
 in pressurized cerebral arteries  
Freshly isolated cerebral arteries were cannulated and loaded with the ratiometric Ca
2+
- 
sensitive fluorescent dye, fura-2 AM (5 µmol/L; Invitrogen), with  0.1 % pluronic acid 
for 45 min at room temperature.  To allow for equilibration and deesterification of fura-2 
AM, arteries were superfused with PSS at 37°C for 30 min.  Following the equilibration 
period, fluorescent ratio (R) was obtained from background corrected 510 nm emission 
from arterioles alternately excited at 340 and 380 nm using software developed by 
IonOptix Inc.  Cytosolic Ca
2+
 concentration was estimated using the following equation 
(Grynkiewicz et al 1985): [Ca
2+
] = Kd x ß x (R-Rmin)/(Rmax-R).  Calibration values were 
not significantly different between arteries from control and SAH animals and were 





-saturated conditions, respectively and were obtained from 
separate sets of arteries in the presence of ionomycin (10 μmol/L) and nigericin (5 
μmol/L).  The ratio of Ca2+-free over Ca2+-bound fluorescence intensities at F380, β (11.5 
± 0.70), was obtained from Rmin and Rmax measurements.  An apparent dissociation 
constant
 
(Kd) of 282 nM of fura-2 for Ca
2+ 
was used (Knot and Nelson 1998).  
   
Statistical Analysis 
Data are expressed as mean ± SEM, and analyzed by Student’s unpaired t-test or One-
way ANOVA followed by Tukey multiple comparison test.   Statistical significance was 





Transient BK channel currents are decreased following SAH. 
At physiological membrane potentials (e.g. -40 mV), micromolar increases in cytosolic 
Ca
2+
 are required to induce significant BK channel activation (Perez et al 2001).  In 
cerebral artery myocytes, sub-cellular Ca
2+
 signaling events (Ca
2+
 sparks) lead to 
localized elevations of Ca
2+
 sufficient to cause the transient activation of nearby BK 
channels.  Ca
2+
 spark-induced transient BK currents were recorded using the perforated 
patch whole-cell configuration of the patch clamp technique (Figure 1).  At -40 mV, 
transient BK current frequency, but not amplitude, was decreased by approximately 60 % 
in cerebral artery myocytes freshly isolated from SAH model rabbits.  Membrane 
potential depolarization increased the frequency and amplitude of transient BK currents 
to a similar extent in myocytes from both control and SAH animals, i.e. frequency was 
about 60 % lower at all voltages in cells from the SAH group.   Temporal characteristics 
of these events (rise time and decay time) were similar between groups, as was cell size 
as indexed by cell capacitance (online supplementary information, Table 2).  These data 
demonstrate a dramatic decrease in the frequency of Ca
2+
 spark-induced BK channel 
activity following experimental SAH.  
 
Maintained expression and properties of BK channels in cerebral artery myocytes 
following SAH. 
The apparent SAH-induced decrease in transient BK current frequency could conceivably 
reflect a fundamental change in the voltage or Ca
2+
 sensitivity, or expression of the BK 
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channel following SAH.   To address this issue, single BK channel currents were 
measured in excised “inside-out” membrane patches.  BK channel open-state probability 
(PO) and voltage-dependence with 100 nmol/L intracellular free Ca
2+
 were not altered 
following SAH and a similar right-ward shift in voltage-dependent activation was 
observed in BK channels from both groups exposed to intracellular solution containing < 
1 nmol/L free Ca
2+
 (Figure 2A, B).  Single channel slope conductance was similar for 
channels from control (231.7 ± 3.6 pS, n = 9) and SAH (231.6 ± 3.5 pS, n = 9) animals, 
consistent with previous reports for BK channels (Perez et al 2001).   Further, the density 
of functional BK channels detected in membrane patches was not different between 
groups (Figure 2C).  To view the ensemble behavior of BK channels across the 
membrane of the entire cell, voltage-dependent K
+
 currents were measured during 
depolarizing voltage steps using conventional whole-cell patch-clamp electrophysiology.  
Here, [Ca
2+
]i was maintained below 25 nmol/L by cell dialysis with 10 mmol/L of the 
Ca
2+
 chelator, EGTA, included in the intracellular (pipette) solution.  Ca
2+
 spark or RyR 
activation of BK currents does not occur using this approach and the amplitude of 
conventional whole-cell BK currents reflects plasma membrane BK channel density and 
their open-state probability at the applied voltage and [Ca
2+
]i. Steady-state outward 
currents sensitive to the BK channel blocker paxilline (1 mol/L, 10 min) were similar in 
myocytes from control and SAH animals (Figure 2D).  To confirm that expression of BK 
channel pore-forming α-subunits and regulatory β1-subunits are maintained in our SAH 
model, quantitative real-time PCR was performed on RNA extracted from intact cerebral 
arteries.  BK channel α and β1 subunit mRNA, expressed as a ratio to glyceraldehyde 3-
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phosphate dehydrogenase (GAPDH) mRNA, were not significantly different between 
control and SAH animals (Figure 2E, n = 6 for each group).  These data suggest that the 
SAH-induced decrease in the frequency of transient BK currents is not due to a decrease 




 spark frequency is decreased in SAH model animals. 
BK channel properties and expression appear unaltered in smooth muscle cells from 
cerebral arteries of SAH animals.  We therefore explored the possibility that the lower 
transient BK current frequency reflects a fundamental decrease in Ca
2+
 spark activity.  
Ca
2+
 sparks were optically measured in freshly isolated cerebral artery myocytes from 
control and SAH rabbits using laser scanning confocal microscopy and the fluorescent 
Ca
2+
 indicator, fluo-4.  Ca
2+
 sparks were observed in cells from both control and SAH 
animals (Figure 3A, also see movies included within the online supplementary data).  
However, as with the frequency of transient BK currents, whole cell Ca
2+
 spark 
frequency was dramatically lower (≈50 %) in myocytes isolated from SAH animals 
(SAH: 0.38 ± 0.04 Hz; Control: 0.76 ± 0.05 Hz, Figure 3B).  Although frequency was 
decreased, Ca
2+
 spark amplitude, expressed as a fractional change in fluorescence 
intensity (F/F0), was similar in myocytes isolated from control and SAH animals (Figure 
3C).  Other spatio-temporal characteristics such as rise-time, duration, size, and decay 
were similar for Ca
2+
 sparks recorded from myocytes of control and SAH animals (online 




A reduction in functional Ca
2+
 spark sites underlies decreased Ca
2+
 spark frequency 
in SAH model animals. 
In smooth muscle, Ca
2+
 sparks tend to occur repeatedly within a limited number of 
distinct areas, or spark sites (Janiak et al 2001; Pucovsky and Bolton 2006).  The SAH-
induced decrease in Ca
2+
 spark frequency could reflect either a reduction in the number 
of functional spark sites or a decrease in the frequency of events occurring at all spark 
sites throughout the cell.  Spark sites were defined as regions where one or more Ca
2+
 
sparks were observed during a 20 second imaging period (Figure 4A-C).  Two or more 
Ca
2+
 sparks were considered to originate from the same spark site if these events 
exhibited greater than 50 % overlap of their spatial spread (determined at 50 % peak 
amplitude).  In 45 cerebral artery myocytes from five control animals, a total of 1,082 
Ca
2+
 sparks were observed with an average of 7.9 ± 0.6 spark sites per cell.  However, in 
myocytes from SAH animals, the number of active spark sites was decreased by 
approximately 43 % to 4.5 ± 0.4 (n = 594 sparks in 48 cells from 6 animals, Figure 4D).  
Although the number of functional spark sites was decreased, Ca
2+
 spark frequency at 
individual sites was similar in cells isolated from control and SAH animals (Figure 4E).  
Further, the correlation between the number of functional spark sites and whole cell Ca
2+
 
spark frequency was similar between groups (Figure 4F).  These data suggest SAH-
induced decreased Ca
2+





RyR-2 expression is decreased and FKBP12.6 expression is increased in cerebral 
arteries from SAH animals. 
It is conceivable that the SAH-induced decrease in functional spark sites could reflect 
either an increase in the activation threshold of RyRs or decreased SR Ca
2+
 load.  To 
assess RyR activity, Ca
2+
 sparks were examined in the presence of a relatively low 
concentration (10 μmol/L) of the RyR activator, caffeine.  Caffeine lowers the luminal 
Ca
2+
 threshold for RyR activation (Kong et al 2008) and at micromolar concentrations 
causes an increase in both Ca
2+
 spark frequency and the number of active spark sites in 
smooth muscle (Janiak et al 2001; Wellman et al 2001).  In absolute terms, the number of 
active Ca
2+
 spark sites and whole-cell Ca
2+
 spark frequency in the presence of caffeine 
(10 μmol/L) remained decreased in myocytes isolated from SAH animals (Figure 5A-C; 
control n = 7 cells from 3 animals, SAH n = 14 cells from 3 animals).  However, on a 
relative basis, i.e. when expressed as a percent of basal activity, treatment with caffeine 
(10 μmol/L) increased the number of active spark sites by approximately 50 % in cerebral 
artery myocytes from both control and SAH animals.  Corresponding to the increase in 
the number of active spark sites, caffeine (10 μmol/L) also caused a similar percent 
increase in whole cell Ca
2+
 spark frequency in cerebral artery myocytes from both 
groups.  SR Ca
2+
 content was also examined in cerebral arteries isolated from control and 
SAH animals using the ratiometric fluorescent Ca
2+
-sensitive dye, fura-2.  Decreased SR 
Ca
2+
 content has been reported to decrease whole cell Ca
2+
 spark frequency and reduce 
the amplitude of individual Ca
2+
 sparks (ZhuGe et al 1999).  Rapid application of high 
concentrations (millimolar) of caffeine leads to a significant release of Ca
2+
 from the SR 
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through activation of RyRs.  The relative amplitude of these caffeine-induced global Ca
2+
 
transients has been used as an index of SR Ca
2+
 content (Santana et al 1997; Wellman et 
al 2001) .  The amplitudes of caffeine-induced global Ca
2+
 transients were not 
significantly different in cerebral arteries from control and SAH model animals (Figure 
5D).   Further, quantitative real-time PCR demonstrated that mRNA levels of the SR 
Ca
2+
-binding proteins calsequestrin-2 and calreticulin and the smooth muscle 
sarco/endoplasmic reticulum Ca
2+
-ATPase, SERCA-2 were not significantly different in 
arteries from control and SAH animals (Figure 5E; n = 6 for each group).  These data 
suggest RyR activation properties and SR Ca
2+
 load in myocytes from SAH animals are 
unaltered, and that increasing RyR activity does not restore the number of functional 
spark sites to control levels. 
The RyR-2 subtype is the dominantly expressed RyR isoform in arterial smooth 
muscle, and is thought to underlie Ca
2+
 spark activity in these cells (Ji et al 2004).  RyR-2 
activity is modulated by the FK506-binding protein, FKBP12.6, that stabilizes RyR-2 
channels in the closed state (Zalk et al 2007).   Conditional overexpression of FKBP12.6 
has been reported to decrease Ca
2+
 spark frequency in cardiac myocytes (Gellen et al 
2008).    Thus, decreased expression of RyR-2 or increased expression of FKBP12.6 may 
contribute to a reduction in Ca
2+
 spark activity following SAH.  To examine whether 
RyR-2 expression was decreased following SAH, quantitative real-time RT-PCR was 
performed on RNA extracted from intact cerebral arteries (Figure 6A).  When normalized 
to GAPDH, RyR-2 expression was decreased by approximately 65 % in cerebral arteries 
from SAH animals compared to controls (n = 6 for each group).  Protein levels of RyR-2, 
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detected by western blot, were also decreased by approximately 50 % in cerebral artery 
homogenates from SAH rabbits (Figure 6B, C; n = 4 for each group).  Interestingly, we 
also observed that FKBP12.6 mRNA expression was increased two-fold (n = 5) and 
protein levels were over four-fold greater (n = 4) in cerebral artery homogenate from 
SAH compared to control animals (Figure 6).  These data are consistent with decreased 
RyR-2 expression and increased FKBP12.6 expression contributing to a reduction in 
functional spark sites and decreased Ca
2+
 spark frequency in myocytes from SAH 
animals.   
 
Decreased RyR and BK channel activity contribute to enhanced cerebral artery 
constriction following SAH.  
At physiological intravascular pressures (e.g. 80 mmHg), constriction was greater in 
cerebral arteries isolated from SAH (34.7 ± 2.7 % decrease in diameter, n = 9) compared 
to control (18.5 ± 2.6 % decrease in diameter, n = 9) animals.  To examine whether SAH-
induced decreased Ca
2+
 spark and transient BK current activity contribute to enhanced 
cerebral artery constriction, arterial diameter measurements were made in the presence 
and absence of paxilline, a blocker of BK channels and ryanodine, a blocker of RyRs 
(Figure 7A-C and online supplementary information, Table 3).  At an intravascular 
pressure of 80 mmHg, paxilline (1 μmol/L) caused a robust constriction in arteries from 
control animals, decreasing diameter from 94.6 ± 10.2 µm to 78.4 ± 8.4 µm, or by 17.1 % 
(Figure 7B).  Thus, with arteries from control animals, BK channel block mimicked SAH 
to enhance constriction.  In contrast, paxilline did not significantly constrict arteries from 
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SAH animals (diameter prior to paxilline: 96.6 ± 8.1 µm; diameter in the presence of 
paxilline 95.5 ± 8.6 µm), consistent with SAH causing a decrease in Ca
2+
 spark-induced 
BK channel activity.    In a similar manner, the inhibitor of Ca
2+
 sparks, ryanodine (10 
μmol/L), caused a significantly greater constriction in arteries from control compared to 
SAH animals (Figure 7C).   Also consistent with SAH-induced decreased BK channel 
activity and enhanced vasoconstriction, global cytosolic Ca
2+
, measured using fura-2, was 
elevated in cerebral arteries from SAH animals (F340/F380: 1.18 ± 0.04; estimated Ca
2+
: 
222 ± 12 nM, n = 4) compared to control animals (F340/F380: 1.00 ± 0.07; estimated Ca
2+
: 
175 ± 12 nM, n = 4).  In contrast to the SAH-induced disruption of the Ca
2+
 spark/BK 
channel dilator pathway, dilations to the endothelial-dependent agonist, acetylcholine, 
and the endothelial-independent dilator, sodium nitroprusside, were similar in arteries 
from control and SAH animals (Figure 7D, E).  These data are consistent with decreased 
Ca
2+
 spark-induced BK channel activity contributing to enhanced constriction of cerebral 
arteries from SAH animals.   
 
Discussion 
Here, we provide evidence that a reduction in subcellular Ca
2+
 release events (i.e. Ca
2+
 
sparks) underlies decreased BK channel activity and enhanced cerebral artery constriction 
following SAH.  The following observations support this concept: 1) cell-wide Ca
2+
 
spark frequency is decreased in cerebral artery myocytes from SAH animals, reflecting a 
decrease in active Ca
2+
 spark discharge sites; 2)  mRNA and protein levels of RyR-2, the 
SR Ca
2+
 release channel responsible for Ca
2+
 sparks in smooth muscle, is reduced in 
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cerebral artery myocytes following SAH; 3) mRNA and protein levels of the RyR-2 
stabilizing protein, FKBP12.6, is increased in cerebral arteries from SAH animals; 4) the 
frequency of Ca
2+
 spark-induced transient BK currents is decreased in cerebral artery 
myocytes from SAH animals, with no change in BK channel properties, whole-cell BK 
currents or BK subunit expression; 5) constriction caused by inhibitors of Ca
2+
 sparks 
(ryanodine) or BK channels (paxilline) is decreased in cerebral arteries from SAH 
animals.  Together, these data suggest that SAH-induced decreased Ca
2+
 spark frequency 
and the resulting decrease in transient BK channel activity promotes membrane potential 
depolarization, enhanced Ca
2+
 influx via VDCCs and cerebral artery constriction.   
  To our knowledge, these findings represent the first demonstration of a vascular 
pathology due to a decrease in Ca
2+
 spark frequency.  Although altered frequency of Ca
2+
 
spark-induced transient BK currents has been reported in other cardiovascular diseases 
such as hypertension and hypovolemic shock, these phenomena have been attributed to 
altered BK channel function/expression.  Enhanced constriction associated with 
hypertension and diabetes has been linked to decreased expression of the BK channel β1 
subunit (Amberg and Santana 2003; Brenner et al 2000; Dong et al 2008) while an acute 
upregulation of BK channel β1 subunit contributes to vasodilation and the drop in 
peripheral resistance associated with hemorrhagic shock (Zhao et al 2007).  In the above 
pathologies, Ca
2+
 spark activity was unaltered.  In marked contrast, we observed a 
parallel decrease in the frequency of Ca
2+
 sparks and Ca
2+
 spark-induced transient BK 
currents following SAH.  Notably, experimental SAH did not directly alter BK channel 
properties or expression.  Our observed lack of direct effect of SAH on BK channels in 
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pial arteries obtained from SAH model rabbits is consistent with observations using 
basilar artery myocytes obtained from a dog SAH model (Jahromi et al 2008b).   
We found that the overall decrease in Ca
2+
 spark frequency in myocytes from 
SAH animals reflected a decrease in the number of functional spark sites.  Both the 
number of functional spark sites and whole cell Ca
2+
 spark frequency were reduced by 
approximately 50 % in myocytes following SAH.  Although the RyR activator, caffeine 
(10 μmol/L), caused proportionately the same increase in the number of functional spark 
sites and Ca
2+
 spark frequency in myocytes from control and SAH animals, both 
parameters remained approximately 50 % lower in SAH animals.  Spark sites within 
arterial myocytes are comprised of a variable number of RyRs, and functional spark sites 




 release and Ca
2+
 
sparks to occur (Janiak et al 2001; Pucovsky and Bolton 2006).  Using quantitative real-
time PCR and western blot, we observed a significant reduction in mRNA and protein 
levels of RyR-2 in cerebral arteries following SAH.  A decrease in RyR-2 expression has 
been previously reported in cardiac myocytes following heart failure (Go et al 1995) and 
in vascular smooth muscle undergoing phenotypic changes during cell culture (Berra-
Romani et al 2008).  It is conceivable that the SAH-induced decreased RyR-2 expression 
caused some, but not all, spark sites to no longer have the threshold number of RyRs 
required for Ca
2+
 spark initiation.   
In addition to decreased RyR-2 expression, increases in the relative expression of 
proteins that reduce RyR-2 activity may also contribute to the observed decrease in the 
number of functional Ca
2+
 spark sites.  For example, we observed increased mRNA and 
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protein levels of the RyR-2 regulatory protein, FKBP12.6.  Binding of FKBP12.6 
stabilizes RyR-2 in the closed state (Zalk et al 2007).  Ablation of the gene encoding 
FKBP12.6 has been reported to increase Ca
2+
 spark frequency in smooth muscle (Ji et al 
2004) and conversely, conditional overexpression of FKBP12.6 has been linked to 
decreased Ca
2+
 spark frequency in cardiac myocytes (Gellen et al 2008).  Our current 
data suggest that increased FKBP12.6 expression acting in concert with decreased RyR-2 
expression underlie the decrease in active Ca
2+
 sparks in cerebral artery myocytes from 
SAH model animals.  Based on the present study, the relative contribution of decreased 
RyR-2 expression versus increased FKBP12.6 expression to the observed SAH-induced 
reduction in Ca
2+
 spark activity is unclear.   
Decreased SR Ca
2+
 content has also been linked to decreased Ca
2+
 spark 
frequency and amplitude in smooth muscle (ZhuGe et al 1999), thus, reduced SR Ca
2+
 
could potentially contribute to decreased Ca
2+
 spark frequency following SAH.  
However, our data argue against this possibility.  First, we observed no difference in the 
amplitude of global Ca
2+
 transients induced by rapid application of a high concentration 
(10 mmol/L) of caffeine following SAH.  Secondly, we observed a reduction in the 
number of functional Ca
2+





 spark amplitude was similar in myocytes from control and SAH 
animals.  Further, mRNA levels of SR-Ca
2+
-ATPase (SERCA-2) and the SR Ca
2+
 binding 
proteins, calsequestrin-2 and calreticulin, were similar in cerebral arteries from control 
and SAH animals.  It is possible that additional factors such as RyR-2 phosphorylation 
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(Zalk et al 2007) could contribute to a reduction in functional Ca
2+
 spark sites in cerebral 
artery myocytes following SAH.   
The present work may help to explain the impact of SAH leading to enhanced 
constriction of small diameter cerebral arteries and decreased cerebral blood flow.  We 
have previously reported an increase in VDCC current density, in part due to the 
emergence of R-type VDCCs encoded by the gene CaV2.3, in cerebral artery myocytes 
from SAH model rabbits (Ishiguro et al 2005).  Membrane potential depolarization 
caused by a decrease in Ca
2+
 spark-induced transient BK currents would be predicted to 
cause an increase in the open-state probability of VDCCs and combined with enhanced 
VDCC expression would increase global cytosolic Ca
2+
 leading to enhanced contraction 
of cerebral artery myocytes.  Additional mechanisms such as decreased voltage-
dependent potassium (KV) channel expression (Jahromi et al 2008a) and activity 
(Ishiguro et al 2006; Koide et al 2007; Quan and Sobey 2000) and increased protein 
kinase C activity (Nishizawa et al 2000) are also likely to contribute to enhanced cerebral 
artery constriction following SAH. 
  In conclusion, we report that the frequency of Ca
2+
 sparks and associated 
transient BK currents were significantly decreased in cerebral artery myocytes following 
SAH, contributing to enhanced vasoconstriction.  Our findings suggest this SAH-induced 
decrease in Ca
2+
 spark frequency results from a reduction in RyR-2 expression and 
increased FKBP12.6 expression leading to a decrease in the number of functional spark 
sites within these myocytes.  This mechanism may contribute to a reduction in cerebral 
blood flow and the development of neurological deficits experienced by patients 
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following cerebral aneurysm rupture.   Further, this mechanism of decreased vascular BK 
channel activity may also contribute to other types of brain pathologies, including 
traumatic brain injury. 
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Figure 1: Decreased frequency of transient outward BK currents in cerebral artery 
myocytes from SAH model rabbits.  (A) Representative traces of transient BK currents 
in cerebral artery myocytes from control and SAH rabbits.  Holding potential was 
changed in 10 mV increments every ~5 min.  (B) Expanded traces are from the region 
denoted by black bars in panel A.  (C) Average traces were obtained from all events at -
40 mV shown in panel A (control: 52 events, SAH: 18 events).  (D, E) Summarized data 
of transient BK current frequency and amplitude, respectively.  Control: n = 9 cells from 
6 animals; SAH: n = 8 from 6 animals.  * p < 0.05, ** p < 0.01      
  
Figure 2: Maintained expression and properties of BK channels in cerebral artery 
myocytes following SAH.  (A) Representative BK single channel recordings from 
inside-out membrane patches in the presence of 10
-7
 mol/L free Ca
2+
.  Closed state (C) 
and individual channel open states (O1-O5) are included in each record.  (B) Ca
2+
- and 
voltage-sensitivity of BK channels in control (n = 6-16 patches from 4 animals) and SAH 
myocytes (n = 12-19 patches from 4 animals).  Free Ca
2+
 concentration calculated for the 
“Zero” Ca2+ solution was < 1 nmol/L.  Open-state probability curves were obtained from 
Boltzman fit of data.  (C)  BK channel densities shown as channel number per patch at 
+80 mV in control (n = 25) and SAH cerebral myocytes (n = 27).  NS: p > 0.05.  (D) 
Current-voltage relationship of paxilline-sensitive currents in myocytes from control 
(open circles, n = 5) and SAH rabbits (closed circles, n = 6).  (E)  Summary of 
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quantitative real-time PCR for α and β1 subunits of the BK channel, normalized to 
GAPDH. 
 
Figure 3: Decreased Ca
2+
 spark frequency, but not amplitude, in cerebral artery 
myocytes from SAH animals.  (A) Representative Ca
2+
 spark images and fractional 
fluorescent traces from cerebral artery myocytes isolated from control and SAH rabbits.  
Gray scale images are an average of 30 images without Ca
2+
 spark activity (F0 image).  
Red crosses depict where individual Ca
2+
 sparks occurred during the 20 second 
recordings.  Pseudo-color images illustrate Ca
2+
 sparks in control and SAH myocytes.  
Fractional fluorescent (F/F0) records are from 2.1 μm x 2.1 μm analysis areas (white 
boxes in first enlarged images) centered over Ca
2+
 sparks.  White bars represent 10 µm.  
(B, C) Summarized data of whole cell frequency and amplitude, respectively, of Ca
2+
 
sparks in cerebral artery myocytes (control: n = 45  cells from 5 animals, SAH: n = 48 
cells from 6 animals).  ** p < 0.01 
 
Figure 4: Decreased functional Ca
2+
 spark sites in cerebral artery myocytes from 
SAH animals.  (A) Gray scale images are an average of 30 images without Ca
2+
 spark 
activity (F0 image) with red crosses depicting the location of individual Ca
2+
 sparks 
during 20 sec recordings. White boxes on pseudo-color images depict distinct spark sites 
within each cell. (B) Numbered images depict individual spark sites within each cell.  (C)  
Corresponding fractional fluorescent (F/F0) traces from spark sites shown in panel B.  
Arrows indicate Ca
2+
 sparks accounted to each site.  (D) Summarized data of the number 
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of spark sites observed in each cell.  (E) Average Ca
2+
 spark frequency in individual 
spark sites.  (F)  Relationship between the number of spark sites in individual cells and 
whole cell Ca
2+
 spark frequency.  Solid lines with symbol color (control: gray, SAH: 
black) represent linear regression analysis of data.  Data was obtained from 1082 sparks 
from 355 spark sites in 45 cells from 5 control animals and 594 sparks from 217 spark 
sites in 48 cells from 6 SAH animals. ** p < 0.01 
 
Figure 5: RyR activation properties and SR Ca
2+
 load in cerebral arteries from SAH 
animals.   (A-C): The RyR activator, caffeine (10 µmol/L), did not restore the number of 
functional spark sites or whole cell Ca
2+
 spark frequency in cerebral artery myocytes 
from SAH animals to control levels.  (A)  Average of 30 consecutive images without 
Ca
2+
 spark activity, with white crosses depicting the location of Ca
2+
 sparks observed 
during 20 sec recordings in the absence and presence  (+Caffeine) of caffeine.  White 
bars represent 10 µm.  (B, C)  Summary of the effect of caffeine on the number of 
functional spark sites per cell (B) and whole cell Ca
2+
 spark frequency (C).  Control: n = 
7 cells from 3 animals, SAH: n = 14 cells from 3 animals.    * p<0.05, ** p<0.01 control 
vs SAH.  (D)  Estimated Ca
2+
 content in sarcoplasmic reticulum (SR) of cerebral arteries 
from control and SAH animals.  The amplitude of global cytosolic Ca
2+
 transients 
induced by rapid application of a high concentration of caffeine (10 mmol/L) was not 
significantly different between groups (control: n = 4, SAH: n = 3).  (E) Summarized data 





ATPase (SERCA-2), calsequestrin-2, and calreticulin expressed as a ratio to GAPDH (n 
= 6 for each group).  ** p < 0.01 
 
Figure 6: Decreased expression of ryanodine receptor-2 (RyR-2) and increased 
expression of FKBP12.6 in cerebral arteries from SAH animals.  (A)  Summarized 
quantitative real-time PCR data for RyR-2 (n = 6) and FKBP12.6 (n = 5).  ** p < 0.01  
(B) Immunoreactive bands corresponding to RyR-2, FKBP12.6 and α-smooth muscle 
actin in cerebral arteries detected by western blot. (C) Summarized RyR-2 and FKBP12.6 
protein levels expressed as a ratio to α-smooth muscle actin (n = 4 for each groups). * p < 
0.05  
 
Figure 7:  Inhibitors of Ca
2+
 sparks and BK channels constrict cerebral arteries 
from control, but not SAH model animals.  (A) Diameter recordings of pressurized (80 
mmHg) cerebral arteries from control (left) and SAH (right) animals treated with the BK 
channel blocker paxilline (1 µmol/L).  Maximum dilation was obtained using a 
combination of diltiazem (100 μM) and forskolin (1μM) in Ca2+-free physiological saline 
solution.  (B, C)  Summarized data of constriction caused by paxilline (B, n = 5) or 
ryanodine (C, n = 4), expressed as a percent decrease in diameter, of pressurized arteries 
isolated from control and SAH animals.   (D) Vasodilation to cumulative additions of 
acetylcholine (ACh) are expressed as percent dilation of pressure-induced (myogenic) 
tone.  Data expressed as mean ± SEM; n = 7 control, n = 5 SAH.  (E)  Vasodilation to 
cumulative additions of sodium nitroprusside (SNP) are expressed as percent dilation of 
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pressure-induced (myogenic) tone.  Data are expressed as mean ± SEM; n = 4 control, n 




Figure 1: Decreased frequency of transient outward BK currents in cerebral 































Figure 3: Decreased Ca
2+
 spark frequency, but not amplitude, in cerebral artery 
myocytes from SAH animals. 
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Figure 4: Decreased functional Ca
2+













Figure 5: RyR activation properties and SR Ca
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Figure 6: Decreased expression of ryanodine receptor-2 (RyR-2) and increased 




Figure 7: Inhibitors of Ca
2+
 sparks and BK channels constrict cerebral arteries from 
control, but not SAH model animals.
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Appendix C: Table 2: Transient BK current and Ca
2+






Appendix C: Table 3: Arterial diameter measurements. 
